var title_f26_36_27200="TLR pathway anal";
var content_f26_36_27200=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F53498&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F53498&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Assessment of TLR4 pathway by flow cytometry",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 440px; height: 304px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal individuals show induction of TNF-&alpha; in monocytes upon LPS stimulation. Individuals with IRAK-4 deficiency do not show optimal TNF-&alpha; expression.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_36_27200=[""].join("\n");
var outline_f26_36_27200=null;
var title_f26_36_27201="Angular cheilitis";
var content_f26_36_27201=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F55357&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F55357&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Angular cheilitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFEAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD1pmGCCCxxgVRnO0YHKjpg1POV+dXAz9aq3ByM4+UknPqa5D1TPncCRV5G2qDYUkjOPf8ASr9wq7N5I35LYz2rMmYlm+bjGTigtakMsgMf3gvBwPeqE/MeMnHerEuXPuenvVaUbspntk8UjRCpwgwcgn86bM4UEBu2M4pPmEZQnAB6+tRq3A59uaCt2PUhU+ZuRjk04EAe+eKhZt3O7B6c1IjEpxzipVtikiRX7g9OpqWIsTjBx1qqqs0gyBt9RV6IL15OBSRtaxOgOeDUkTqOCAMHrUYfhQcgDpUblonbJDAnJ+lOzQKNzVV8L0qaKQqcAE+tUfN3wqRwVPzH2qeaf92GwAWOBitOQXIWLe527nO4YpZdS3XMYGBu71UjkLxqqAZXgmkEcXmbScMP4qajYtQV9S/fXRJjUHkVAJClyAkmcjJyKzr2RiyPuJZDjGOKbE7fad78DpgGmy40vdNWaQ7wSOf51DNdt8hDMp96juJmBVlUlcYXNQyyyunzKoKnmnYcYGrFcHyiZFyM+tWor8hhtXj1zWGjrJESzN0p9rcLlEU4470ridFG/HqDBiWPfpV1LtSwBQjPpXPKA8qtnOW9eBWr5piuFO07V6cU1qc9SmlojYSRPJYswB9DSxCNxkHOewNYEkjtI5Zh1zg8VLZXKyOVwybTxz1oaRk6Olzba3cfNj5AOaj8sBcgj8qYb5FVkkmIGO9Ri8t3VmDZAHajlRmoyQ4gA5Vsc+tTyofLUhhuAzWQb+NiQoAP61XuLtQinzyGPaiyNFRk2aMjBGJLcdTSmZSRsI2nisYahEIpfNUltvBJqk2pFLZMK/PPFLlSNfq7Z0nmbclfTtWfNd/PgnBPcVkNqs20EE89apyXbNcAbsc9aXQuGGaepsXF2qycnPtQLlTFH8xO4/lWK9yn2pcHcAOakjvojIEU/MD1NFi3R00RuHa74wCfSquooYoi6gtgZxVSK9LXO8HC+lXpLhJIH3YwOtTy30OedOUTnrgCdVZVwT2ogB+6SQRUk4CyJgc9eKVDk5XvUONjVJ8uoroApySMc5NQzfcz/ATzVlgWB9/Wq0wUhgfXPpTWpi1YpgYc/jUcnQjHPYimh8SEADikl3GRSOh9qQcrEZfk9/eo2JL7c84HFOkbJPJOfakflcnqOntTJY1s87Tn29KiD7W29cc4qQZ25JAamOcEk8c4FMQkX3lbJ4q0OQRkEDoaqZztVTjip4RtVcdzyKBEWGLYzt561bjJLEdx6d6DENhbioIZeTnPP6UAemXBL4yOc5PFV7hwIhjI9Pap5S4kJ3fdHFV7oGTJYfL3Pv1NCMDMuVGzcxJJOOBVG4dsqq4GBtBNaN0q5Vskjntis2VGPzNwOtOxaZHdRlCoB3kAYNVXUhlOzAbnAParjrhhnnPvxiq0023GDjgge1A03sVLskABMZPaosAqNwwTTGOXBPKjvTmwTnPHNJm0VYdGiksGBJNSwqdvyjNES/XsasAAfJnBxkCpSNooaBhhtXA9qsgrHH97HfpVMzhecdDTUlSTczHNaxjZGqi3uae7fCxznB7DtUbpujLdWXjHqKqo0mAqkBR3HepLeUkkNgAHIzTskaKFiaKWQrkdO/t7VYil862KOdpPINZ00hR1lXHzEgqKtRjIymQMZI7ii5coLcsxfJHEH4JPLA8mmXE/Owr071DK4O0qfmzzmkkcygq2M+oouTy9S7JhrIrgh+Cfeq3EqfKvQURHbMokzjGOaYZGDSIoAA4yRjii44xexdgmUghzjj5QRVWSRnRsffyQc062eOUokhKleN1TahCqDfGVYdCR1p20BWUrFZXVF5yrN2NLJJGsyFQxYDnNRSkCRVkA5HWmsmWEkedmMYPepsa2W5dhmWR8ZCHrnPFaEOpMFw7IQD2rnLxjFJHsQL7nvUElxuk2sQPXPFPYl0lM7R9StpAY3iLf7QqpHiSb9zMUZecMa5wXhRdwbBXjg9asQ3e5t2xjnkmqumR9X5VobsWoF5ZEnGccdOpptzqKIQqIIjjoe9ZVxqBJPl42nHbBFMknIuI2lYv8uQSKLgqSerReN2kb5ILEn71Q3d0spKEYI/izWfdXQlHDcegHWqvnsufMyT2FTexrGkt2aStiMozgnPBp095+7KMQCBVBnYwgOQN3pWZd+Ys6kOzKeSc0r2NFTUnqXvtO6TIUlevWq5kM0xZwwA6D3pWkxF0UHHA60+FAUBdtrEZAPek9SlaI+3nZZ2YbWGMcjpToVWSTdzkc4qOIkKdoB5wR61Z/1YYoQoPJNMiT7EczsZNoOCDxzT5rqR4goyuepz1qAk53OCMng+tRSXAaQhT0GKCHG5ct5CxLluAOpqaObO3BOW7ms0uQmZPwxUgnzGCcY6+4osjKUDXEgyQh6etMmCqrZIyR+VZ32xfMADfLjnPenXdwxACgZznNS12MJUuhTuspOMdP504OScH9RUZDPIXPO3mpoYzIPmH4Vkk+YmUbIrlyoOTjtSI+cr29qfNFhyPTk1Acg8AAihXRk4pjpGIfH8PfNMkGRjt1qNmIKk9PT1prSHd6irM7FpFz93+HqfakUnzcrk7TnNQxyEYx9KnjYFCB8pFPcnYu2/znBGM8fU1Olj5kqhc4JwPciq0AULzwR90e9bNm+1AcYIPBoREnY6t5RuCH5eOpNQSsWYqDk8/nUsyqJBnGDz6VWZ1Vsk5kILHjpVbGZSnB2lmI5H6E1UuCfLOV/pVxx86MeRgZA7VBfsZYtyqQMdOmKYIzXlG3A4/HpxWbcuX/ALvXjAxgVemQAZJC4GPc8VmSMQhBGAe/rUm8EMVsMcd+asJgvgcjGKpxHLZXHNXbECN8yc/SpszdItou0cnHvWdfXAjKkE7wMcVank2qcPyP0rD8xpbgkD29Ku1jroQuWFlySWbGeTT0kySACFB596qMGYEYx6ZqxA/l7RnJ7/WjmOrkSVzSWTZCvPSlkf8Au/d9c9aiRQ+exxyM9aa7bV47cUrkxSuWSd4B6YPrV2OVgNny88ZrCE5UruyFzVyK4BztyRjrQE4mpJIpBWRASBwe9VhuyrFeB6moGuBn5cn6037UUVtxAA5xRclI0lnAfJTPeo2OZGaQHntWUmpKjnI+X1p66ipkPzCjmDkaNqHYVGDwf0oWJDu3NkHtmsuO9Qc71FOF3HgEsOearmRHKye9QQvFlsoTgU+RtuwZ+X0qndXMZiU7gSDSSTqycfrTuh62VyO8nPmqAwPp7VDOZTHgqrc53VVunJdaf9pKYOcVHMjZOyViy6KY85Ab+715qzb27+WhDEhh0FZEt5kfL1HWoBfTbSBKQOuKh1Ehe80dE9tJBCrsAIj3JyagW9QyEZJHaslJnaAAFmPXG6qkl0wbHQ9/ej2yCMb7nT7rVtjecoPp6VVvJFeXKMWAH51z/msygjuKsJKSoUkn05oVW71GouL3NGMkABeePWlCKch+R16VXiGVyCR+NT+coQhm46VotQc+xEqkttAzzjJqy8Y25ZssBkYrOmmYzDaflz1oe4ff0Bx3pXRWrLizvEq5x1p8bGRDtz14qpExbJc8dhmpkJWTI/KncmTLs0pMSo7EsBWdsYS/uycEdTU5lGBxkmoJmJGeSc9MUPYmD5SSOaVmBbIUdfehmy5Kg7R+tQhtzck4xzg8Ukk4I2gAKO/vSuO13cmAVmB/iWmMzoplZifaiFlCEnndTJiZSFQg7ev0qkyGtQjn2W+5mzmrlpcKyblPLelYN0P3ZRT7kZ6VNDL5ManBbHv0pJmc6Stc2rrG0HJ5PWq8q4QZyTiqbXyvJtHy4GRntV9cNFuIwWGRipdmzlnBxRmsx4HO2mq5xxng1LcwMvzdutVvuhgeTj1qOuplYtKSQvHXp71NExUjA5PNVI5CyhT1FWQPmUx8EYyKtGbLqDdKNgPtW1G4YKrcqq5Bx+dYlqCCTnJ68GtS0dW3A8ALwD6UGbO1dBuMrcqD39KqM3zklcg5GauyD7xJOfTFU364BJwR+NOxmU24ZwxONwwB1NRXQZIRvXZgHHtV/arBTgDPJ9qp6iAQEzkdBjvVdBJ3ZhXrBV3ldznkH2+lZXm5BJ6j8qv6q3lBg4+bGAR2rKXLJ6nFRJ9DqprQdAvz5z0NWnbywwJ56j2qGIeUhx39elVLp2ZJNxwQOD2+lUlpc66cbkrSqXJYkqRioBGpmGM4PSqscrsBxuAOKsI5yOwFDZ2xjbYnyAxRDyfXtTlUbcFQD3Iqtv8A3odcAdD9ac10qDcT7GpKehdWQL1I4qGe4X2z15rKutTC8RvgetUI2lvJQEzk8VDl0QWS96WhqXN2itwcmoo71l4QkA+laekeFzcYa4kPuK7DT/DFlCoHlBsdzzVKEpanLVx9KnotThILi4d9qRvIDwMDPNWVsdSkJJtpcY6Fa9TstJghI2RIv0HStD7EEUA459RT9i+pxSzSz92J44dE1RkkcQlUAy2TUdvod+7BgAMgdDXrV3bqIZl45Uis6xt1ZQQBkdOKiULOyGszm1exxNv4a1GY5wFHoTVxfB9+wOJ4+Oea9EtLcDAGOK0LeFSeVBI9auNG+5hPMqvQ8vi8HaiyMWePaPU1PH4SvXX57hB6d69QMACbMADr9ajjtVz0xz3qlTJ/tGqzzeLwXK7hTcZJ9BVxvAMSBQ1585OBn19K9FitwgJACk8A+lW4beNguUywOQSKapdzKWPrdGeUyeBUjJ3SyH36VFP4Ot44mIZzxnrXrGo2YCkkcEViXNuChAH0odKy0BY2q92eZaF4fS6WUM7LtdlGPStAeCYclvMY89xXV6PZrGJRtxlyc1twWm51VVyx4FZ0ad46mlTGVFJ8rPOpvAUjIGtpEGex4rGn8JahESo2nB9a90ls/JtQzDr8tZVxZo6llH1pzp2V0KGYVVuzxj+wtSiVsxkkehqvJp1/hg0EuR7V68Lfa4OKYIfLJYoCemCKzUWdCzCS3R4jLY6gjbjaynHtUTS3UefMiYfVele1PZq2eBiqV1p0ZGSg59qpQbNVmj6xPHv7SZABjGD1NOTVkBAY4PevQdQ0aCQHdDH0/u1l2Phuxn8zdbqW3Yz0xSs07Gyx9Nq7Rzi6hE5ySMVIt5vLYYAYwTXUt4J05+RG6NjsayNU8EyRoWspmPqrcVpyzSHHG0ZO17GQtwN23cCPbvTiwwCCM+lZ13pGo2bZZGOPSs5r24R8OMeuajmtujrhKMvhZ0a3G4lVwT0xTgSCSCNzdcVjWtzkDL8nmrXm4PytxQmaWJ51zu/vHvUXKxYUkEfjUkMuIio5z6ioZdwbjkE5NVewrX3IUkYPhT35JrXt7xG4LdOlY0m3kLkEntR5ghKjBzRcyqQUjoriZXjAyM4/Ks2XrgcE0WzggcksecYp84DYbGG9al3e5wyjyuw2LKD5B096vQNgoecEgZPaqUK7mbn6Cr0IwoDDKnnrTic87F5IyHOAAxPPPQ+v0q5aK27JXJP8qqQ8x5PJXH5Vfg3LtYgn2HH61VtTJnaPvbagOcDHNQMMPtBA4yfrUqbgQzA9uahk2mZMEHOfzoM/IQfdYnGcY/HNZ11vD7SevI//AF1pshXOPmOOlU7mMlRxx2z61TJW5yWtExgA5OTn2FZqTR8Icbg3J/pW3q0azI6LyEPH/wCusE2wWchgSP8AOKh73O6C5omvHHGIS2eQO/esa8VQWx90nBGc1dmkVVC7jjrWVKQ0oIbKjOB0rVnVQi1uPhAAIzx1pXYIM9ARjr0qBW+Y7e1JJtKck/jUM61o7sjnnAUhe9Z8963+rTLNTbu52ZVDz0qz4ftJLmYjdsRyFd/aoUXN8oVqypR5mbvgPwpJ4l1SK3bJz8ztj5UUdfxrQl0mPTdfubSJf3cUhQeor0zQbA+FfDV/d20nmyMqtE23aVDcBv8A61eZXl6qap5ly5aWUlmJPf1NdapJRPBeKnXqN30Or0yJRtya6C3XtkflXO6ZcRzxq0Lq477TnFdBbngZBppXOWbZqwqpHXj1q9DbtNavIozs6mspJNwwCRWvpF6LeR1fPlyLtbNO1zBmPexFlYdyCM1laXJHJCpRwyqShI55FbGtzw2VlcXEsgSGJSxYnjArxn4M+I5tQ1bWbOXBjeVrmM/U8/0rnnG0rm1PWLPaYccbfxrTso1JXeCxbhVrJgPy8ZyOuK2tIeNbgSSEbkGVJ9a2S0MWya4g8l/mB9Ae1JZWxuZMKp2dz6VqXsbSLEZGyxUk+gpmgSqqvEfvE5FKxN9Bt1ZOkHyDKrzz1q5pkKm0XcvJJq8QDlT37VHhYjncqqO1FiXK6ItQiQ2UgI6DIrjbhQK7O/kRbSbLDIX8q4yZgxAzVWuODKlmDlyB3Pet3RojJeR9fl5rGjGwHkEHmun8NhY4JJXIHbk9KiMbIubLGsFTHHET8/WsSRSGKmtDUZ453Ro2BkZ9o56Cqt0m1ysfzAdTRJXFEzZYucnrUDRjkYNWXbrgjiq8kqjvknrWSiaXIJUCjgEVUlAwT1/CrUzgdOaruwOQOa0SsFzIu064/Cq3h1IpUleMhsSMpI9Qeam1e7jsrW5uZmAjhRmYntxXAfAzxPHqS6rYTMBc/aGuYwTyyMefy/rRZcyL5nynrcVupYL1/CoL+IZ2AYxWxpiRSXR81wqIhc+5Hasq8bczN610WME3c5rUrNX3ZGfr3rhdf0VJN7RKocdvWvSLsDBJNcrq3G88H3rCcE9zuw9WUXdHk9xuhmZArBk6rUtrfBTyePTNddpsMaaitxJEkoDZKt/EPSsbxRpCSXk91p8It1ZiyxD7qj0FYyw7UeZHrUsenLkmEdxuGc59BUgmJUg9DXNQXLRna2dw4x0rTjugwHX86yUu56CaZbdsONvbtQMuSHJA7GoA25gcjH86mcgjqe3NUmKS6FmxkZZduQe2fatGQBzlcisWFmDjPRTx71r2kgkT0b+tUtdDjrQ6k1uCpyfyq7BIvmBAOmCD7VXCnblTg+lSQL8x5OMcfX0pL3XY4Zq5pQR8BQcZbmr+dqgJwMjp+tZ1nKzzshI24yvvxWuIcpwcBhgdqpaq6MXo9Tp7g/MgU7iASRmkTaGJIyw9OgpjlA64HJwBUsQTDY64yM0kZtaDQQrNnJByf0rOvS43c9Rxz09q1NowuQCcf0rMlHmluFIxg9qdwjuZci+YTgbUJ3fpWHdgLL82QCcV0gGCu3rg9qp31qJYi5B3DqR2HrSszsouz1OWvFCkj+dZu5Q5yfvdM1q3gCoTuxjjp1rJlQyA+WMkU27bHp00rDWmKk4LY+lULi4IJxkevvU8sjKmCTmsTUrhhx07VlJmuxHJKZZ1UE8nFdTp+pm3tVhht1BU/wCsJ5rkrCGZwJcfL2NdNpunvOil5Mr6DvW9FSjqjycTVjN69Dfl8Q63qMC2rXUzxKABHv4AHT8qrPZsIyZWLydST/IVvaZaRLAFSMKo7AVS8T3MWmaXc3ErABFOPc10+ztG8jz/AGivaKseR3fizVNC8S3T6TctGgIUoeVYj1FdNpnxp1qLAurO1nHqMqa8umLTTvI/3nYsfxqWGI5HrWCdtjOzk7nu+mfG22Kr9r0qdW7+W4I/Wtk/GbSPILLY3hbspx/OvAIYDgZFaKW25VLHAI6UKTNFRT1aOp8dfEDUvFcZtkAtbAHPkofvf7x71W+GWpQ6H4ljnupPLt5AY3bsvvWQtsqcD05pDArPjGcVMrvc2jTWyPqTTdb0+6UfZ723kJ6bXGa2La7RWDB1PtmvkuK3ZAGRmXHocVbS4vUIAvZ09CJDTU5IiWDvsz60OqsFw0wKDoCelQWur2ouAWnXPfa4zXylLfagylZL+5ZTxzIcVVR5twKzyq3qHNNykzP6pbdn23HrNlHD+7kd3PUkZNZc+s5lChW8rPfqfevkceIdZtV2xapdBR0w5pP+E015QANVui3+9QpvqQ8LbqfWV3fCboW+Y9OlZGoX0VnaTXN1II4YlLMx4wK+Yz428QjGNUugT6mszXPEmsapbeReajcywnqjNwfwo9oH1ex9HeCfGFn4ptZWtjtnichoiecZ4P0rr4rp41ZR36ivi3RtTvtKvBcafcyW8o43IcceldbH4/8AE5Ct/aspPuBTU2tBOjzPQ+oRcMjBlqY3QEbHJ3E+tfLo8feKXXP9ouR67RSHxv4pkGf7UmHbAAFJ1GV9Wfc+l3kIz96q8kgyO/FfNsvjDxK5Ak1W4A9jUQ8Ua8G/5Cl1nt81TzMpYZ9z6UYkqB6DrVNpGZvlPNfPv/CU6+cD+1bjj/aqnPrmtuSW1S7z7SEUOTBYdrqdn8bfEHk2K6TbyKZJ+Zdp6KOx+prx3Q9Uu9D1WG/0+QxzxHIPY+oPtVm7innkeSV3kduSzHJNUXhKrk9KfMDp2R9Q+AviDpfiezjXzVttRVcSW7sASfVfUV09zN1GODzXxiC0TB43ZHXkMpwR+NaMni/xEoA/ti9x0/1prRVHaxhKmlqfU15MNrfTPNcTr9+CDHAcuepHYV4Hc+JNauBibVLx/rKa9Q8F6guq6PC5O6Vflf1yKtPmdmaU2lsamn3Zt2KXAyD0b1q3NNDMv3uo7027s0kU5HOK5y6aW2fy0YsD0HcVTbgrdDVWl6lXxJp4Q+dDjJPNZllcfLtNX7q5coY5FIXHesIZhlZk5jziuOtBXuj0sNieX3ZHSQDcwGQMegqeTAP8uaybS5zjDDPWtKGRX7hT0rOJ6ad9R6gnptB9c1b0/wCUjOcA9aptLztTAGav6eC0gGPkb1NPczqLQ6GNSUyp4A79qa6YchAVXgfjSKMBQvAx1FW4kAjVT/F+lU1c8qWhZsbZVmIGMcYI61pIp3YJOAeMnnNQ2SqJB/dxjI7+tWVHzkZ5zjmmlZWOaTuzck+V8EMeefWrEe3IPtgioZW5VsAr0XI/WrMMeSu0EkZpJBJ6CvENpOPlH+FVmUY3KNoGBxV9hmCTb94YA9+tU7gMq7v4euSO9VYmJmXCEFgc5RgOPSsrUpZYwURNpP8AEDWzcthy5I75+vrXOa3cF2wpOB2z1p7I7KEXJnP3isSSQCc1QkDAknAz2qzcpIXODx69qp3cmE6DOKi56trIzb6bAOOPeufuCZJwCck1oXrE5Oap2kPn3LA54Xr6GpjFzmkjDFVOSm2bum4aIKUAA4xVt75NKJldwIRywP8ASso3D2UeZMMg5zXDeKNel1OXyYzsgXqB/FXdJ2VjwHNLU9403X9MezSZLuBVK7vvivLfiP4oGt3n2WyYmziPUfxt/hXn8AzxzitO2gY4qJ1HJWFDXUjjiJIGOa1bK0BGCMH3qSytQrbmGT2Fa8NuM5K4PpWO51QgV4oVXoM1YEJyPX0q2sSKMOBUihSQF+YUHRGmU/J3YJyq+lSrEFXK856VoxwFzjbj3NWY7T0/l0pamyikY6ROx5OB71Olvnk529PrWwtlHsJZsN6VE0KrwATg9Kqz6jsjLa2HIJwfSoZbYlPl6E1rvE4bOM01YwFyy9801qQ4GF9mkPQHA6inLbJ1KHHetuQDadpB78Cogcuu+M7PWhqxHIZLWyseBxUclgpAwOa1WiDFmBwB0FRlQFKjLN0BqbofszGOmgkjAVe1NgsXjLL1Xsa3Y0Uphh8/epURecDAznkUrIXsjGS2fAwePSpY7eTtgcdK2BGDgkAd+lPMa4O0duadilAxWt2Bzt69aaLYNknHFbDxhjwQMdvWmNCGAyBnvikVyaGW1ueqqQahdGLcjFa3lsByOF700QDbnqaCXAxpUZM5HWqjQK4OSAa3HgAbDDr0qncWZRuOnrSM5QOdu7UqSQOf51nTw/n6V0ssOU6896yriLBO4cHvTTOWcDDZcVt+DdfOhakHk3NaycSKO3vWbcR7SapOOa0TOSXuu6PcR4lstQgb7BL5jEcDpiqNpmaVjLw+eRXnPg2++yaoqSHCOcV6bJC7FJrcZfv71vH31ccamhcvLVDA3C4I71yV3HsZhwa6rzmMe2RWXArlNduPLLCLjFOquxUJ8u5kvM1tKNvCkcj0rUtLwNgNnHqK5K6u5ZJwjlc9j3+lbOmz7o13feHXNefUVnoezga7krM6m1kDsMrmtKGQb+uT6DsaxrWQLggcGtW0G8hlOc0JnfNXOgsmkZT0J961YtzKCy5OMZ96zdMTaBhQB05PJratlCyADj8etaJW3PNqrUtWkQUBRk55+lXcgSYbAznOeeKijTYmcgu1PQ7gCQAQOT60HG0X7i5xJ5e4KFYAcda1rZt6rg98detYF/As08cmcMkvzDPBrYgkaFFJYZBHT8qUWOcbrQsySbC20Hg9qrMWIYvg/wAQPYVWluxmXcxIVhjHekuLuNbdzkcxg9O9HOhxpPsUtQKspZxkkAj6Vzdy4dmHOBnrWnqF4AFaMfIBnrWFc3MbA4GCe+anmPUo0uVGXdyhc5GcH0rFu5SATg81q6g6845J/KsO4Yt16UmddijcAv8AexjsKqRX0Ni8jSMBxgCrV0dqFn4AFcDqdwbq7kfPy5wPpV0NJXPLzGolDl7ml4g117weVD8sf865sNk4qVyApAqKNd0lbzd9zwupoWcecEit6xTJOBis/T4yABjit+2UKBgdutZNnfShoWViVFDAVPGHkJyDg0sMRlbB4A9q0kijRPmOB60jtpw6EcNp5nt2Jq3DYhG6AtnrT4XBBJx9PapGJYZTOfQelVZbs25WnYn2Lt2sAABxinQqvBY9Og9PeoopBLgFSGxye1I4d8nI3jjHrTuug+XoyyQGHHJB7d6iYKxJHCjg8URxSquFbDdcVIYZRkk9aL3Hy2IJQucJwQOc1BIy7SWbafYVK/LnAB9TSCNBnkZz6c0m7hydyrguPlGTnrTlR3KgZx0+tXEiXODn1pUTbw7AKOnFHK2HKjPaBi4PQeg7mpQpIAWMBgevvVxQcktwOgNJs2RkBTu9RRygkir5JY9MHGPxoit2BOWJye3ar1svbHuAalCrGSAPmPahR6ia6GdLBsB4yAOfrUcL7eCQBjpWnPCkhwclj2FN8hF6qM9z6ChxdxqyRVMCNlhwOoHvTTAFIPOW6inncJiuDjHH0q2qMFJI3HsKFqJxsUDCC3LbB6EdajkiCgZABHFSXNz8+3ZwfbOKGjWZMMCCOc0tG7Ibi0rspPsY/wCyOmPWoZctxgA1aNoY35O4Mc59KrSq0RI4Jz1pakygnsZ89uGDf3h3rHu7c88Y9q6F1Doy4wR3rLvI2JJxnHenurnLUgczcJkEH8Ky50w3ArevIwGPrWTcoMVSZ59WJQLNG6unDDkGvS/B3iiGaJYrtwsg45715rJRGxjYMuQRWsJODujmaPc9RvrcwlkkGCOK891y8VpiEyzetRaTfNdQCMuSw7Zq1Jaqp3vgmt5y50JaHPLBIZPNfjvWnZMY35+6etOSOO5mYMeB2BpYowpKg8KcVxVo21PTy6WrRvWcnIAOM/lW/pyg/ezjOAc8GuStMjHWum0mQHCt29KwjLU97eJ1dnIoXYgO7qSK6C2XKqY8DaM5I9q5uwdeiKc10UCylV7Ctuhw1oml5EzohWMje2F4wCfQVY8gRylChjK4BVjnBq1apFPawI8jo8SbcBSw69RjvzUt02+RcZIVVX5uCeOtFjzZSexBCBGx3q3zHPJ4z6U2W5iWXDsMBlJz6dcVZulUCMjlw2ce1c9rlxNBK4X92OCPfjFZP3UdEIc7FnuJDdMzLH8xLKR9auXXkfYUCSMZ8fNuwFArKAkewSRmw4IXGcFvp61j/b7yK6fbBuh2lQzjJyfasVe9ztp0XPVPYv6nI6hRBteNhwc1zt3LgsvRgecVDqN7LlmMhyeOnWsVbkvJktyfSqejPRhTstS5OxOcsTkd6oMx/ibmief5sA1j63qK2kDOTlzwoHrVbmVWagrszfE+obEMKn52/lXJsckVLcSyXMrSSHLNzURGOtdMFY+axFV1pcw1uRT7NcyjNRnrVix5mA7VUjniryRv2Scg+lbdrEAQc8msiw5bntW9pyGQljj0rLqerRiaEJEfyjqe4qRFeZssKkjiXGOcevrU25QMAc98d6b8zsihBEVfJ4BGMGpY3IfZgdOTS8sOV3DHHPSoydhOCC3T60noaJXLsKhW4I9BkdKfInUx8nNZ7zspBAZhjsKkWdiFYZHY4/rTUlsHs2tS2MsFV87/AOLtinKxOF6gdDVWa4CrtDcn+KnJNHEvXjGMmn1Hy6XGrGTOzNwCeppJIQZMenXtmm3U37shBnPINNTc0Ydid3QYo06Fa2uTu4j24bnpnrSSOHfkHkelVvmkeQEYQcH60HLEhWIboAaE7icbbl2EmPhmBXOeaRpQ0uxOvUn1qnLMqYXByOPY1DHcHlWGSBSctbByXNR3EZLE4BGM+lI5EyhlbjqT7VnSTBwGbjA/Kkgu1XbsB2rQ5LYfI7XRroQD97J6DFVLmV1Yj+Nj+Qqvc3LtgQnPGasRSfLhx1GCR3pt82iEo8urJw6na3RulOEjea6FgTjqOlU55gquByemKq2fmYY4wfWlzNOwuRNXNGZI32tjG3v60k5XcSrAqRxioGaSQH5sH3GBVZkZWJR+nb0obBQ01JZ0lJV1bjHIpjRhYhk89TxTy/OdxBx2qB3YvyDyO1K63DlK8wVgTnrVOU+YpTGCtaDoFDDjNUZhsbJHJppnPOJz99Bntmsa6hK5BHFdPekEc4ye1YF5kZH50Lc86tExXUZINR4qWX71RsDWhwMkt5Xt5A0ZIxV261yeSLa306VnqwJwaR1BFPmeyCxNbXbsd24gmt/SJAyMGPOfWuUT92/pW3pVxtlHoeDWc1dHRg6nLUVzqok+YEcVuaWEDgng+1Y1sN+MY9q2LTASNgeehA9a5kup9NB3R2WnbUjVsA1tWcuTycqc5rkLScoF3MceldBpV55cqSRjcRzhhkH61alcxq0tGzurWfNja+XdRxOqncN+PxNQyM5mO6US8DLKc9vWqFvqkjuv7q3IB5xEOK0PNMpEm1ATj7owKu9zyZ03F6iXFwsUu+Rgdo+73ye1cj4suPLlTyBEvmjJ3tnn6Vf8R6qLDM6IGYAgZ45/+tmvOLu+m1DUzJbxhmJyAexrnrS+yddGi1752S3V0ywOrQRNAhJblgT7Z4rJa/kuQJRKsWD97J5Ptii4WW2BXcZZMKojTkv65+nSpG06K7sQ9sw8uNcPtJG0+hz3qaabuehh7KN5HMa1JPBLi43fOMqQOGHqKpQkKuQc56GtnxFsSGAyyu8iqQEJzsFcuXkQAnjIyKq1nqdTl7ty5IwLFucCuF1+5a41BgT8q8AV1UkpETFj2xXD3j7rqRvet4Hg5hUdkiRCNopX2kdKrBz704sfetUzyriMMc1paZENhdhWVu55rdt/ltgQo5HrT3Q4bly0lw4U85rprJ/LCnA9veuSscvdKB264FdVFHyrOcEdKybsevhlc1orhXzgA81YSMZDZGP1BqpAESMfdznpVuAEks4JHtS5m9zuUbEodEYZ4JHcUwRgyF2z6D3pzxxvIsgYfKMgGobssnKEcdcUNs0UeiJZQit3zjtxio1f5WwMg8nNUvP3vvJfAHSm/a8y7VBKmo9oi/ZdCwH8zocc4pHcu+zDbexPaooXZ1JZcHkcVPGwBAPfqKpNMTjYIw6llc5UHg0C4LZwTxwaZOd3CEjPOD3qAv5TKVOMnnijmtsLkuTR3IOd+QQeKHmHMmeOuaqzghvUelIsqBSWx+Pep5+hXJ1LHnbxuUlz2HpSeaGJJIz6GoGfau4cD2pysgQZXnGRmnzh7MckhkySRgHvTUJKlRlU6ZqLeWIJHFS7z91hjnjFRzXL5GiYSn5VHJx0A7U55j0AAZewqEbvmZThumKjjJUsYzgHqT3quYlwuWxd7eHHUdPenmbCA9TVJ5PNZRjp+lKZGGR/CafO0J0yWaaTeCvBI9aW3uD5e1jlj1AqmW2P1JGe/WlSQRguw+YHHAqed3uX7NWNBxuBycc547UoU7AV/Wq8jNcJmM4I60ebsCq+CT056VfMZuDEkkKTbOuagukLqfm//XVl2Qjc3JzVa7YGMcHrmqRzzijKugOuckVhakhILKDW1fsAm4DL5qif3itnHTv2pp3POrROZlU7qRYmYVZdf35HGKsQIM81pc85wuzMaF17U3kda25IgyHgVk3ChWIpEuNio+DnNS28hUjBIxUbcU1W+frTMdmdtoV35kQDcMP1roLS6jjk/eqdpGCR1B9a5TQR/o4Y9q2vMy3APpXPLQ+nwknKKudQdyqu1g6H7pB61paTdMswjb5ieg7VyNlOQ3cqOSAa3dNuWeZHyNyEEFv6VK1O+2lmej6as0zxgRviT7gA4bFbiEJsiaHy5VAyCeaydLula1Ro4rkukJg3ADYo3ZLfXBxWgblTcBVjYGJQnz9eB1NaPQ8StFyexyniXTbvUpWjgXIAOeO9c/pekyWcjNcZieM5CsMZx1FeiRNJDdybUX94OGPOD7Vh6zaf2jqG52jSUjaqFuCc8/SsalNN8xvTqOX7t7HOnUViknuwr7ydkRBx05rJe5nuXkBLsjHc0ZbAz2yBXTtpwWSS3MOZ1+U4OQO/FLa6Q20fu1AyeQcfhk1Gux6cKtOCscVqELSR7iuADzWRqZUyq0S7FCgFa9Eu9FklhljhCSunzFVPzY+neuI1G1xkqMYODmqaNFONVWRzN7NiF1J9xXJsMyMT3NdTqEZAYYyK5iQFJGBHetqTufOZhFqSuPQCnkDFQ76RpcA1sjgbAgFxW9b4NoNuMAVgRnJzWjZynYyg4qkETS0Fd12zeldbHGZIgAOSetYPhq33I7ep610SMY4TtI44x3rCZ7mDXuo0I0RFx1HGSadFPuVsdBxkVRhlLblb7pFPCkrgAqc9u9Q5dj0YxvuXrdMRMcEvnIz+tNMMhkIfBBHbvQBKsqNk+XjHSlmdjEdnUHhqN0VZ30IpLddhwTiqwCxAJ1OcZq2pZVVZWGT+ORQ8SlclQfcVL2NFpuRKgUEHH4VDM/zYI5HTHepnj8wMBlfTBxUcx8obWILep70N2GoghUNksd2O/rQEDswyD7GmxiNzvcYI4ApcIXAViSo5oT6i5SJom5Jbr09qYI1wVIycZIqwwZpCNuSBxioY0ZmYeh5zUstR0GkZ4xgY601lyfl5IHJqfy8YTHQ54p32cdUyAOopFctishBZS44z+tT7gJAWxkd6jEZ2BQrcmnsrYDKAfpSTBxI3kaTrlfmyOaassjLtAH0pHDBicfN/KkjLKSM8djRzByCLLtIUfifSnZds8cdqYqBwVJPB5461KoJGE4A4zTuS4ECqc8HJ70/zAV+cYHvUixgFgBnHc0hUPlOgHX1ouFgt5HJfGNvapWYtJtZQfftUX+qHsO1OV2kUsFIGe9UmRJEdxJhclmXBpjTeYrA+lPdc8k+9U5ZvLYjrxjI7VV7M56i0sUL1XWMlm79azmkC8deOtXNSn3WxYDvWQ0u4dR06VpE8jEOzKcz/AOkkirEMgxzVGV/nBp6S4Oc1skedzWZrM37visW8OXJ96vCcMmKoXJzSYSd0U3NMU5cZpspINLBlnUe9Pocm7sdloLBbXBrSaRSPl+9WDaOUiVRmr0AeSQYPHvXLNn02FVkkdN4bnihkkW4TcHHBA5FbEZCXRmh6A9x/SsXTIF2g5O4e1dLpcCFFL7Wy4yDSi76Ho6R1O40u4hvVtoobhIJBbGDynOPm3Z3DtyK1DJE9yCP3mxRGWP8AHtxk1DYRzPDYHTkiMSqQ52KTnPI57VtyFJLaRm8oBcKmwDhsfMBjqK0a7njVpK+gkkKNMpccjn8qwbyyU3wAGZAMhT0PcnP9K6G6DK6SHmMA5FVZbVZpAwTcyt8qE4JJGB+FW43OenU5OplXi+Rdxy7DuBH3WAJ9j7YqJjM09zMRiJWD+Xtzz6Vsy6eyyIJwg2nlF4HTvU7wiaKZcctg/JxjFSlc2VZLzMG9kYwR+VE0M0f3SoAY8dzXnOswkyTMy5Zs5I65r1G+SMbnly7DJUdvxrh9Ri3MSygccUpRO7CVFrY84v4QCQQc1yWs2xikLgfKe9ekajakBtw6ntXK6laiRGRhk1lCXKx42gq0NDiy3NHWnXMBgmKsOhpy4xXUfMtNOzFh44NT2zATbT0JqA8EU6I4kDehp7FR0PQNKgaCyUAcY/OtC3UkFz39KrWjhrVCP7oq1E/G0fjWc0j6HD6LQmtmAIOMtnpWgWXy4wQA1UoEAkZh1PtVmVkZ15BbFR0OxWuJIzAthjtx60yKRuMnGOcDtSFyxIxt9/Wp4YFb5myCT09ajVmyslqRSozpiPIbtTgJEZCVLepFXCqozHnjqM1e02ynvdPubiBU8q3XdJucAgfQ8k0+XWxTkorXYwbjzBt2rnn5qebYShdwwfatUWU8zE2sEk2BufaM7QOSfpUJ3EIVX5GOOnftS5e5SkuhTS1VcFgCuDnP86je3A+dQAcZGO9bws2kgnlgt5pbWFR5rsPu545/Gs8iNtqABVHCgUpKwQnzFIK4w5HzAdqVImcjKg561dAiSJyX6elDSICrRlS2M81PqWiGO0CFi4w2PvHirCW0IA8sje33j2NVzI7hjuyx/vdKltd0krfuzxwAPT1pproEk7bkptlIOV5x9M1A9uM+g6VactsyWPyjqalvbS7s7a1lmTZDdx+ZE/UFc4yKdiL2smYjWqhjuxuY9QKia0DOAGBOcA1KBLvynygHlSM5qL5knEnQ56E8VFzWzEaERoTk59MUkUAUFmOEPI9TU16ZEmMYljYKfvJyp+hquXbBKEj60Cs2SnYnXAY1BPHtUmM5OOTUW0uwMmQRzkd6czF1xGwBqrktWZEEbIy2fWrDMI4+QMVCPvhSfm9alD7eoLURdiJEMo3LmPG01SukAX5K1WOYTkc+tZsoYLlsc1bRzVHoY15gxyLjtnFc2XOSPwrqr4KOR6VyzqPOb0zWsEeJjHqQzD5hTdvFScM59Kaw2t7Vsea9dRm4rxTXbIzRKe9VnfBxUkylYa4DMR3qawhJmyOcVWQl5AB1PFdHp1sUQcc9TxSnLlVisNRdWfkW7OHCgkHPStuxtyWHyg1Ws1BIwB9a37NfL2sOD6jvXI3c+poU+VFyztWxnGBXQadb5WPYuWX19faqOlwPISVYhciunsYCI18s9euauMBVqtlZHQaKY4Leyia0SVmhkkEjZOXzyorUljU+SyxCNDGDsAxtBHf8TWbbCK3tLNvKnnk+Z96OVCknGOOhqyJ/Mk3IXjBwCrks31rQ8mpLmd0acpMkzK4+TOPzFNhXbMU3gpkFmzz+FMmT5SQR05B7DpmpbELAgG3eQc4I4qzkv2LEkJEp+ffkZG73poQrGAGAc54PUYpjM7g7V2HbyT+NNlfqrfw5BI709B6mfdAMoVFywzknuK5XU7VQS2PkGR9a7CVRlTI23HTA6isbUEDlldSV5P8AhRa52UKnKzgL+FiSGXryM1y+r2bK7Y5I9K9C1OxEJJOcnkLXOXtuZnYBVzjJZmH6VhUi0etTqKaPM9WsjMjMB+8HP1rAAKnDcEcV6Dqdiy5dMY781zWo6b526SH747etFOdtGeVjcJd88NzDY5ozxSMCpIIwRwRQeldFjyL2Ox8O6gslsI2bDL2rpbeVDH8vU8V5bZ3DQSqyHkV1um6pu2knms3oethMQpRSZ2EW1QQTg9etK0pQllxuAxisZ74NyG49ah+3ncPm4rOTVj04TVzo4WDKGcAk9fap4puDkAAfrWDBd5POcHgVbNwB3AqVI6lZl9rhGVyyGQnoRxtPrTYbsxskmMFSDxxVVZjt5J56UqkOuHGQeKm5qmtjpfD/AIiGlarcXNuZY4nRwqHD5J6K+RgrnrUnirxU/iB7NmsLWzlt02Zt127/AHNcmyMOFHGc1IoPlkk9OuafNK1iHSp8/tLampbahcLG8Qlk+zysDKgY4b3xXoHhzTfBKMz6lqq3KSLhI2R02f7xH9K8t5G0qTjFCOSxJJ2imp23FVpe1VlJx9D0230fwsdVmV9ZsGsnRuDHImw9sH1HvXDXEEEdzOofesblUJUguuevtWeZcKCCcfWphc7k+bO49MmhyT6FUqcoNtybOz1C08MDwZBLp91M2s8NMki/L6EdPyrI0/XHs7W6iijh23UIikLINygd1PrWMr4Xlskdj0NVyGZs4x2pOT6BCkuVqbvrfU0ZJw0fJzgY471u3nihrmCztLqOG6tIIY4gDHtZQpyQD2z0JrlEU7SAM1ExIXPf2pKTQ5U4T+Loes2WueDLnSyy6bDY3UZwySKXMq7T0PTOT39K8ouIwJeTkcnA/lRbOTyVAAPWoriQBufrVSlzJGdGjGg3ytu/fUhZgOOePWoXG45DEDrxT2IY9aYWC/wn3qLHS5oIyXzu4wcZpQgRiyjg8ZoIAOR35xUcj7QcZ4707GbmSOwBPHQUzzAB/Sq5k4JzyDURcnPYCmjGU7Gj537ra3AqtPKgX5iOe1UprnI5JBArE1LUSpKjk+tXFtnJVrKKuyXVboLGw7k8VzTSHcfeluZ2lbk5qDJzW0VY8HEVvaSJ4j3NPlIIpkf3ajkfkDNWYXsiGZsZzVN3JPFSXEmWwDVrS7PzWEsv3AeB609Iq7MlB1ZcsSbSrQ5Ejg5P3RXS20ewDdn8DUFrGNo9OwrVs4t/O04zzXJOTk7n0WEw8aUbIuWKq2SwBHYmugs4YzIOMg44PrVSztj5aTbSYxwrBcgGtnT7cM6sXx3Y0oRudk6iijcsbPEAOCpPH4VuW9uCAu3BHQA9B/WqVlJ0wRxhcgferbtZPLdGIVu43DpXS4o8mpUlc0rNzHZwLHfJDsTDJyOSTzx3qncRl79JFufNYYy4JwePerP20hT+4tTkcDyxVK7YyyeYEVRgfKgwBj2qWjmjJ3Nsoo5J3fj2zUrgMm5cggj8qrhWVcg4bPPrmpFdtu1ixyevammRsLE/y5Zv4MDA60x3IbPy7znt06UAghV53AZ6frSE5x824BcFqYIrXGd3DZbp9Ky5QWDEKQCfvHvWoSSy5VSCe5qjNGzMASBnn2A9aSOiDMW+i81GAXd8pyeua5S+gHmsHUoOmTzj8K7aQMBhDt3ZbPoK53U45FcuMGTrk9BSnqrnfh5u9jldRiRpCiRMCp5Yjr71h3OlTS7nt43OOSVrr7cxzhnuXJQH5i/9KyL+WNVlZg6ZP7pEbGB71y2d7vY7LX91nn+q6cz5ZVxKOo9awWDIxVwQe4Nd/NarKSOp9apXGmI4+ZA4B6mtIVbaM87E5bzvmg9TiA218HirtpcFDjOK6RdLsXB8y2GT3BIrnNWsmsbkqh3xnlW9RW/NGa0PKlRq4Z3ktDVhumKjmpvtXfPNc9b3JUYNa2n2d7qLYs7aSX12jj86hw6HVTxN1oa8F3uRRnBq8t2u0YY5xSaf4I1yfH7uKIdfmf8AwpmseHNW0aPzbmLfCOrx8gfWolSlvY7KWMS0bLqXgbgnBq3Fcrxzz61yUd2CODzVyO9K9M81nZnbHEpnStdqSR+lOS6UjKn2Nc6bolTg9elPjujwA1GpXtkdClwpBBOOe9J5yocg8elYRuiGJz360j3uTyaepXt7G0ZwWGMjNKJxvXJ4HasJb3knJxQLsluH+tKwfWEdOlwgAw2fWk80bs5znp7Vzgvip4NSfbzj73NAe3R0sVyVQ5wB3qCa5BzgjNYbXxK9c+9Qve8HnHHFC1E6yNsXKqTgn1qOW5VzyRnrWEbxvWm/aT6/jTsT9ZRtLKAMjFP+0rzk1gm8IHJwKja8Prx1qkrEvEG+bkYGSKhmuhngisNrs+uBVaS9+bg5os2ZyxC7mzJcBc9PpVaW9wOtZL3eR7+9VZLlmPU59qaVjnniC/dXg28HmsSeYu5qxBFc39ytvaxPLKxwAor0TRvhuiwrJeI88hHIzhQfbvWsItnn1qrnoeVM3zU5TzXq998PNP6nzYm9FauK1nwvLplycyb7c9G7/iK05XHc4+SW6MEE84qCbexwiMT7DNbtvYQhiZGPlr96rTzELtt4xGnTOOTSc1EuFCdTQ5azsZZpf3ilVHUniuksrUBQAMKBwBU0Fq0jcjGf1q6sbRREAfN2NYTqcx62EwapK/UZBGA4z/CeldTDpbLYi+t5EcDH7vBzj19K5mFSpw4Iz09663w3eCNGiJLR4zsPTNYavY75JqOha09YpGiCqYmI+fHIJ7HFb1nF87JsAkxnPrxWXBEE2MM7mOcY6D+orYjaR1jZxwo4PoPSummmlqctWXY0bJTGcgZOfu56Gt6EiOVTIgfbztPSsuyhJQEd1yT9a0YyNvHUcVq2cNSVzdhh8yJJPs1oFK7vmcg4z169Kzr9GW8KhY1K4+WMnANTxyMFt/OibaytATkYYdiPfmqmpyEXWNjxlFCgNjPA6nFT0MIp3NHeGVgcD1Hc8+tPGW3jqAOlVlbA65UnNTAkuAvTGMjvSuNoUnaOeCOCV7mnKrMhBPPXHaj5mAwvfpjipsYGcr9DTEVJPmIVuxwMCq1whwV2jdjBxWjgZLMxBI6g4qD5G+cnpxjvnFBSlY52+gZWGSwyOfQCsHUi1xthi6txubgAetdZeDesmBgYxyK568TEojQ7S3H0FJq6O+hPqzBubOKGFgg8/wD2ugBrCuIRIu45ebp83PFdPcRKhZFcgd8HpWVFEpyAGZj+tZzj0PQhO+pz7WuwkdzwcHvSSweVHtT5tx9K6CHTjcErGFQKCXdugFRSaa5K7fTIz1IrFwa2OhTXUw47USRn5Rgd6q3mnK6lXQOuOhFdVLYrbMqP9/qRmq81sX+ZVo5WhNRlo9jgxodml0rMjbc8pnivQNBnt44kjhCIFH3Rxj8Kz57IMOFwx9qYLFgwKbkYd6uFSUXdnHVwFNr3NDvrW7AUncARWhG8VxEyShWDDaQe9ecxXd9asd2JVHduta9jr0IT963lueMEHNd0MTGW55NbAVYarUueH/BOlQT373FvHOksn7pXGfLX0H41sDwLokxybCNR/skioNI1AMSMjBOevWuntrtSqkEZ9aP3bOeTqRe5zzfDrQ2T/j3ZCT/fNWLX4P216m+ztrhk/vBziulFwmQwIyK9E8Kagh023gilAmZj3xz6Gk4QfQzeJqxW54PqvwkjsObhbqEHoS2Qa5nUPho2A1lfdTyJV/wr6M8d6kZDHaToY2Xlge/09q4SKW3N9sdAVAzUumjSGKqNas8bk8A3aZxexkjj7hqB/AmpYJilgP1yte8izhmkxCqZ61bl8PGKAPIIQD/DvGRUOh2LWLZ84TeDtZQnEcTj2kqr/wAI1rSOV+yMfcEc19FyaGrkY2k98EZqpfeHXsthnhZFblc96l0ZGixZ852mm6jc3psoreT7QBkqwxgeprRPhPVSo3LEp9C9ezNp9ulx5iqqSEbcgc49M1oW+mxTAMAu8ngHjNEaLYSxTPC08IaswPMAGP79SJ4L1JwSZYl9hkmvdjp0UeVdEBHtTGtI9udqZPoOlX7BkfW2eHDwNfMP+PlBn1Uiq7eC9W/tBbZQhjZc+cfuj2+te2z28QJAAABqrPLEmBuC+mT1oVEft5M8uj+G90Rl7vB77UzV62+HVpHgzNNMw9TtB/KvYtDvdJitZBcoxfHGOayL25i86Ro1CxknAzWnsY2vcz+sTb2OIg8F6dCMR2MTN3LHdj86tReHbaLbthhQeiIBW9Ldqo644rHvdZgg+/KgIHdulHLBAnUlsEen2dhc+dBGiTuArsoAyKu/2kUQBTj3NcbqPiCJ2/cFnIOeBUd14lv7rT4bWOBFWJiVcjkZzx+tCxEIaI2WCqztodLf6juBJJzjNcXr97GwIyGY9F6mqz/bbliJ5nxnoDilGmhQD8xJ/iPNc9TEOex2U8vcfiMGKykmwQOM+vSr8GlvgEgkVoJb7CScZHcCtCBfNRtn+sHOwdxWF+Y7o0YwWhmwRIGAcMuP4h1FWHgjTAJyD1+XrUpTdKQKuLBE9onJEyngEdaEuhTskVoLWNoVhliLKDlH7g+hqzaQiCQGI7XxzkcGrFm2EeJhuDfoacYtkgKsSG5DGteVWuYuXQ1IMPEykFZFAkQjv68VqWcRYMWP0FZtoPN2YXAKjGP4fWtm3QmMEEll/lWqOKoX4g8IO09hxj0q2jFvL2glsnoMmoIiVkBkGQTyc0wSlJcKxjIPDDsaGc1m2b0apeW8JcXCGJcDZGWVhnt6VWvpA05+R1CoFAkGGwB1qSGSK1tbUzT3e903bY3+UDnn9Kde28Z3vHLM7oqEmQ53K3Q5/pRujLZlldp+ZckdKYshZshRnpx/hT9wTbsHKgHHvT4VBOQV3PxgVJXQkjAY49KkcKxGTgj8qiUhVAA2sOg+lMTafvE7ic5xwKZI+Z2O1VJ8vOSarNIB1GMnPFWBEFBDE455HOKiYBzwucUFqxQuuuOME5JI4rC1NC7k4I5yDmuiuFJBRQcjj1ArA1gFU6EnPrTvodFJ6mHOBKdvIA/DNNEaIoAXGehpLeORpfM3DYTzVuRCzR7lIGMii3MrnbCavYrRx/KRj5Cencinzh5JXkn5bACjsBVnyQz7mOxe2T+lOlMKKOCPfualo6Iu+pkvAd4LYx29zVgf6OzIFwT1fNWJVWZsopCgcYFMRUWVTICyg9Kza7Grs0Z175A2LFndnJaoJ5eAGwVq7JB5rs6ptGetKlpD5oVmLKw6nsazkn0LdktTKaMN90cmqN7aNnC9utbQREmbn7p4p0gDnJXGR0rPdActtvLN8xu8eOeDV218Q6pbdWD46BhWlJCjnBzuFH9m7kOEyT6U1KS2IlRhL4kEHjLUEYbrdD+dadt8QGgVd8UiPnJ2Px9R71iva3CssaKp7dKnXw8I1826Csz8gDtWiqT6GE8FQe6N/VPiNFqDJNO9xJKFC4btis2Dxdbm5MjbwMYxiqEmjxKhIQZ9KoSaTl8hSoz1odSfUmOX0eh3Ft42sCATKw9sVrr4x0vy1J1CNiR0OeK8wk0dFXdk57Vmy2ZUk7fxqvbTW5LyqlLZnrc3jLTVXK3iHPpWXqHj2zdgFlll29OOledQ2hYANnB6VbXShgHIz9KPrEmUsqorc6WbxjbtIGCPjOelK3jqBV2rDIfrXPvp6BAvWqsmmgg8kfhU+2mupf8AZ1FnUTfEA4Oy2J47tVZvHtwVOLVQD33GuYa1I4FR+V83IOKl159ylltHsdFL41un6W64PqTVK48SXc5XMC4Bz1NQwWyumApFWY7AE/MoFP2kn1D6lSj0Fi8TX4P+oQ+nJqtceJNTfgqq+mBV9dLR+FyD2FEulBByCTVOc7CWFop7HPT39/dgrJcSAHsDiqgszuBkck56mttrIxyuR096RICzEFRtHeseZvQ3jRhHZFe3tWjGflIHtV6NQwG1h9MVK8TQbDvBjcelFnEhkG48A81SfQqytcPJUylWTHHFXDZkRKHHsKsXltGkasrgnPGKR0mMaS8mPIGR2q1Gz1M27rQgjsIgjtLt4XgN0NZUMbLKHQkYOeK2pSZUYbjz0zUUUA/i4bp9apJX0M1dXuV4VEmS3MhJ7YzU6258tlCluN3vinxxhGwDhuoPp7VZiXOTkAdhVJGc5WM5CyFSgIYHNWfLaaUJ/C2fwqUqHdiOcHmr2nwgSkuoxgkD1qjnnK2pLp8G1VwOwx/KtmBCqLjr0zUVvCElUjng8Z6VeigJXOcZOOvSqRxTndjWH7sAA88EVRnmZCEcfKx5JrUePjoRzxisu9UyTsdyAn9KT2CDudBp0629lAt3NGQwLRIYhIVUn9KS7e4JeCSUOkhEgYD74xx9APSqsFxD5KJc2yzeUoCHcVOPQ47U6+8zzY3cKMRqyqvRVI4X8Kq5g1qa2whfmJJ6HB6c1ZXajZx2456UxtoUqR75/wAaBjgADp19KjqAsZBBL9QcgVKFDSMWOVUAD8KYUJAxg8dM04jK8gAH8KNhegpct8w6HsBTCEQk4BG3v/KpVVQwROvuaUhCDnJwe3rT3G3YzpEc/MRz+X6ViakgZGZs+ntXTFAxwBj3Y1l6jAzDcEzn0FM1py1OVgs3jdiASp5zVtYmK5J4AxWj5eMDBpJY1APvz+NNOyOqGjMskyHHIK9gOtEIQ7d4LODwO1WooCOvc5pWjwQQAD3xRudalbYjbO0xRplm9ByKqPbkkBsAr271dQEYfcAR0otyskz7snvn3qWawdtSpICsflJjHXNL5EIhXemZM84q2sI+0AbSDzxirYT9yVZVB6520dC2+hzU9pGzMdvNU2hAPzFl54966KWOMMSucY6kdaIrSOSMEqDz3rHk7GvNbU56G1UoTISDu4x3rQto1ROeSe1aU1ijEJGp468U37AVU/N06UlCzJlNSRDBbxPJlxt47dquSW8PlfJKD/sntVb7FIuAHzk8077BJI2PM+X0ql6GTjfqU55Y42bKqfSs2aUyZ2qADWz9gZHKEAn3pjWcYU70z6UrSNIWRjeWSvAz7VXS1E5wBz0IrpLeGMx/MvIB4osrZGdjtwc+lPkvuXztJnLwacYrk7sjacgVoCyEjBmOB9a2Lq2VZ1JAIPerC2wkHyqcYoVNDlUbVzMFmkDK6hGxzzTLuDzYiSVBPoK1vsRCHJ/CoHtQVOQcU2rKxmnfW5zsVmnAYDHelfTon/hBANb8FgvllwO/WpBAMFWX6H0qVTNJVHfQwYrBYuvQ0yWzRlKktweK347NmO3APYUn2ICORifmHam4Ec5gpuhUYPK9Cakkn84ESHk98VpLbqYzx3/GoZLMKdp7nijkY7q5kSAF+ntTkWJZQWUgdwPSr32H5ieuKkEHGMAmkou+o20ZV/aeYAY3zH2AqO3tACd56elawgDPwMEHmo7q2MDqc8N3FHItxRfQi8tYlA7enqKcEBUBDgZ6VPEuYyZOQBjGKa6u8MTbNoB4PrWpmyvOFRzngGoZXyQf85qZwZCCwOfbvUWD5nQ5JqWSSHy+G7HoPSpNm7kcHripI4RIRwPWrUcS8blyKo5ZsrxwgMvYn9a0raJUG4ck8Yp0NsCVYZyOOlaCRcqRjjOc8U0tDlnMFgVpFLZOB1HGDVxQFG1iccURZCgMFIH8Rp52scjIY9Bj86aRytsinGEUqpJz19aqtHH5weRCyA5KqcEirkoYnKEjHbP8qZbW5nuEjHVzjJ6Chq4RdkOWawMYIs7gZH/Pb/61RXk8dxP5salFCBAhOTxx1qcw6ehKtPcHB+8EGPyzmql9EIZ/LRlKFRIrDjIPTijoTo2dFjCZJwSKlUSLy2Dnt/WoO5+YLg8ZH6VYiJ3beAqcdetQDHLlQcjnk496VssBkDsPpSMDjdg9cD/69Oxjn1OBTEkIhBAZRlsU5WUSAfxe1KAAC2DxQhO/KkBjwc0w3FZGKtg5PQ8ciqVwvYsxU+vatJ1GCCdxxxg1VkUNtQfXAoHFmabZd5CkkNRJCMbdvbsKuMvzHaoHt3oeI7wQ1BvGRQMC7eeGxmqM9vjPOfQiuheELjJJ45wKpSxAvlRwKTOinUMYQ/KMgZprQi1Icnqelaf2fL8dqme3WSMqQPoaDpVSxjRT75GIPHXpSy7puASQB24xWglqGBXaBzUc1qYlyhwB2FBtGpG5nXGBGIx94nr6CrkFsvljcxCjqTVJx+9ILD1xVmOY/Kjcj2NNG0k2lYuDYq/KD71FcbjESABkY6VKnbPOfWrtra+epJwcDrRuY3UdWY64MWXAz9O9RQFt5bsOmO9dA+mI0ORgDrSWuivIm9xtiAJFDg0NVYWbOellbzDwefaoZQQcflXU2ulR+Z5svI61BNp8a3UTAZRzRyspVoJ2RzyRZ6/e9KbZMPtLoMgg11VzYQJbKVILlsFqzLTS1j1R0LZDcgk0ctilWjKLZmX3ygq49/wqe3QrbBuowDn0q/f2SfaXhc4G3jvzU9zaxxwogblxjjoKrl1FzpxSMy5/dorqAcjJqApLJBv6KfX0rpZ4If7McKo3BOabYwRf2YUlx80R2nPSjlIVZKN7dTn7aNvsjHOeefehisTR7xkMa2NBtohaHz13OzEUuqWsJjIChWBBAzRbQbqLncTIn2icBeUPpTihkjKqAcnFaEsMIlCjacqCM1Tu3jjviI5AEJBotbUE77GZIhjc5HIPIpl7yqNtyeo46Voag8LXTlT/AA4JPrWfI6vHCO4yDSsarWzGGLZMcgYI6ikngBWJl/i+9T2uFNps/wCWit09qcEUJmRsDOQM9KG0S7op3YaMFABkHr7U24UEqrcggEVoSRGUAnk9Ki+xMSpLY28g1FiedFCEsLjcwBVhtI/rTRE2woST1I+tay2u0fOMMTwacsGPm4465pmcqiZkQ24CjI+fPSphZEt0G71xV8w/MDzz3qd4iyLtGD9KDCU9TLW1KcgEn2q3HCxYHoB7VfhtxkE9utTpCm8devYU7HNKoV4ogVyQc1ZWIhQMc+/epo08svkjB6UAALgYDZ6E0zmk7kSMqqUYnOeAaQgn7gwTzijy2WQvID259qlB/wBn5R29qUSZEDOACTkR9MHsabCzCZGgDGXdldg6/SkmQsrYztA5psMbB0Ckbz0AzkH2p3u7C6F9/tDIWfSkLZ6+Q3X1xWVqKzNcGW53JMBgqy447cela1zb6hcSszAKxxuXzQCSB1xnrWJcLKsrRzBhIDhgx5FDFE6Zif4QR7e1PiAIy2c9T9ewp4XBB6j1xQB8h2+nI9TUDvcmJCx4H8OefU0vIUb8D8KhT5l2tk5bmrBjGOTxnoaWoDCzHJJ2jd2qfGdqoMjpUCttYBxxU2SQMuc9QBTQmhzEgYQYFM4A3HBPZelN6Nu3HB5p7YZ8gc9yaoSQyRAcFh19P6U9UHzMV6+tKg3Z2gdPyqUIpK4/XvRuWnoMCk/wDHrUUsB3DA+XHNXUQE5OcdcVK6LtyBzRYanZ6GQYQMsetRJEQc++ea05EX+DDYHIqIRNkt271LOiMymIwWJOAT6Us0AIGeh6cVd+zMeTTnjIAB60k7Fc+pgvpgYnjnNVZtNfeSpP4V0ZXOc5yajaDCju3rQzohiJRMBraREAJOQfWp0uZYB8pGD1rRkhJUg8D1xTPso3EbeKE2a+2T+Ir/2hN5S4UY+6RU0mpTSW2xSeOMGrP2YMAu3APGagktfLbhc803Nojng+hWe8n8gxEYBHWsyWe7kaPaCPLPStzylZQdp69PWmNABJwhA9aXMzSFWMehmxvcmIRnPPJNaPmRefG4Q7guOBU4t8jAzinJaoG6kmjmInUTILyFbmRX5xjgiopLN8IrYJHvWl5QHA6mmSKyud2cetDkyFUeyKk1uxtZI0PUcis77PcBMJkYGMVtxgswxg04IRkHJPrRzNjjWcdDmWkuba3RBnIPGO9U2ubmWdywZsetdI9oWYkjI6jNMFmVkBVRk8ZpNs6Y14rVrU5hvtMk5Az6AntTZrWYRZcknqPeusNmNxyAMUqWoK9M49qWo3i10RxgtribOVZVzmpF0+UyLwQMcj1rskth2jKkcn2qQ2qlThe351UfMiWM7I5mz04McMMk96t3enfudqYzjuK3YrXaBkDHt3pz2zOMjiqaOZ4luVzmIYXgQAgHPf0pYofl+cYA6VvrZkOQQNuOlNktNyjb1Gc0rsHWTepkeV5hUAZx+lI9o2AAMg81sJbBEHqByacIiydABxQ9dTJ1ddDHhgBQDAyODxTxEQMKST6CtIwBVI/HNQ7SR3B6cUGbncgigzwu0H3OM1IExuJGPWpgB1Yf8A1qCVByDv9M1RhJtkEgyScZB7U1YkbJYZNWZF2HIGN3cCoWyBjIBP5/Wi5KuNlJO4YG3GDVN8orMA2DxipwR5gR2O1ulNuBuj2fxUJ3CxVywY9D3B7U+3ufs9zG+0NsIYrnmnH/V56MBzSWBVbuCSUDZvHJH60IWhNJbWQ3ObqdVb5irxfN/PmqeoSedcKVVlVUCLv+8QBgE/WtBrjJe2v5hNH1Eo+bYfUH+lV9UZDcKEZJAsaLuU5B4qmSjZGdoA6E9Aae67cZI4HXtTOEKg5JPYduKnkBcRgZ9jUAwVhk5PzewqTcOhz06Y65qsCCwx17D1qwN24AnPr9KkYxo8sQBknnpUyxlQcdTT+iYLd+9OUDaDyePWgbZWmcBWZs4/WnQEvGOOAOvrT7lGZcdQKjslZY8sSTnpjoKa3sC2LSKcY4AxzmpGG0jB4xn8aaDlQQCzZxzTgf3gXOPf1qhCocjGck96kcr5fHHHNNZsIQDuJ54pgDHIzk9yR2p3KS1uPRRsB4yacoBHvT44wwA9+vpQybAD3HJ46ilZFpgFGT6U1lLcsoB6DNSLlsZ6HoKn2YDEjn0NK1w5rGdPDkAdKaLYnJOR34NaDxkEZGQBwBUqRbVDHb9KLF+0sjKEK7eQQPWni3wSAK1GjHlnoQaQoMDC8470cpLqszfIPpimNFg4ZT9c1qMoGDwP1phjMhOen0ocQVRmf5I4+UDjrQLddp3Lx7GtJYcYDY6U8w4GccH0o5QdRmUIevYYppgwuVGDWoYxuPftTzEAMjPvntS5Q9ozHWJwxJ4PTBpfKZsZXjpWuYlPHfrmiOEEc9cniqUUL2plJAAcbc1KIVOeOPWtURLjJXA68imGNcErQ0S6rZmG2IHzE8dqX7MSen6VqiLKfMBu/WkEe3kjpSsHtGY724wfl+Y8UwW+M9j6VsxwByd3SkMAB4AA9adrle1a0M0Ww24OcU2S2KqcH6VpMiEnn5hSeVhTyM45osLnZlLDgkfw1IY9iKO5q6yY68Z6YqNwpJOM0BzXKk0WQuPpUDIVIz3NaH8IVuvcmmFQU+bg9etAuexQIAOMYzUExC8AE1ek+Y8DOPWql1EWKlW6dqmWxSdyLZhMkg5qKSNSRsypHNTxhgMDjv8AjTpEDAEck9qFqJytoVWQsMHr24qJ1IbJGB6GrJ+/3HrUEu5nHTGcimyUNYgpnqw71VlbP3gRz26GrDsNvXp1qGQbiR37UNgtCFPvc9R0zTJ1XaAAQc9T3pdpD4P4HNOY5xkcdqI7Dfcqs7BgT0IpUjZnEYUnJ+UepNR3IZW29WPANWLWRI54yznZ0J9OP/r009RSXYDbQKpRpW8zHO2MlB+Pf64qhNG8UphYfMvUjp7Ee1bZidLmGcLKXVQoCDKHA7NnABrK1B0aZVQg7EWMuvQ+uPamSmbljIZ7ZJmADkD7vTpVljtQEdRmiioQn0II3O8Hvnr+NXFJCsfTgUUUluxssRDfEN3PelJ2sMd6KKENjmYkDNJgIV29xzRRQwRMeo9MU8ou0HHOaKKpiQiAcjA6mnDqccD2ooplEg+V1xxmpJCcn8qKKAW5LCoOeKsMoWIEDmiihAyDeWUE464qxgBRwKKKYMbIBtX2qbaMdO1FFBMtiIgB3AHGcUufnIwMUUUuo2SoBtz705gNp9iKKKZL3IQMO2KUqOD3NFFIbGAcD3pwJG3FFFAiVhgjk8ilVRlfc0UVTJHyAZb8qjY4JwBwM0UU3uC2GsxIJ6cZ4po+bcpAxRRQMilUEn6VE7EKwz0ooqOpYrcjceuKjwDz7UUU2SiKZQMDnnk0SgcjHHpRRSGU5DtGR1zVU/61T6nBoopMtA3DYHrSNxJgdMUUUdBES89exNVn5kx2xmiihhErSctz6Z/Wkc7ZAF4zRRQVLYhf/WMMdBUW8srBuQBxRRQiegxlB2sc5pknGQOlFFNbiIHJC7Mnb6ZqGU4QdOc0UUPYa3P/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythema and fissures are present at the corners of the mouth.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_36_27201=[""].join("\n");
var outline_f26_36_27201=null;
var title_f26_36_27202="Patient information: When you have multiple health problems (The Basics)";
var content_f26_36_27202=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"13\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?0/30/483\">",
"         Patient information: Dealing with side effects from medicines (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?33/16/34050\">",
"         Patient information: Going home from the hospital (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?25/21/25939\">",
"         Patient information: Medical care during advanced illness (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?36/43/37554\">",
"         Patient information: Medicine brand and generic names (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?6/21/6483\">",
"         Patient information: Reducing the costs of medicines (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?31/34/32290\">",
"         Patient information: Taking medicines when you're older (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?11/18/11554\">",
"         Patient information: When you have depression and another health problem (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?31/61/32726\">",
"         Patient information: Reducing the costs of medicines (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: When you have multiple health problems (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H283971788\">",
"      <span class=\"h1\">",
"       Is it common to have multiple health problems?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes, it is common to have more than 1 ongoing health problem. Doctors call this having &ldquo;multiple comorbidities.&rdquo; This is especially common in people as they get older.",
"     </p>",
"     <p>",
"      Here are some medical conditions that often occur together:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Heart disease",
"       </li>",
"       <li>",
"        Diabetes",
"       </li>",
"       <li>",
"        High blood pressure",
"       </li>",
"       <li>",
"        Arthritis or chronic pain",
"       </li>",
"       <li>",
"        Depression or anxiety",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H283971803\">",
"      <span class=\"h1\">",
"       What are the concerns about multiple health problems?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Sometimes, people with multiple health problems see different doctors about each of their problems. These doctors do not always realize how the problem they are working with fits into the &ldquo;whole&rdquo; of you. They might focus on your blood sugar level, but your first worry might be to stop the pain you have from arthritis when you walk. Sometimes, treatment (such as exercise) for 1 problem can make another problem worse. And some medicines can help 1 problem but make another worse. Your doctors need to know who else you see as a patient and work together to form a plan of care that meets your needs best. You can help them do that.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H283971820\">",
"      <span class=\"h1\">",
"       What should I do if I have multiple health problems?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you have multiple health problems, do the following:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Work with your main doctor to decide what matters most to you when it comes to your care. Always remember that you can choose which treatments you want and don&rsquo;t want. Think about these questions and talk to your doctor about your answers:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Which of your health problems bothers you most? Which 1 do you want to focus on first?",
"       </li>",
"       <li>",
"        What matters most to you: living a long time, staying independent, or having the least amount of pain or other symptoms?",
"       </li>",
"       <li>",
"        Are any of your treatments causing side effects or problems?",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Plan your doctor visits wisely, ahead of time. When you see your doctor, make a plan for what you want to discuss and come prepared with notes or questions. Do not try to do too much at once. If you need to, make more than 1 appointment.",
"       </li>",
"       <li>",
"        Make sure that your main doctor, and any other doctor or nurse who prescribes medicines for you knows about",
"        <strong>",
"         all",
"        </strong>",
"        of the medicines you take. This includes any over-the-counter or herbal medicines you use on a regular basis. It is also helpful to bring the actual bottles of pills you take to each visit, so your doctors or nurses can review them. Ask your main doctor or nurse to go over all your medicines with you at least once a year.",
"       </li>",
"       <li>",
"        Keep a list of all the medicines you take that includes the dose you take, your reason for taking it, and the doctor or nurse who prescribed it. Carry this list with you and bring it with you to all of your medical appointments. You can find an example of this kind of list at the following Web site:",
"        <a class=\"external\" href=\"file://www.fda.gov/Drugs/ResourcesForYou/ucm079489.htm\">",
"         www.fda.gov/Drugs/ResourcesForYou/ucm079489.htm",
"        </a>",
"        .",
"       </li>",
"       <li>",
"        Ask your doctors and nurses if there are things you can do on your own to deal with any of your health problems. Some medical problems get better with lifestyle or diet changes. If you can improve your condition with lifestyle changes, you might be able to avoid the risks and side effects of some of your medicines or treatments.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H283971835\">",
"      <span class=\"h1\">",
"       Is there anything I can do on my own to feel better?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. There are things that all people can do to improve their health. Here are some things you can do:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Choose a diet rich in fruits, vegetables, and low-fat dairy products, and low in sweets and processed flours. For example, choose whole grain breads and pastas over white bread or pasta.",
"       </li>",
"       <li>",
"        Do some sort of physical activity most days of the week, and build up your activity level slowly. Even small amounts of activity done several times a day can help you get stronger.",
"       </li>",
"       <li>",
"        Try to get enough sleep. If you have trouble sleeping, talk to your doctor or nurse about possible solutions.",
"       </li>",
"       <li>",
"        If you feel depressed or anxious, talk to your doctor or nurse. Depression and anxiety can make other health problems hard to manage.",
"       </li>",
"       <li>",
"        Plan activities with other people, so you aren&rsquo;t stuck at home alone for days. If friends and family are not around, look at your local paper for ways to meet new people through senior centers, religious groups, libraries, garden clubs, or other activity groups.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H283971850\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/18/11554?source=see_link\">",
"       Patient information: When you have depression and another health problem (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?31/34/32290?source=see_link\">",
"       Patient information: Taking medicines when you're older (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?0/30/483?source=see_link\">",
"       Patient information: Dealing with side effects from medicines (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?33/16/34050?source=see_link\">",
"       Patient information: Going home from the hospital (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/43/37554?source=see_link\">",
"       Patient information: Medicine brand and generic names (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=see_link\">",
"       Patient information: Reducing the costs of medicines (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?25/21/25939?source=see_link\">",
"       Patient information: Medical care during advanced illness (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?31/61/32726?source=see_link\">",
"       Patient information: Reducing the costs of medicines (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?26/36/27202?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 86146 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-6BDFF69EB2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_36_27202=[""].join("\n");
var outline_f26_36_27202=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H283971788\">",
"      Is it common to have multiple health problems?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H283971803\">",
"      What are the concerns about multiple health problems?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H283971820\">",
"      What should I do if I have multiple health problems?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H283971835\">",
"      Is there anything I can do on my own to feel better?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H283971850\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?0/30/483?source=related_link\">",
"      Patient information: Dealing with side effects from medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/16/34050?source=related_link\">",
"      Patient information: Going home from the hospital (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?25/21/25939?source=related_link\">",
"      Patient information: Medical care during advanced illness (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/43/37554?source=related_link\">",
"      Patient information: Medicine brand and generic names (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/61/32726?source=related_link\">",
"      Patient information: Reducing the costs of medicines (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=related_link\">",
"      Patient information: Reducing the costs of medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/34/32290?source=related_link\">",
"      Patient information: Taking medicines when you're older (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/18/11554?source=related_link\">",
"      Patient information: When you have depression and another health problem (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_36_27203="Unoprostone: Drug information";
var content_f26_36_27203=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Unoprostone: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F16160983\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Rescula&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F232423\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Ophthalmic Agent, Antiglaucoma;",
"     </li>",
"     <li>",
"      Prostaglandin, Ophthalmic",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F16328381\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Open-angle glaucoma or ocular hypertension:",
"     </b>",
"     Ophthalmic: Instill 1 drop into affected eye(s) twice daily",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F16328382\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F16328383\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F16328384\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F16160984\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, ophthalmic, as isopropyl ester:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Rescula&reg;: 0.15% (5 mL) [contains benzalkonium chloride]",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F16328385\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be used with other eye drops to lower intraocular pressure; if using more than one product, wait at least 5 minutes between application of each medication. Remove contact lenses prior to administration and wait 15 minutes before reinserting. Minimize contamination by not touching the eyelids or surrounding areas with the dropper tip; keep bottle tightly closed when not in use.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F232401\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     To lower intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F16328366\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &gt;10%: Ocular: Burning/stinging (10% to 25%), dry eyes (10% to 25%), injection (10% to 25%), ophthalmic itching (10% to 25%),  increased length of eyelashes (&ge;1 mm) at 12 months (10% to 14%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cardiovascular: Hypertension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Dizziness, headache, insomnia, pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Endocrine &amp; metabolic: Diabetes mellitus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Neuromuscular &amp; skeletal: Back pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Ocular: Abnormal vision (5% to 10%), eyelid disorder (5% to 10%), foreign body sensation (5% to 10%), lacrimation disorder (5% to 10%), decreased length of eyelashes (7%), blepharitis, cataract, conjunctivitis, corneal lesion, eye discharge, eye hemorrhage, eye pain, irritation, keratitis, photophobia, vitreous disorder",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Respiratory: Bronchitis, cough increased, pharyngitis, rhinitis, sinusitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Miscellaneous: Flu-like syndrome (6%), accidental injury, allergic reaction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &lt;1% (Limited to important or life-threatening): Color blindness, corneal deposits, corneal edema, corneal opacity, diplopia, acute elevated intraocular pressure, hyperpigmentation of the eyelid, increase in number of eyelashes, iris hyperpigmentation, iritis, optic atrophy, ptosis, retinal hemorrhage, visual field defect",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F16328362\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to unoprostone or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F16328363\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Ocular pigmentation: May cause permanent change in eye color (increases the amount of brown pigment in the iris, may not be noticeable for months to years); long-term consequences and potential injury to eye are not known. May also cause pigment changes to periorbital tissues and eyelashes during use; reversible upon discontinuation in most patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Infection: Bacterial keratitis, caused by inadvertent contamination of multiple-dose ophthalmic solutions, has been reported. Minimize contamination by not touching the eyelids or surrounding areas with the dropper tip; keep bottle tightly closed when not in use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Ocular disease: Use with caution in patients with intraocular inflammation (eg, uveitis); may exacerbate intraocular inflammatory conditions. May cause macular edema, including cystoid macular edema; use cautiously in aphakic patients, pseudophakic patients with torn posterior lens capsules, or in patients at risk for macular edema.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Contact lens wearers: Contains benzalkonium chloride which may be adsorbed by contact lenses; remove contacts prior to administration and wait 15 minutes before reinserting.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Contains benzalkonium chloride 0.015% as a preservative.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F16369113\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F16369111\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F16328359\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F16328360\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     In animal reproduction studies, adverse events were observed when administered subcutaneously at doses greater than the recommended human dose. Following ophthalmic administration, systemic absorption is minimal; systemic absorption would be required in order for unoprostone to cross the placenta and reach the fetus. If ophthalmic agents are needed during pregnancy, the minimum effective dose should be used in combination with punctual occlusion to decrease potential exposure to the fetus (Samples, 1988).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F16328361\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F16328441\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is not known if unoprostone is excreted in breast milk; however, systemic absorption is minimal following ophthalmic administration. The manufacturer recommends that caution be exercised when administering unoprostone to nursing women.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16570488\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Rescula Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.15% (5 mL): $118.80",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F16328372\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The exact mechanism of action is unknown; however, unoprostone likely decreases IOP by increasing the outflow of aqueous humor. Cardiovascular and pulmonary function were not affected in clinical studies. IOP was decreased by 3-4 mm Hg in patients with a mean baseline IOP of 23 mm Hg.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F16328374\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Absorption: Through cornea and conjunctival epithelium (minimal systemic exposure)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metabolism: Hydrolyzed by esterases unoprostone-free acid",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life elimination: 14 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Excretion: Urine (as metabolites)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Day DG, Schacknow PN, Wand M, et al, &ldquo;Timolol 0.5%/Dorzolamide 2% Fixed Combination vs Timolol Maleate 0.5% and Unoprostone 0.15% Given Twice Daily to Patients With Primary Open-Angle Glaucoma or Ocular Hypertension,&rdquo;",
"      <i>",
"       Am J Ophthalmol",
"      </i>",
"      , 2003, 135(2):138-43.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/36/27203/abstract-text/12566015/pubmed\" id=\"12566015\" target=\"_blank\">",
"        12566015",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Harms NV and Toris CB, &ldquo;Current Status of Unoprostone for the Management of Glaucoma and the Future of Its Use in the Treatment of Retinal Disease,&rdquo;",
"      <i>",
"       Expert Opin Pharmacother",
"      </i>",
"      , 2013, 14(1);105-13.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/36/27203/abstract-text/23199345/pubmed\" id=\"23199345\" target=\"_blank\">",
"        23199345",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Samples JR and Meyer SM, &ldquo;Use of Ophthalmic Medications in Pregnant and Nursing Women,&rdquo;",
"      <i>",
"       Am J Ophthalmol",
"      </i>",
"      , 1988, 106(5):616-23.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/36/27203/abstract-text/2903673/pubmed\" id=\"2903673\" target=\"_blank\">",
"        2903673",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 87470 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-122.72.76.133-59BD6D52C2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_36_27203=[""].join("\n");
var outline_f26_36_27203=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16160983\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232423\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16328381\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16328382\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16328383\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16328384\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16160984\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16328385\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232401\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16328366\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16328362\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16328363\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16369113\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16369111\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16328359\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16328360\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16328361\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16328441\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16570488\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16328372\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16328374\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/87470\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/87470|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_36_27204="ECG tutorial: Chamber enlargement and hypertrophy";
var content_f26_36_27204=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   ECG tutorial: Chamber enlargement and hypertrophy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/36/27204/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/36/27204/contributors\">",
"     Jordan M Prutkin, MD, MHS, FHRS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/36/27204/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/36/27204/contributors\">",
"     Ary L Goldberger, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/36/27204/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/36/27204/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/36/27204/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     LEFT ATRIAL ABNORMALITY/ENLARGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atrial activation follows discharge of the sinus node. Normally, activation of the right atrium occurs first, followed by left atrial activation, sometimes leading to slight physiologic notching of the P wave. Delay of left atrial activation (interatrial block), as may result from left atrial distension, hypertrophy, scarring, or conduction delay, causes the P wave on the surface ECG to become broadened and often substantially notched, with an interpeak interval &gt;0.04 seconds (",
"    <a class=\"graphic graphic_figure graphicRef79437 \" href=\"UTD.htm?32/54/33645\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef52162 \" href=\"UTD.htm?41/21/42335\">",
"     waveform 1",
"    </a>",
"    ). The voltage of the terminal portion of the P wave is increased if there is left atrial enlargement (&ldquo;P mitrale&rdquo;), reflecting left atrial depolarization.",
"   </p>",
"   <p>",
"    These ECG changes are most apparent in the inferior leads. Leads V1 and V2 show a deeply inverted or negative portion of the P wave (reflecting left atrial activation which is directed posteriorly) with an area that is greater than that of the initial upright portion of the P wave (reflecting right atrial activation, which is directed anteriorly). The negative portion of the P wave in V1 is &gt;1mm wide and &gt;1mm deep, with normal voltage and sweep speed settings. If the P wave in V1 is completely negative, this usually reflects left atrial abnormality, but may be normal or indicate an ectopic atrial focus. In lead II, the P wave is &ge;.12 seconds. The left atrial vector may also increase toward the left (-30&deg; to -90&deg;) if left atrial enlargement progresses and becomes more pronounced, resulting in a negative terminal deflection of the P wave in leads III and aVF.",
"   </p>",
"   <p>",
"    As noted below, a narrow but prominent, entirely negative P wave in lead V1 may also, paradoxically, occur in certain cases of right atrial abnormality, especially when the right atrium is located below the level of the V1 electrode. In such cases, tall, peaked P waves are usually seen in the inferior leads, more typical of right atrial abnormality (&ldquo;P pulmonale&rdquo;).",
"   </p>",
"   <p>",
"    The following criteria suggest left atrial",
"    <span class=\"nowrap\">",
"     enlargement/abnormality",
"    </span>",
"    when correlated with echocardiographic data:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Negative phase of P in V1&gt;0.04 sec &mdash; sensitivity 83 percent; specificity 80 percent",
"     </li>",
"     <li>",
"      Negative phase of P in V1&gt;1 mm &mdash; sensitivity 60 percent; specificity 93 percent",
"     </li>",
"     <li>",
"      P-terminal force &gt;0.04",
"      <span class=\"nowrap\">",
"       mm/sec",
"      </span>",
"      &mdash; sensitivity 69 percent; specificity 93 percent",
"     </li>",
"     <li>",
"      Notched P, interpeak interval &gt;0.04 sec &mdash; sensitivity 15 percent; specificity 100 percent",
"     </li>",
"     <li>",
"      P wave duration &gt;0.11 sec &mdash; sensitivity 33 percent; specificity 88 percent",
"     </li>",
"     <li>",
"      P",
"      <span class=\"nowrap\">",
"       wave/PR",
"      </span>",
"      duration &gt;1.6 &mdash; sensitivity 31 percent; specificity 64 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6705790\">",
"    <span class=\"h2\">",
"     Interatrial block",
"    </span>",
"    &nbsp;&mdash;&nbsp;Interatrial block reflects delay of conduction to the left atrium, usually at the level of the Bachmann bundle. Diagnosis of interatrial block versus left atrial abnormality can be difficult or impossible from the surface ECG. First degree interatrial block is recognized by a P wave &ge;.12 sec, which is usually bimodal in leads I, II, or III. This common finding in the elderly may be seen in those with no evidence of left atrial enlargement on imaging. So-called third degree interatrial block is much less frequently seen. There is absent conduction through the interatrial septum and conduction to the left atrium occurs through the coronary sinus musculature. The ECG criteria are a P wave &ge;0.12 sec, with a bimodal P wave in lead I and aVL and biphasic P wave (positive then negative) in leads II, III, and aVF, and frequently also in V1-V2. Second degree interatrial block has been defined by a pattern of changing P wave morphology from normal to interatrial block or from first degree to third degree interatrial block.",
"   </p>",
"   <p>",
"    First degree interatrial block with a prolonged P wave duration, especially with a P wave &gt;.123 sec, has been associated with an increase in all-cause and cardiovascular mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27204/abstract/1\">",
"     1",
"    </a>",
"    ]. Third degree interatrial block has been associated with supraventricular arrhythmias [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27204/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     RIGHT ATRIAL ABNORMALITY/ENLARGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Delayed activation of the right atrium as a result of dilatation, hypertrophy, scarring, or a conduction abnormality leads to simultaneous activation of the right and left atria. This synchronous electrical activity has an additive effect upon the surface ECG, resulting in a relatively narrow P wave that is of increased amplitude (&ldquo;P pulmonale&rdquo;) (",
"    <a class=\"graphic graphic_figure graphicRef63181 \" href=\"UTD.htm?36/30/37357\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef78126 \" href=\"UTD.htm?22/59/23472\">",
"     waveform 2",
"    </a>",
"    ). The most common finding is a P wave &gt;2.5 mm in lead II. In addition, a P wave &gt;1.5 mm in V1 or V2 or a P wave that has a rightward axis may be seen. The amplitude of the P wave may become significantly increased in the presence of right atrial",
"    <span class=\"nowrap\">",
"     hypertrophy/overload,",
"    </span>",
"    and it becomes peaked due to the increase in amount of depolarized tissue. If the right atrium becomes sufficiently large it may extend toward the left, causing P waves in V1 to be inverted and giving the illusion of left atrial enlargement. In contrast to left atrial abnormality or interatrial block, the P wave duration is usually normal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     LEFT VENTRICULAR HYPERTROPHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pathologic left ventricular hypertrophy (LVH) is present when there is substantially increased LV muscle mass associated with concentric, eccentric, or asymmetric patterns. LVH is usually the result of an increase in systolic pressure generated by the LV in response to increased resistance to contraction; this type of pressure load most commonly occurs with long standing hypertension or aortic outflow obstruction, particularly aortic stenosis. LVH can also be due to sustained mitral or aortic regurgitation (volume loads) or to dilated cardiomyopathies. More rarely, LVH can also be associated with other diseases such as hypertrophic cardiomyopathy and its variants.",
"   </p>",
"   <p>",
"    It takes longer for an electrical impulse to traverse the hypertrophied ventricular muscle, and the amplitude of the impulse is increased since there is a greater muscle mass. Thus, the QRS complex has an increased amplitude and is often slightly widened, reflecting an intraventricular conduction delay (",
"    <a class=\"graphic graphic_waveform graphicRef69040 \" href=\"UTD.htm?41/58/42922\">",
"     waveform 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/13/3285?source=see_link\">",
"     \"Electrocardiographic diagnosis of left ventricular hypertrophy\"",
"    </a>",
"    .) The widening is primarily observed as an initial slowing in the inscription of the QRS complex to &gt;0.04 seconds (the time to reach the peak of the R wave is delayed); this is known as a delay in the intrinsicoid deflection. A similar pattern of tall QRS voltage may be seen in young people who have thin chest walls; however, in these patients the intrinsicoid deflection is normal and there is no hypertrophy or delay in activation or conduction.",
"   </p>",
"   <p>",
"    The changes of LVH are often associated with other ECG abnormalities, including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Left atrial abnormality",
"     </li>",
"     <li>",
"      Left axis deviation due to the increased mass of left ventricular muscle",
"     </li>",
"     <li>",
"      ST segment and T wave abnormalities (downsloping ST segment depression and T wave inversion)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The ST-T wave abnormalities have often been termed a \"strain pattern\", though are now more frequently described as &ldquo;LVH with associated ST-T wave abnormalities&rdquo;. They probably represent either subendocardial ischemia, which results from a relative lack of blood and oxygen supply to the hypertrophied muscle as demand is greater than supply, or repolarization abnormalities of the hypertrophied cardiac muscle. The changes are most frequently seen in the left lateral leads (I, aVL, V5-6); they may also occur in the inferior leads when a vertical heart is present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     ECG criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;There have been multiple ECG criteria proposed for diagnosing LVH. The most popular include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sokolow and Lyon &mdash; Amplitude of S wave in lead V1 + amplitude of R wave in V5 or V6 (whichever is the tallest) &ge;35 mm.",
"     </li>",
"     <li>",
"      Cornell &mdash; Amplitude of R wave in aVL + amplitude of S wave in V3 &gt;28 mm for men, or &gt;20 mm for women.",
"     </li>",
"     <li>",
"      Roberts &mdash; QRS voltage in all leads &gt;175 to 225 mm.",
"     </li>",
"     <li>",
"      Scott &mdash;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;Limb leads:",
"    <br/>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;R in I + S in 3 more than 25 mm",
"    <br/>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;R in aVL more than 11 mm or &gt;18 mm if left axis is present",
"    <br/>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;R in aVF more than 20 mm",
"    <br/>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;S in aVR more than 14 mm",
"    <br/>",
"    <br/>",
"    &nbsp; &nbsp; &nbsp;Chest leads:",
"    <br/>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;S in V1 or V2 + R in V5 or V6 more than 35 mm",
"    <br/>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;R in V5 or V6 more than 26 mm",
"    <br/>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;R + S in any V lead more than 45 mm",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Romhilt-Estes scoring system &mdash; This index gives different weights to specific findings (",
"      <a class=\"graphic graphic_table graphicRef51012 \" href=\"UTD.htm?43/2/44075\">",
"       table 1",
"      </a>",
"      ). A score of 5 or more indicates \"definite\" LVH; a score of 4 indicates \"probable\" LVH.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Among the most specific (although not sensitive) criterion is the amplitude of the R wave in lead aVL; LVH is present when this is greater than 11 mm (or 18 mm in the presence of left axis deviation).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     RIGHT VENTRICULAR HYPERTROPHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Right ventricular hypertrophy (RVH) is present when there is an increase in muscle mass of the right ventricle. This may be seen with pulmonary hypertension, pulmonic stenosis, or severe lung disease and cor pulmonale.",
"   </p>",
"   <p>",
"    The right ventricular forces become predominant in patients with RVH (especially due to a pressure load as with pulmonic outflow obstruction or severe pulmonary hypertension), producing tall R waves in the right precordial leads (V1 and V2), and deep S waves in the left precordial leads (V5 and V6) (",
"    <a class=\"graphic graphic_waveform graphicRef63763 \" href=\"UTD.htm?41/46/42730\">",
"     waveform 4",
"    </a>",
"    ). Because of the increase in the amplitude of the R wave and decrease in the depth of the S wave, the R:S ratio in V1 &gt;1 is suggestive of RVH. However, there are other causes of an increased R:S ratio that must be excluded before a diagnosis of RVH can be definitively established (",
"    <a class=\"graphic graphic_table graphicRef72039 \" href=\"UTD.htm?11/27/11707\">",
"     table 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Right bundle branch block",
"     </li>",
"     <li>",
"      Posterior wall myocardial infarction",
"     </li>",
"     <li>",
"      Wolff-Parkinson-White syndrome",
"     </li>",
"     <li>",
"      Hypertrophic cardiomyopathy (septal hypertrophy)",
"     </li>",
"     <li>",
"      Early precordial transition (counterclockwise rotation)",
"     </li>",
"     <li>",
"      Normal or positional variant",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Obtaining an R:S ratio &gt;1 from a right sided precordial lead (V3R or V4R) may be a more reliable indicator of RVH.",
"   </p>",
"   <p>",
"    Right axis deviation (axis &gt;+90&ordm;) is often present with RVH. There also may be associated right atrial overload and ST segment and T wave abnormalities in the right precordial leads, reflecting subendocardial ischemia or repolarization abnormalities of the right ventricular myocardium.",
"   </p>",
"   <p>",
"    Thus, reported clues to the diagnosis of right ventricular hypertrophy include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Right axis deviation (&gt;+90)",
"     </li>",
"     <li>",
"      R in V1 &gt;6 mm",
"     </li>",
"     <li>",
"      R in V1 + S in V5 or V6 &gt;10.5 mm",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       R/S",
"      </span>",
"      ratio in V1 &gt;1",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       S/R",
"      </span>",
"      ratio in V6 &gt;1",
"     </li>",
"     <li>",
"      Late intrinsicoid deflection in V1 (&gt;0.035 sec)",
"     </li>",
"     <li>",
"      Incomplete right bundle branch block",
"     </li>",
"     <li>",
"      ST-T wave abnormalities (\"strain\") in inferior leads",
"     </li>",
"     <li>",
"      Right atrial",
"      <span class=\"nowrap\">",
"       hypertrophy/overload",
"      </span>",
"      (&ldquo;P pulmonale&rdquo;)",
"     </li>",
"     <li>",
"      S&gt;R in leads I, II, III, particularly in children (S1S2S3 pattern)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     BIVENTRICULAR HYPERTROPHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biventricular hypertrophy is suggested on the ECG if there are voltage criteria for LVH, combined with right axis deviation, prominent R wave in V1-V2, prominent S wave in V5-6, tall biphasic",
"    <span class=\"nowrap\">",
"     R/S",
"    </span>",
"    complexes,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    right atrial abnormality (",
"    <a class=\"graphic graphic_waveform graphicRef75570 \" href=\"UTD.htm?41/51/42810\">",
"     waveform 5",
"    </a>",
"    ). In some cases there will be evidence of left atrial enlargement or tall R wave and deep S waves in V2-4 (&gt;60mm combined) combined with criteria diagnostic of RVH, including",
"    <span class=\"nowrap\">",
"     R/S",
"    </span>",
"    ratio &gt;1 in V1-V2 or",
"    <span class=\"nowrap\">",
"     S/R",
"    </span>",
"    ratio &gt;1 in V5-V6, a deep S wave in V5-V6, or right axis deviation. The latter may also be seen with mitral stenosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6705841\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There is no single best electrocardiographic criterion for diagnosis of hypertrophy of any of the cardiac chambers. Several different sets of criteria have been used with various sensitivities and specificities.",
"     </li>",
"     <li>",
"      Left atrial",
"      <span class=\"nowrap\">",
"       abnormality/enlargement",
"      </span>",
"      is characterized by P waves that are broad and often notched, with an interpeak interval &gt;0.04 seconds (",
"      <a class=\"graphic graphic_figure graphicRef79437 \" href=\"UTD.htm?32/54/33645\">",
"       figure 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_waveform graphicRef52162 \" href=\"UTD.htm?41/21/42335\">",
"       waveform 1",
"      </a>",
"      ). The voltage of the terminal portion of the P wave may be increased, especially if there is left atrial enlargement (classical &ldquo;P mitrale&rdquo;), reflecting left atrial depolarization. These ECG changes are most apparent in the inferior leads and V1. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Left atrial abnormality/enlargement'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Right atrial",
"      <span class=\"nowrap\">",
"       abnormality/enlargement",
"      </span>",
"      is characterized by P waves that are relatively narrow but of increased amplitude (classic &ldquo;P pulmonale&rdquo;) (",
"      <a class=\"graphic graphic_figure graphicRef63181 \" href=\"UTD.htm?36/30/37357\">",
"       figure 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_waveform graphicRef78126 \" href=\"UTD.htm?22/59/23472\">",
"       waveform 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Right atrial abnormality/enlargement'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Left ventricular hypertrophy is characterized by the QRS complex having increased amplitude and usually slight widening, reflecting an intraventricular conduction delay (",
"      <a class=\"graphic graphic_waveform graphicRef69040 \" href=\"UTD.htm?41/58/42922\">",
"       waveform 3",
"      </a>",
"      ). There are often associated ST segment and T wave abnormalities. Evidence of left atrial abnormality and left axis deviation is commonly seen. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Left ventricular hypertrophy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Right ventricular hypertrophy is characterized by an increase in the amplitude of the R wave and a decrease in the depth of the S wave in the right precordial leads, causing an increase in the R:S ratio (",
"      <a class=\"graphic graphic_waveform graphicRef63763 \" href=\"UTD.htm?41/46/42730\">",
"       waveform 4",
"      </a>",
"      ) usually with a vertical or frankly rightward QRS axis. Evidence of right atrial abnormality may be present. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Right ventricular hypertrophy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6705767\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The UpToDate editorial staff would&nbsp;like to thank Dr. Philip J. Podrid for his contributions as an author to previous versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27204/abstract/1\">",
"      Bay&eacute;s de Luna A, Platonov P, Cosio FG, et al. Interatrial blocks. A separate entity from left atrial enlargement: a consensus report. J Electrocardiol 2012; 45:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27204/abstract/2\">",
"      Magnani JW, Gorodeski EZ, Johnson VM, et al. P wave duration is associated with cardiovascular and all-cause mortality outcomes: the National Health and Nutrition Examination Survey. Heart Rhythm 2011; 8:93.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2123 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-DA858D2583-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_36_27204=[""].join("\n");
var outline_f26_36_27204=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H6705841\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      LEFT ATRIAL ABNORMALITY/ENLARGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6705790\">",
"      Interatrial block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      RIGHT ATRIAL ABNORMALITY/ENLARGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      LEFT VENTRICULAR HYPERTROPHY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ECG criteria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      RIGHT VENTRICULAR HYPERTROPHY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      BIVENTRICULAR HYPERTROPHY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6705841\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6705767\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/2123\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/2123|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/54/33645\" title=\"figure 1\">",
"      Left atrial enlargement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/30/37357\" title=\"figure 2\">",
"      Right atrial enlargement",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/2123|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?43/2/44075\" title=\"table 1\">",
"      Romhilt Estes point score",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/27/11707\" title=\"table 2\">",
"      Causes and diagnosis of tall R waves in V1",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/2123|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?41/21/42335\" title=\"waveform 1\">",
"      LA enlargement tutorial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?22/59/23472\" title=\"waveform 2\">",
"      RA enlargement ECG tutorial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?41/58/42922\" title=\"waveform 3\">",
"      LVH tutorial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?41/46/42730\" title=\"waveform 4\">",
"      RVH tutorial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?41/51/42810\" title=\"waveform 5\">",
"      Biventricular enlarge tutorial",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/13/3285?source=related_link\">",
"      Electrocardiographic diagnosis of left ventricular hypertrophy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_36_27205="Calculator: Rheumatoid arthritis Clinical Disease Activity Index (CDAI)";
var content_f26_36_27205=[" <div id=\"topicText\">",
"  <div id=\"mc3k\">",
"   <form action=\"\" id=\"RheumatoidArthritisCDAI_form\" name=\"RheumatoidArthritisCDAI_form\" onkeydown=\"clrResults();\" onkeyup=\"RheumatoidArthritisCDAI_fx();\" onreset=\"rrclr();\" onsubmit=\"return false;\">",
"    <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"100%\">",
"     <tr>",
"      <td bgcolor=\"#eeeeee\" width=\"1%\">",
"       <br/>",
"      </td>",
"      <td align=\"left\" bgcolor=\"#eeeeee\">",
"       <span class=\"medCalcFontTitleBox\">",
"        Calculator: Rheumatoid arthritis Clinical Disease Activity Index (CDAI)",
"       </span>",
"      </td>",
"     </tr>",
"    </table>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <center>",
"     <div id=\"calc_equation\">",
"      <table cellpadding=\"10\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"       <tr>",
"        <td align=\"left\" bgcolor=\"#6c9a9c\">",
"         <span class=\"medCalcFontFormuli\">",
"          CDAI = SJC + TJC + PGA + EGA",
"         </span>",
"        </td>",
"       </tr>",
"      </table>",
"      <br/>",
"      &nbsp;",
"      <br/>",
"     </div>",
"    </center>",
"    <div id=\"calc_main\">",
"     <center>",
"      <table cellpadding=\"6\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"95%\">",
"       <tr>",
"        <td align=\"right\" width=\"50%\">",
"         <center>",
"          <span class=\"medCalcFontIO\">",
"           Input:",
"          </span>",
"          <br/>",
"          &nbsp;",
"          <br/>",
"          <table cellpadding=\"3\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              PGA",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"PGA_param\" onblur=\"RheumatoidArthritisCDAI_fx(); minMaxCheck();\" onchange=\"RheumatoidArthritisCDAI_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"PGA_unit\" onchange=\"RheumatoidArthritisCDAI_fx();\" style=\"width:105px;\">",
"              <option selected=\"selected\" value=\"1|0|#\">",
"               #",
"              </option>",
"              <option value=\"1|0|index\">",
"               index",
"              </option>",
"              <option value=\"1|0|none\">",
"               none",
"              </option>",
"              <option value=\"1|0|number\">",
"               number",
"              </option>",
"              <option value=\"1|0|points\">",
"               points",
"              </option>",
"              <option value=\"1|0|score\">",
"               score",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              EGA",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"EGA_param\" onblur=\"RheumatoidArthritisCDAI_fx(); minMaxCheck();\" onchange=\"RheumatoidArthritisCDAI_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"EGA_unit\" onchange=\"RheumatoidArthritisCDAI_fx();\" style=\"width:105px;\">",
"              <option selected=\"selected\" value=\"1|0|#\">",
"               #",
"              </option>",
"              <option value=\"1|0|index\">",
"               index",
"              </option>",
"              <option value=\"1|0|none\">",
"               none",
"              </option>",
"              <option value=\"1|0|number\">",
"               number",
"              </option>",
"              <option value=\"1|0|points\">",
"               points",
"              </option>",
"              <option value=\"1|0|score\">",
"               score",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"          </table>",
"         </center>",
"        </td>",
"        <td align=\"left\" bgcolor=\"#eeeeee\">",
"         <center>",
"          <span class=\"medCalcFontIO\">",
"           Result:",
"          </span>",
"          <br/>",
"          &nbsp;",
"          <br/>",
"          <table bgcolor=\"#eeeeee\" cellspacing=\"4\" summary=\"MedCalc 3000 Table\">",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              CDAI",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input name=\"CDAI_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"            </td>",
"            <td valign=\"top\">",
"             <span class=\"medCalcFontOne\">",
"              <select class=\"medCalcFontSelect\" name=\"CDAI_unit\" onchange=\"RheumatoidArthritisCDAI_fx();\" style=\"width:105px;\">",
"               <option value=\"1|0|#\">",
"                #",
"               </option>",
"               <option value=\"1|0|index\">",
"                index",
"               </option>",
"               <option value=\"1|0|none\">",
"                none",
"               </option>",
"               <option value=\"1|0|number\">",
"                number",
"               </option>",
"               <option value=\"1|0|points\">",
"                points",
"               </option>",
"               <option selected=\"selected\" value=\"1|0|score\">",
"                score",
"               </option>",
"              </select>",
"             </span>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td colspan=\"3\">",
"             &nbsp;",
"             <br/>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"center\" colspan=\"3\">",
"             <span class=\"medCalcFontOneBold\">",
"              Decimal Precision:",
"             </span>",
"             <select class=\"medCalcFontSelect\" name=\"decpts\" onchange=\"RheumatoidArthritisCDAI_fx();\">",
"              <option>",
"               0",
"              </option>",
"              <option selected=\"selected\">",
"               1",
"              </option>",
"              <option>",
"               2",
"              </option>",
"              <option>",
"               3",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"          </table>",
"         </center>",
"         <br/>",
"         &nbsp;",
"         <br/>",
"         <center>",
"          <span class=\"medCalcFontOne\">",
"           <input name=\"reset\" type=\"reset\" value=\"Reset form\"/>",
"          </span>",
"         </center>",
"        </td>",
"       </tr>",
"      </table>",
"     </center>",
"     <br/>",
"     &nbsp;",
"     <br/>",
"     <center>",
"      <table border=\"0\" cellpadding=\"5\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"80%\">",
"       <tr>",
"        <td align=\"center\" valign=\"top\">",
"         <table border=\"1\" cellpadding=\"10\" class=\"medCalcFontOneBold\" summary=\"MedCalc 3000 Table\">",
"          <tr>",
"           <td align=\"center\" colspan=\"2\">",
"            <b>",
"             Tender Joint Count",
"            </b>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td align=\"left\" valign=\"top\">",
"            <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"medCalcFontOneBold\" summary=\"MedCalc 3000 Table\">",
"             <tr>",
"              <td bgcolor=\"#ffffff\" height=\"20\">",
"               <br/>",
"              </td>",
"              <td align=\"left\" bgcolor=\"#cccccc\" colspan=\"8\" valign=\"middle\">",
"               &nbsp;",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"               &nbsp;Shoulder",
"              </td>",
"             </tr>",
"             <tr>",
"              <td bgcolor=\"#ffffff\" colspan=\"9\" height=\"5\">",
"              </td>",
"             </tr>",
"             <tr>",
"              <td bgcolor=\"#ffffff\" height=\"20\">",
"               <br/>",
"              </td>",
"              <td align=\"left\" bgcolor=\"#cccccc\" colspan=\"8\" valign=\"middle\">",
"               &nbsp;",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"               &nbsp;Elbow",
"              </td>",
"             </tr>",
"             <tr>",
"              <td bgcolor=\"#ffffff\" colspan=\"9\" height=\"5\">",
"              </td>",
"             </tr>",
"             <tr>",
"              <td bgcolor=\"#ffffff\" height=\"20\">",
"               <br/>",
"              </td>",
"              <td align=\"left\" bgcolor=\"#cccccc\" colspan=\"8\" valign=\"middle\">",
"               &nbsp;",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"               &nbsp;Wrist",
"              </td>",
"             </tr>",
"             <tr>",
"              <td bgcolor=\"#ffffff\" colspan=\"9\" height=\"10\">",
"              </td>",
"             </tr>",
"             <tr>",
"              <td bgcolor=\"#ffffff\" class=\"tipl\" height=\"20\" width=\"20\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\" colspan=\"8\" valign=\"bottom\">",
"               Right hand",
"              </td>",
"             </tr>",
"             <tr>",
"              <td align=\"center\" bgcolor=\"#cccccc\" height=\"20\" width=\"20\">",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\" colspan=\"8\">",
"               <span class=\"medCalcFontTwo\">",
"                MCP 1-5",
"                <br/>",
"                IP 1, PIP 2-5",
"               </span>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td align=\"center\" bgcolor=\"#cccccc\" width=\"20\">",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" width=\"3\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\" width=\"20\">",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" width=\"3\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\" width=\"20\">",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" width=\"3\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\" width=\"20\">",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" width=\"3\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\" width=\"20\">",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td bgcolor=\"ffffff\" class=\"tip1\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\">",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\">",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\">",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\">",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\">",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td bgcolor=\"#ffffff\" colspan=\"2\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" class=\"tip2\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" class=\"tip3\" height=\"30\">",
"              </td>",
"              <td bgcolor=\"#ffffff\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" class=\"tip2\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" class=\"tip1\" height=\"30\">",
"               <br/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td colspan=\"9\">",
"               <br/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td height=\"20\">",
"               <br/>",
"              </td>",
"              <td align=\"left\" bgcolor=\"#cccccc\" colspan=\"8\" valign=\"middle\">",
"               &nbsp;",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"               &nbsp;Knee",
"              </td>",
"             </tr>",
"            </table>",
"           </td>",
"           <td align=\"left\" valign=\"top\">",
"            <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"medCalcFontOneBold\" summary=\"MedCalc 3000 Table\">",
"             <tr>",
"              <td align=\"right\" bgcolor=\"#cccccc\" colspan=\"8\" height=\"20\" valign=\"middle\">",
"               Shoulder&nbsp;",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"               &nbsp;",
"              </td>",
"              <td>",
"               <br/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td colspan=\"9\" height=\"5\">",
"              </td>",
"             </tr>",
"             <tr>",
"              <td align=\"right\" bgcolor=\"#cccccc\" colspan=\"8\" height=\"20\" valign=\"middle\">",
"               Elbow&nbsp;",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"               &nbsp;",
"              </td>",
"              <td>",
"               <br/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td colspan=\"9\" height=\"5\">",
"              </td>",
"             </tr>",
"             <tr>",
"              <td align=\"right\" bgcolor=\"#cccccc\" colspan=\"8\" height=\"20\" valign=\"middle\">",
"               Wrist&nbsp;",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"               &nbsp;",
"              </td>",
"              <td>",
"               <br/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td colspan=\"9\" height=\"10\">",
"              </td>",
"             </tr>",
"             <tr>",
"              <td align=\"center\" bgcolor=\"#cccccc\" colspan=\"8\" valign=\"bottom\">",
"               Left hand",
"              </td>",
"              <td bgcolor=\"#ffffff\" class=\"tipr\" height=\"20\" width=\"20\">",
"               <br/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td align=\"center\" bgcolor=\"#cccccc\" colspan=\"8\" height=\"20\">",
"               <span class=\"medCalcFontTwo\">",
"                MCP 1-5",
"                <br/>",
"                IP 1, PIP 2-5",
"               </span>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\" width=\"20\">",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td align=\"center\" bgcolor=\"#cccccc\" width=\"20\">",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" width=\"3\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\" width=\"20\">",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" width=\"3\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\" width=\"20\">",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" width=\"3\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\" width=\"20\">",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" width=\"3\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\" width=\"20\">",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td align=\"center\" bgcolor=\"#cccccc\">",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\">",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\">",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\">",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" class=\"tip1\" height=\"30\">",
"               <br/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td bgcolor=\"#ffffff\" class=\"tip1\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" class=\"tip2\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" class=\"tip3\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" class=\"tip2\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" colspan=\"2\">",
"               <br/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td colspan=\"9\">",
"               <br/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td align=\"right\" bgcolor=\"#cccccc\" colspan=\"8\" height=\"20\" valign=\"middle\">",
"               Knee&nbsp;",
"               <input name=\"TJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"               &nbsp;",
"              </td>",
"              <td>",
"               <br/>",
"              </td>",
"             </tr>",
"            </table>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td align=\"center\" colspan=\"2\">",
"            TJC &nbsp;",
"            <input name=\"TJC_param\" onfocus=\"blur();\" size=\"3\" type=\"text\"/>",
"            &nbsp;&nbsp;&nbsp;",
"            <input onclick=\"TJCAll();\" type=\"button\" value=\"Select All\"/>",
"            &nbsp;&nbsp;&nbsp;",
"            <input onclick=\"TJCClr();\" type=\"button\" value=\"Clear All\"/>",
"           </td>",
"          </tr>",
"         </table>",
"        </td>",
"        <td align=\"center\" valign=\"top\">",
"         <table border=\"1\" cellpadding=\"10\" class=\"medCalcFontOneBold\" summary=\"MedCalc 3000 Table\">",
"          <tr>",
"           <td align=\"center\" colspan=\"2\">",
"            <b>",
"             Swollen Joint Count",
"            </b>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td align=\"left\" valign=\"top\">",
"            <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"medCalcFontOneBold\" summary=\"MedCalc 3000 Table\">",
"             <tr>",
"              <td bgcolor=\"#ffffff\" height=\"20\">",
"               <br/>",
"              </td>",
"              <td align=\"left\" bgcolor=\"#cccccc\" colspan=\"8\" valign=\"middle\">",
"               &nbsp;",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"               &nbsp;Shoulder",
"              </td>",
"             </tr>",
"             <tr>",
"              <td bgcolor=\"#ffffff\" colspan=\"9\" height=\"5\">",
"              </td>",
"             </tr>",
"             <tr>",
"              <td bgcolor=\"#ffffff\" height=\"20\">",
"               <br/>",
"              </td>",
"              <td align=\"left\" bgcolor=\"#cccccc\" colspan=\"8\" valign=\"middle\">",
"               &nbsp;",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"               &nbsp;Elbow",
"              </td>",
"             </tr>",
"             <tr>",
"              <td bgcolor=\"#ffffff\" colspan=\"9\" height=\"5\">",
"              </td>",
"             </tr>",
"             <tr>",
"              <td bgcolor=\"#ffffff\" height=\"20\">",
"               <br/>",
"              </td>",
"              <td align=\"left\" bgcolor=\"#cccccc\" colspan=\"8\" valign=\"middle\">",
"               &nbsp;",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"               &nbsp;Wrist",
"              </td>",
"             </tr>",
"             <tr>",
"              <td bgcolor=\"#ffffff\" colspan=\"9\" height=\"10\">",
"              </td>",
"             </tr>",
"             <tr>",
"              <td bgcolor=\"#ffffff\" class=\"tipl\" height=\"20\" width=\"20\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\" colspan=\"8\" valign=\"bottom\">",
"               Right hand",
"              </td>",
"             </tr>",
"             <tr>",
"              <td align=\"center\" bgcolor=\"#cccccc\" height=\"20\" width=\"20\">",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\" colspan=\"8\">",
"               <span class=\"medCalcFontTwo\">",
"                MCP 1-5",
"                <br/>",
"                IP 1, PIP 2-5",
"               </span>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td align=\"center\" bgcolor=\"#cccccc\" width=\"20\">",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" width=\"3\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\" width=\"20\">",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" width=\"3\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\" width=\"20\">",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" width=\"3\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\" width=\"20\">",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" width=\"3\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\" width=\"20\">",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td bgcolor=\"ffffff\" class=\"tip1\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\">",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\">",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\">",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\">",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\">",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td bgcolor=\"#ffffff\" colspan=\"2\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" class=\"tip2\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" class=\"tip3\" height=\"30\">",
"              </td>",
"              <td bgcolor=\"#ffffff\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" class=\"tip2\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" class=\"tip1\" height=\"30\">",
"               <br/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td colspan=\"9\">",
"               <br/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td height=\"20\">",
"               <br/>",
"              </td>",
"              <td align=\"left\" bgcolor=\"#cccccc\" colspan=\"8\" valign=\"middle\">",
"               &nbsp;",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"               &nbsp;Knee",
"              </td>",
"             </tr>",
"            </table>",
"           </td>",
"           <td align=\"left\" valign=\"top\">",
"            <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"medCalcFontOneBold\" summary=\"MedCalc 3000 Table\">",
"             <tr>",
"              <td align=\"right\" bgcolor=\"#cccccc\" colspan=\"8\" height=\"20\" valign=\"middle\">",
"               Shoulder&nbsp;",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"               &nbsp;",
"              </td>",
"              <td>",
"               <br/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td colspan=\"9\" height=\"5\">",
"              </td>",
"             </tr>",
"             <tr>",
"              <td align=\"right\" bgcolor=\"#cccccc\" colspan=\"8\" height=\"20\" valign=\"middle\">",
"               Elbow&nbsp;",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"               &nbsp;",
"              </td>",
"              <td>",
"               <br/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td colspan=\"9\" height=\"5\">",
"              </td>",
"             </tr>",
"             <tr>",
"              <td align=\"right\" bgcolor=\"#cccccc\" colspan=\"8\" height=\"20\" valign=\"middle\">",
"               Wrist&nbsp;",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"               &nbsp;",
"              </td>",
"              <td>",
"               <br/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td colspan=\"9\" height=\"10\">",
"              </td>",
"             </tr>",
"             <tr>",
"              <td align=\"center\" bgcolor=\"#cccccc\" colspan=\"8\" valign=\"bottom\">",
"               Left hand",
"              </td>",
"              <td bgcolor=\"#ffffff\" class=\"tipr\" height=\"20\" width=\"20\">",
"               <br/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td align=\"center\" bgcolor=\"#cccccc\" colspan=\"8\" height=\"20\">",
"               <span class=\"medCalcFontTwo\">",
"                MCP 1-5",
"                <br/>",
"                IP 1, PIP 2-5",
"               </span>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\" width=\"20\">",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td align=\"center\" bgcolor=\"#cccccc\" width=\"20\">",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" width=\"3\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\" width=\"20\">",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" width=\"3\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\" width=\"20\">",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" width=\"3\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\" width=\"20\">",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" width=\"3\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\" width=\"20\">",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td align=\"center\" bgcolor=\"#cccccc\">",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\">",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\">",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\">",
"               <br/>",
"              </td>",
"              <td align=\"center\" bgcolor=\"#cccccc\">",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"              </td>",
"              <td bgcolor=\"#ffffff\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" class=\"tip1\" height=\"30\">",
"               <br/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td bgcolor=\"#ffffff\" class=\"tip1\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" class=\"tip2\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" class=\"tip3\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" class=\"tip2\" height=\"30\">",
"               <br/>",
"              </td>",
"              <td bgcolor=\"#ffffff\" colspan=\"2\">",
"               <br/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td colspan=\"9\">",
"               <br/>",
"              </td>",
"             </tr>",
"             <tr>",
"              <td align=\"right\" bgcolor=\"#cccccc\" colspan=\"8\" height=\"20\" valign=\"middle\">",
"               Knee&nbsp;",
"               <input name=\"SJC_box\" onclick=\"RheumatoidArthritisCDAI_fx();\" style=\"height: 12px; width: 12px;\" type=\"checkbox\"/>",
"               &nbsp;",
"              </td>",
"              <td>",
"               <br/>",
"              </td>",
"             </tr>",
"            </table>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td align=\"center\" colspan=\"2\">",
"            SJC &nbsp;",
"            <input name=\"SJC_param\" onfocus=\"blur();\" size=\"3\" type=\"text\"/>",
"            &nbsp;&nbsp;&nbsp;",
"            <input onclick=\"SJCAll();\" type=\"button\" value=\"Select All\"/>",
"            &nbsp;&nbsp;&nbsp;",
"            <input onclick=\"SJCClr();\" type=\"button\" value=\"Clear All\"/>",
"           </td>",
"          </tr>",
"         </table>",
"        </td>",
"       </tr>",
"      </table>",
"     </center>",
"     <br/>",
"     &nbsp;",
"     <br/>",
"     <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"70%\">",
"      <tr>",
"       <td bgcolor=\"#eeeeee\" width=\"1%\">",
"        <br/>",
"       </td>",
"       <td align=\"left\" bgcolor=\"#eeeeee\">",
"        <span class=\"medCalcFontTitleBox\">",
"         CDAI Interpretation",
"        </span>",
"       </td>",
"      </tr>",
"     </table>",
"     <br/>",
"     &nbsp;",
"     <br/>",
"     <center>",
"      <table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" summary=\"RRTable\">",
"       <tr id=\"rr1_1\">",
"        <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px\">",
"         <span class=\"medCalcFontOneBold\">",
"          CDAI &lt;= 2.8:",
"         </span>",
"        </td>",
"        <td align=\"left\" style=\"border-left: 0px;\">",
"         <span class=\"medCalcFontOne\">",
"          Remission",
"         </span>",
"        </td>",
"       </tr>",
"       <tr id=\"rr1_2\">",
"        <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px\">",
"         <span class=\"medCalcFontOneBold\">",
"          CDAI &gt; 2.8 and &lt;= 10:",
"         </span>",
"        </td>",
"        <td align=\"left\" style=\"border-left: 0px;\">",
"         <span class=\"medCalcFontOne\">",
"          Low Disease Activity",
"         </span>",
"        </td>",
"       </tr>",
"       <tr id=\"rr1_3\">",
"        <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px\">",
"         <span class=\"medCalcFontOneBold\">",
"          CDAI &gt; 10 and &lt;= 22:",
"         </span>",
"        </td>",
"        <td align=\"left\" style=\"border-left: 0px;\">",
"         <span class=\"medCalcFontOne\">",
"          Moderate Disease Activity",
"         </span>",
"        </td>",
"       </tr>",
"       <tr id=\"rr1_4\">",
"        <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px\">",
"         <span class=\"medCalcFontOneBold\">",
"          CDAI &gt; 22:",
"         </span>",
"        </td>",
"        <td align=\"left\" style=\"border-left: 0px;\">",
"         <span class=\"medCalcFontOne\">",
"          High Disease Activity",
"         </span>",
"        </td>",
"       </tr>",
"      </table>",
"     </center>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_hints\">",
"     <br/>",
"     &nbsp;",
"     <br/>",
"     <span class=\"medCalcFontOneBold\">",
"      Notes",
"     </span>",
"     <ul class=\"medCalcFontOne\">",
"      <li>",
"       In the hands, the joints that are evaluated include the first through fifth metacarpophalangeal joint, the interphalangeal joint of the thumb, and the second through fifth proximal interphalangeal joint.",
"      </li>",
"      <li>",
"       The",
"       <b>",
"        PGA",
"       </b>",
"       or Patient Global disease Activity estimate represents the",
"patient's self assessment of disease activity on a 0-10 scale where 10 means maximal activity.",
"      </li>",
"      <li>",
"       The",
"       <b>",
"        EGA",
"       </b>",
"       or Evaluator Global disease Activity estimate represents the",
"evaluator's assessment of disease activity on a 0-10 scale where 10 means maximal activity.",
"      </li>",
"      <li>",
"       A",
"       <b>",
"        CDAI",
"       </b>",
"       reduction by 6.5 represents a moderate improvement.",
"      </li>",
"     </ul>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_refs\">",
"     <span class=\"medCalcFontRef\">",
"      <b>",
"       References",
"      </b>",
"     </span>",
"     <ol>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        Aletaha D, Nell VP, Stamm T, et. al. Acute phase reactants add little to composite disease activity  indices for rheumatoid arthritis: validation of a clinical activity score.",
"        <i>",
"         Arthritis Res Ther",
"        </i>",
"        . 2005;7(4):R796-806.",
"       </span>",
"      </li>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        Aletaha D, Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity  Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis.",
"        <i>",
"         Clin Exp Rheumatol",
"        </i>",
"        . 2005  Sep-Oct;23(5 Suppl 39):S100-8.",
"       </span>",
"      </li>",
"     </ol>",
"    </div>",
"   </form>",
"  </div>",
" </div>",
" <div id=\"topicAgreement\">",
"  Use of UpToDate is subject to the",
"  <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"   Subscription and License Agreement",
"  </a>",
"  .",
" </div>",
" <div id=\"printDisclaimer\">",
"  Information on this page may not appear correctly if printed.",
" </div>",
" <div id=\"disclaimerCalculator\">",
"  <div class=\"medCalcFontTwo\">",
"   <p class=\"header\">",
"    Legal Notices and Disclaimer",
"   </p>",
"   <p>",
"    All information contained in and produced by the MedCalc 3000 system is provided",
"			for educational purposes only. This information should not be used for the diagnosis or treatment",
"			of any health problem or disease.",
"    <b>",
"     THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR",
"			GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER.",
"    </b>",
"    <a class=\"medCalcDisclaimerLink\" href=\"./med-calc-disclaimer\">",
"     Click here for",
"				full notice and disclaimer.",
"    </a>",
"   </p>",
"   <p class=\"copy\">",
"    MedCalc 3000 is Copyright &copy; 1998-2013 Foundation Internet Services",
"   </p>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_36_27205=[" ",
"",
"",
"function log(i){",
"return Math.log(i) * Math.LOG10E;   ",
"}",
"",
"function ln(i){",
"return Math.log(i);",
"}",
"",
"function sq(i){",
"return i * i;",
"}",
"",
"function sqr(i){",
"return Math.sqrt(i);",
"}",
"",
"",
"function power(x,y){",
"return Math.pow(x,y);",
"}",
"",
"function eTo(x){",
"return Math.exp(x);",
"}",
"",
"",
"function fixDP(r, dps) {",
"if (isNaN(r)) return \"NaN\";",
"var msign = '';",
"if (r < 0) msign = '-';",
"x = Math.abs(r);",
"if (x > Math.pow(10, 21)) return msign + x.toString();",
"var m = Math.round(x * Math.pow(10, dps)).toString();",
"if (dps == 0) return msign + m;",
"while (m.length <= dps) m = \"0\" + m;",
"return msign + m.substring(0, m.length - dps) + \".\" + m.substring(m.length - dps);",
"}",
"",
"var currenttimeout;",
"",
"",
"var calctxt = ''; ",
"var xmltxt = ''; ",
"var htmtxt = ''; ",
"",
"",
"",
"function RheumatoidArthritisCDAI_fx() {",
"",
"currenttimeout = self.setTimeout('minMaxCheck();', 3000);",
"",
"with(document.RheumatoidArthritisCDAI_form){",
"",
"",
"doCalc = true;",
"if (PGA_param.value.indexOf(',') >= 0){ PGA_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(PGA_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = PGA_unit.options[PGA_unit.selectedIndex].value.split('|');",
"PGA = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"if (EGA_param.value.indexOf(',') >= 0){ EGA_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(EGA_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = EGA_unit.options[EGA_unit.selectedIndex].value.split('|');",
"EGA = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"TJC = 0;",
"for (jcount = 0; jcount < 28; jcount++){",
"if(TJC_box[jcount].checked) TJC = TJC + 1;",
"}",
"TJC_param.value = TJC;",
"SJC = 0;",
"for (jcount = 0; jcount < 28; jcount++){",
"if(SJC_box[jcount].checked) SJC = SJC + 1;",
"}",
"SJC_param.value = SJC;",
"dp = decpts.options[decpts.selectedIndex].text;",
"CDAI =  SJC + TJC + PGA + EGA;",
"",
"unit_parts = CDAI_unit.options[CDAI_unit.selectedIndex].value.split('|');",
"if (doCalc) CDAI_param.value = fixDP((CDAI - parseFloat(unit_parts[1])) / parseFloat(unit_parts[0]), dp);",
"",
"",
"",
"",
"if (doCalc){",
"",
"rrclr();",
"if (CDAI <= 2.8){ document.getElementById('rr1_1').bgColor = \"#cccccc\";",
"}",
"if ((CDAI > 2.8) && (CDAI <= 10)){ document.getElementById('rr1_2').bgColor = \"#cccccc\";",
"}",
"if ((CDAI > 10) && (CDAI <= 22)){ document.getElementById('rr1_3').bgColor = \"#cccccc\";",
"}",
"if (CDAI > 22){ document.getElementById('rr1_4').bgColor = \"#cccccc\";",
"}",
"",
"",
"",
"}",
"",
"",
"}",
"",
"}",
"",
"function minMaxCheck(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.RheumatoidArthritisCDAI_form){",
"",
"if (PGA_param.value && PGA < 0) {",
"PGA = 0;",
"PGA_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for PGA is 0 #.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (PGA_param.value && PGA > 10) {",
"PGA_param.value = \"\";",
"clrResults();",
"PGA = 0;",
"doCalc = false;",
"alert(\"The maximum value for PGA is 10 #.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (EGA_param.value && EGA < 0) {",
"EGA = 0;",
"EGA_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for EGA is 0 #.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (EGA_param.value && EGA > 10) {",
"EGA_param.value = \"\";",
"clrResults();",
"EGA = 0;",
"doCalc = false;",
"alert(\"The maximum value for EGA is 10 #.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"",
"",
"}",
"",
"}",
"",
"",
"function clrResults(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.RheumatoidArthritisCDAI_form){",
"",
"CDAI_param.value = '';",
"",
"rrclr();",
"",
"}",
"",
"}",
"",
"",
"",
"function TJCClr() {",
"with(document.RheumatoidArthritisCDAI_form){",
"TJC = 0;",
"for (jcount = 0; jcount < 28; jcount++){",
"TJC_box[jcount].checked = false;",
"}",
"TJC_param.value = TJC;",
"RheumatoidArthritisCDAI_fx();",
"}}",
"",
"",
"function TJCAll() {",
"with(document.RheumatoidArthritisCDAI_form){",
"TJC = 28;",
"for (jcount = 0; jcount < 28; jcount++){",
"TJC_box[jcount].checked = true;",
"}",
"TJC_param.value = TJC;",
"RheumatoidArthritisCDAI_fx();",
"}}",
"",
"function SJCClr() {",
"with(document.RheumatoidArthritisCDAI_form){",
"SJC = 0;",
"for (jcount = 0; jcount < 28; jcount++){",
"SJC_box[jcount].checked = false;",
"}",
"SJC_param.value = SJC;",
"RheumatoidArthritisCDAI_fx();",
"}}",
"",
"",
"function SJCAll() {",
"with(document.RheumatoidArthritisCDAI_form){",
"SJC = 28;",
"for (jcount = 0; jcount < 28; jcount++){",
"SJC_box[jcount].checked = true;",
"}",
"SJC_param.value = SJC;",
"RheumatoidArthritisCDAI_fx();",
"}}",
"",
"",
"",
"",
"",
"",
"",
"function rrclr(){",
"document.getElementById('rr1_1').bgColor = \"\";",
"document.getElementById('rr1_2').bgColor = \"\";",
"document.getElementById('rr1_3').bgColor = \"\";",
"document.getElementById('rr1_4').bgColor = \"\";",
"}",
"",
"",
""].join("\n");
var outline_f26_36_27205=null;
var title_f26_36_27206="HIV infection and malignancy: Epidemiology and pathogenesis";
var content_f26_36_27206=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"14\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   HIV infection and malignancy: Epidemiology and pathogenesis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/36/27206/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/36/27206/contributors\">",
"     John F Deeken, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/36/27206/contributors\">",
"     Liron Pantanowitz, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/36/27206/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/36/27206/contributors\">",
"     Bruce J Dezube, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/36/27206/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/36/27206/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/36/27206/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV-infected individuals have an increased propensity to develop malignancy. The occurrence of an extremely high number of cases of Kaposi's sarcoma (KS) was noted early in the AIDS epidemic and many of them had an unusually aggressive clinical course. KS was therefore included as an AIDS-defining illness in early case definitions from the Centers for Disease Control and Prevention (CDC). Non-Hodgkin lymphoma (NHL) and invasive cervical carcinoma were subsequently added as AIDS-defining conditions.",
"   </p>",
"   <p>",
"    The spectrum of neoplasia in HIV infected patients has changed in areas where the use of potent antiretroviral therapy (ART) is widespread. The incidence of KS and NHL has decreased markedly, but there has been a relative increase in tumor types that collectively are referred to as non-AIDS-defining cancers (NADCs) compared with the general population. NADCs now are a major factor contributing to mortality in HIV-infected people.",
"   </p>",
"   <p>",
"    This topic will review the epidemiology and pathogenesis of malignancy in people infected with HIV. General management considerations for these malignancies, as well as epidemiologic features and management considerations for specific tumor types are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30202?source=see_link\">",
"     \"HIV infection and malignancy: Management considerations\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1560489307\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The era of potent ART began in 1996 with the availability of the protease inhibitors. In most patients, ART causes both an immunologic response manifested by normalization CD4 lymphocyte counts and a virologic response with nearly complete suppression of HIV viral replication. Both immunologic and virologic responses are important in achieving at least partial immune restoration, thus decreasing the incidence of opportunistic infections, reducing the risk of developing NHL or KS, and prolonging survival [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27206/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36234?source=see_link\">",
"     \"Selecting antiretroviral regimens for the treatment naive HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1560514490\">",
"    <span class=\"h2\">",
"     AIDS-defining malignancies",
"    </span>",
"    &nbsp;&mdash;&nbsp;The overall impact of the introduction of ART is illustrated by the Swiss HIV Cohort Study, which analyzed the incidence of AIDS-defining and non-AIDS defining cancers in 9429 patients with 54,715 years of patient follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27206/abstract/3\">",
"     3",
"    </a>",
"    ]. The incidence of cancers was broken down into three periods: 1985 to 1996 (pre-ART), 1997-2001 (early ART), and 2002-2006 (late ART).",
"   </p>",
"   <p>",
"    In this study, the incidence of AIDS-defining cancers fell progressively compared with the non HIV infected population (standardized incidence ratios [SIRs] 136, 28, and 15, respectively). Furthermore, the AIDS-defining cancers comprised a progressively smaller percentage of the cancer burden in the HIV population. Among the patients with AIDS or HIV infection, AIDS-defining cancers accounted for 467 of 529 malignancies (88 percent) in the pre-ART period, 89 of 189 (47 percent) in the early ART period, and 46 of 140 (33 percent) in the late ART period. Similar trends have been reported in other large series [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27206/abstract/4-8\">",
"     4-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The impact of immunosuppression on the incidence of specific AIDS-defining malignancies since the introduction of potent ART is illustrated by the following examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the Swiss HIV Cohort study, KS had an SIR of 246 compared to the non-HIV infected population and comprised 51 percent of all cancers and 58 percent of the AIDS-defining cancers in the pre-ART period (1985-1996) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27206/abstract/3\">",
"       3",
"      </a>",
"      ]. By the late-ART period (2002-2006), the incidence of KS had fallen dramatically, and was approximately 23 times higher than the general population. In that period, KS comprised 30 percent of AIDS defining malignancies and and 10 percent of the total cancer burden in the HIV infected study population.",
"     </li>",
"     <li>",
"      Similarly, the incidence of NHL relative to the non-HIV infected population fell progressive through these same periods (SIRs 103, 27, and 16, respectively) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27206/abstract/3\">",
"       3",
"      </a>",
"      ]. Thus, NHL comprised 36, 28, and 23 percent of the cancer burden in this cohort.",
"     </li>",
"     <li>",
"      Data from United States AIDS and cancer registries were analyzed for 325,516 adults with AIDS prior to the introduction of potent ART (1990 to 1995) and following potent ART's widespread utilization (1996 to 2002) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27206/abstract/9\">",
"       9",
"      </a>",
"      ]. As in other studies, the incidence of KS significantly decreased (1839 versus 335 per 100,000 person-years) as did the incidence of NHL (1066 versus 390 per 100,000 person-years). The incidence of KS and NHL was inversely correlated with the CD4 cell count. Among the patients with NHL, this relationship was limited to those with diffuse large B-cell lymphoma or central nervous system lymphoma.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In contrast to KS and NHL, the incidence of cervical cancer has not decreased with the introduction of ART [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27206/abstract/3,9\">",
"     3,9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1560514482\">",
"    <span class=\"h2\">",
"     Non-AIDS-defining cancers",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of non-AIDS-defining cancers (NADCs) appears to be mildly elevated compared with the non-HIV-infected population, but is less clear whether ART has had a significant impact:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the Swiss HIV Cohort Study, the incidence of NADCs was elevated compared to the general non-HIV infected population but did not change significantly (SIRs 2.3, 2.7, and 2.2, respectively) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27206/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In contrast, a prospective cohort study of 11,112 patients followed in a single HIV registry over a 25-year period found that there were no significant increase in the incidence of non-AIDS-defining malignancies to the introduction of potent ART (1983 to 1995) but there was a significant increase in such malignancies after the introduction of ART (SIRs 2.05 and 2.49 for the periods 1996 to 2001 and 2002 to 2007, respectively) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27206/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The increased incidence of NADCs has contributed to a changing pattern in the causes of death in HIV-infected patients. Before the introduction of potent ART, malignancies accounted for fewer than 10 percent of all deaths among HIV-infected patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27206/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. By contrast, in a French study that included 64,000 HIV-infected patients who received follow-up in the year 2000 (964 of whom died), death was due to malignancy in 28 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27206/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The relative incidence of different tumor types, compared with non-HIV-infected individuals, varies in different studies. Many of these tumor types also have an increased incidence in immunosuppressed individuals following solid organ transplantation, although there are substantial differences between these populations for some tumor types. The results of a 2007 meta-analysis are summarized in the table (",
"    <a class=\"graphic graphic_table graphicRef74024 \" href=\"UTD.htm?27/4/27725\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27206/abstract/13\">",
"     13",
"    </a>",
"    ]. &nbsp;(See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/23/34170?source=see_link\">",
"     \"Development of malignancy following solid organ transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Changes in the incidence of specific malignancies are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30202?source=see_link&amp;anchor=H1560506284#H1560506284\">",
"     \"HIV infection and malignancy: Management considerations\", section on 'Non-AIDS-defining malignancies'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30202?source=see_link&amp;anchor=H1560506132#H1560506132\">",
"     \"HIV infection and malignancy: Management considerations\", section on 'AIDS-defining malignancies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1560514497\">",
"    <span class=\"h2\">",
"     HIV infection diagnosed during childhood",
"    </span>",
"    &nbsp;&mdash;&nbsp;People diagnosed with AIDS during childhood remain at elevated risk for malignancy into adulthood, despite the management of their HIV infection with ART.",
"   </p>",
"   <p>",
"    In a study of 5850 individuals diagnosed with AIDS at ages 0 to 14 years, the risk of any cancer decreased with the introduction of ART, but remained elevated compared to the general population (SIR 40 versus 17 in the 1980-1995 versus 1996-2007 periods) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27206/abstract/14\">",
"     14",
"    </a>",
"    ]. This increased risk was due almost exclusively to the AIDS-defining malignancies KS and NHL (SIR 1694 versus 1146 for KS and 338 versus 116 for NHL, respectively, during these same time periods).",
"   </p>",
"   <p>",
"    The only non-AIDS defining malignancy for which there was a significant increase compared to the general population was leiomyosarcoma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30202?source=see_link&amp;anchor=H1560506480#H1560506480\">",
"     \"HIV infection and malignancy: Management considerations\", section on 'Sarcoma'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple factors may have contributed to the increased incidence of malignancy in patients infected with HIV. These include immunosuppression, direct effects of the HIV virus itself, coinfection with other oncogenic viruses, environmental factors, and possibly the use of antiretroviral drugs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Immunosuppression",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development of neoplasia in HIV-infected patients is similar to that observed in solid organ transplant recipients who receive chronic immunosuppressive agents, as well as in patients with profound cell-mediated immune deficiencies (",
"    <a class=\"graphic graphic_table graphicRef74024 \" href=\"UTD.htm?27/4/27725\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/23/34170?source=see_link\">",
"     \"Development of malignancy following solid organ transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Untreated HIV infection is characterized by progressive immunologic deterioration. This immunologic decline, as reflected by the CD4 cell count, closely correlated with the increased incidence KS and NHL prior to the introduction of potent antiretroviral therapy (ART) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27206/abstract/15\">",
"     15",
"    </a>",
"    ]. In contrast, there does not appear to be the same correlation between immune compromise and the incidence of other malignancies. (See",
"    <a class=\"local\" href=\"#H1560489307\">",
"     'Epidemiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Role of the HIV virus",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of HIV-associated neoplasia is complex. HIV infection may have a direct effect on a variety of cellular processes that contribute to the development of cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27206/abstract/8\">",
"     8",
"    </a>",
"    ]. Postulated mechanisms include the activation of protooncogenes, alterations in cell cycle regulation, inhibition of tumor suppressor genes, or other genetic alterations that lead to oncogenesis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Coinfection with oncogenic viruses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients infected with HIV are at increased risk of coinfection with other viruses that are known to cause cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27206/abstract/8\">",
"     8",
"    </a>",
"    ]. Furthermore, the natural history of these viral infections may be accelerated in patients with HIV.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1560490920\">",
"    <span class=\"h3\">",
"     HHV-8 infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The epidemiology of Kaposi's sarcoma (KS) suggested a link between the development of disease and a transmissible agent. In 1994, a novel gamma herpesvirus was identified in biopsies from KS [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27206/abstract/4\">",
"     4",
"    </a>",
"    ]. This virus was subsequently named human herpesvirus 8 (HHV-8) or Kaposi's sarcoma-associated herpesvirus (KSHV).",
"   </p>",
"   <p>",
"    HHV-8 has also been associated with the multicentric form of Castleman&rsquo;s disease and primary effusion lymphoma. Both of these entities are found primarily in patients with HIV infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/51/6970?source=see_link\">",
"     \"Castleman's disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/15/30969?source=see_link\">",
"     \"AIDS-related lymphomas: Primary effusion lymphoma\"",
"    </a>",
"    .).",
"   </p>",
"   <p>",
"    The role of HHV-8 in tumorigenesis, its epidemiology, and its transmission are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/27/30138?source=see_link\">",
"     \"Virology, epidemiology, and transmission of human herpesvirus 8 infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     HPV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The relationship of human papillomavirus (HPV) associated cervical dysplasia and neoplasia to HIV infection may be due to lifestyle risks for acquiring both viruses, as well as to attributes of and host responses to HPV. HIV-infected patients may be unable to clear oncogenic strains of HPV due to T cell deficiency. There is a significant relationship between the risk of persistent HPV infection and the degree of immunosuppression. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/35/16954?source=see_link\">",
"     \"HIV and women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/53/26455?source=see_link\">",
"     \"Virology of human papillomavirus infections and the link to cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/14/18665?source=see_link\">",
"     \"Preinvasive and invasive cervical neoplasia in HIV-infected women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The relationship between HPV infection and cervical neoplasia was illustrated in one series of 309,365 American patients with HIV infection or AIDS, in whom the relative risk for in situ HPV associated neoplasia (ie, squamous intraepithelial lesions [SIL]) increased over time, suggesting that the gradual loss of control over HPV infected keratinocytes was related to advancing immunosuppression [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27206/abstract/16\">",
"     16",
"    </a>",
"    ]. However, the incidence of invasive squamous cell cancers did not increase with advancing immunosuppression in HIV, which suggests that late-stage cancer invasion was not influenced by immune status.",
"   </p>",
"   <p>",
"    In addition to its relationship to cervical neoplasia, HPV infection is associated with cancers of the head and neck (especially the oropharynx and base of tongue) and anogenital (anus, penis, vagina, vulva) regions, which have increased in incidence since the introduction of ART. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/55/887?source=see_link\">",
"     \"Human papillomavirus associated head and neck cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1560488906\">",
"    <span class=\"h3\">",
"     EBV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hodgkin lymphoma is not an AIDS-defining malignancy, but its incidence has markedly increased in HIV-infected people since the introduction of ART. Epstein-Barr virus (EBV) infection has an established etiologic role in some cases of Hodgkin lymphoma, and EBV is more frequently implicated in Hodgkin lymphoma in HIV-infected individuals than in non-HIV-infected people. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/39/3703?source=see_link\">",
"     \"The role of Epstein-Barr virus in Hodgkin lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical manifestations and potential treatment of Hodgkin lymphoma in this setting are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30202?source=see_link&amp;anchor=H1560506291#H1560506291\">",
"     \"HIV infection and malignancy: Management considerations\", section on 'Hodgkin lymphoma'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1560489075\">",
"    <span class=\"h3\">",
"     HBV and HCV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infections with hepatitis B virus (HBV) or hepatitis C virus (HCV) are a major cause of hepatocellular carcinoma. Coinfection with HIV and either HBV or HCV can result in more rapid progression of liver disease, resulting in cirrhosis and hepatocellular carcinoma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/38/25194?source=see_link\">",
"     \"Epidemiology and etiologic associations of hepatocellular carcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/55/7033?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of hepatitis B in the HIV-infected patient\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/32/30218?source=see_link\">",
"     \"Epidemiology, natural history, and diagnosis of hepatitis C in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1560489104\">",
"    <span class=\"h3\">",
"     Merkel cell polyoma virus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Merkel cell polyomavirus has a causative role in Merkel cell carcinoma, which is much more frequent in HIV-infected people. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/35/6712?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical features and diagnosis of Merkel cell (neuroendocrine) carcinoma and sebaceous cell carcinoma of the skin\", section on 'Merkel cell polyomavirus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1560503896\">",
"    <span class=\"h3\">",
"     Other environmental oncogenic stimuli",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infection with HIV may sensitize cells to the oncogenic effects of environmental stimuli such as tobacco [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27206/abstract/8\">",
"     8",
"    </a>",
"    ]. As an example, there is a significant increase in the risk of lung cancer in HIV-infected individuals. Although there is a higher incidence of tobacco use in this population, the risk of lung cancer remains approximately three-fold higher compared with the general population after adjusting for smoking status [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27206/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1560490343\">",
"    <span class=\"h2\">",
"     Antiretroviral drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple epidemiologic studies have looked at the relationship between malignancy and the introduction of ART. Whether antiretroviral drugs contribute to the development of NADCs is unclear, and additional research is required to understand this issue [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27206/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      HIV-infected individuals have an increased incidence of a wide range of malignancies, including both AIDS-defining malignancies (Kaposi's sarcoma [KS], cervical cancer, and non-Hodgkin lymphoma [NHL] including systemic NHL, CNS lymphoma, primary effusion lymphoma, and Castleman's disease), as well as a number of non-AIDS-defining cancers (NADCs). (See",
"      <a class=\"local\" href=\"#H1560489307\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Factors contributing to pathogenesis may include direct effects of HIV, immunosuppression, coinfection with other oncogenic viruses, other environmental oncogenic stimuli, and possibly ART itself. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The widespread use of highly active antiretroviral therapy (potent ART) has prevented severe immunosuppression for prolonged periods in most HIV-infected individuals in the United States and Europe. This has been associated with substantial decreases in the incidence of KS and NHL, and a relatively better prognosis in response to treatment than in the pre-potent ART era. (See",
"      <a class=\"local\" href=\"#H1560489307\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The frequency of NADCs is increased compared to the non-HIV-infected population, and cancer deaths from these NADCs account for an increasing fraction of the deaths in HIV-infected individuals. (See",
"      <a class=\"local\" href=\"#H1560489307\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27206/abstract/1\">",
"      Grabar S, Le Moing V, Goujard C, et al. Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy. Ann Intern Med 2000; 133:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27206/abstract/2\">",
"      Bonnet F, Balestre E, Thi&eacute;baut R, et al. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France. Clin Infect Dis 2006; 42:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27206/abstract/3\">",
"      Franceschi S, Lise M, Clifford GM, et al. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer 2010; 103:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27206/abstract/4\">",
"      Powles T, Robinson D, Stebbing J, et al. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol 2009; 27:884.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27206/abstract/5\">",
"      Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008; 148:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27206/abstract/6\">",
"      Shiels MS, Pfeiffer RM, Gail MH, et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst 2011; 103:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27206/abstract/7\">",
"      Herida M, Mary-Krause M, Kaphan R, et al. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 2003; 21:3447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27206/abstract/8\">",
"      Deeken JF, Tjen-A-Looi A, Rudek MA, et al. The rising challenge of non-AIDS-defining cancers in HIV-infected patients. Clin Infect Dis 2012; 55:1228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27206/abstract/9\">",
"      Biggar RJ, Chaturvedi AK, Goedert JJ, et al. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst 2007; 99:962.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27206/abstract/10\">",
"      Stein M, O'Sullivan P, Wachtel T, et al. Causes of death in persons with human immunodeficiency virus infection. Am J Med 1992; 93:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27206/abstract/11\">",
"      Kravcik S, Hawley-Foss N, Victor G, et al. Causes of death of HIV-infected persons in Ottawa, Ontario, 1984-1995. Arch Intern Med 1997; 157:2069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27206/abstract/12\">",
"      Bonnet F, Lewden C, May T, et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 2004; 101:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27206/abstract/13\">",
"      Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007; 370:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27206/abstract/14\">",
"      Simard EP, Shiels MS, Bhatia K, Engels EA. Long-term cancer risk among people diagnosed with AIDS during childhood. Cancer Epidemiol Biomarkers Prev 2012; 21:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27206/abstract/15\">",
"      Carbone A, Gloghini A. AIDS-related lymphomas: from pathogenesis to pathology. Br J Haematol 2005; 130:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27206/abstract/16\">",
"      Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000; 92:1500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27206/abstract/17\">",
"      Kirk GD, Merlo C, O' Driscoll P, et al. HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis 2007; 45:103.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8035 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-115.66.252.144-2A34E2F131-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_36_27206=[""].join("\n");
var outline_f26_36_27206=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1560489307\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1560514490\">",
"      AIDS-defining malignancies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1560514482\">",
"      Non-AIDS-defining cancers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1560514497\">",
"      HIV infection diagnosed during childhood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Immunosuppression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Role of the HIV virus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Coinfection with oncogenic viruses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1560490920\">",
"      - HHV-8 infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - HPV infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1560488906\">",
"      - EBV infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1560489075\">",
"      - HBV and HCV infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1560489104\">",
"      - Merkel cell polyoma virus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1560503896\">",
"      - Other environmental oncogenic stimuli",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1560490343\">",
"      Antiretroviral drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/8035\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/8035|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?27/4/27725\" title=\"table 1\">",
"      NonAIDS cancer SIRs",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/15/30969?source=related_link\">",
"      AIDS-related lymphomas: Primary effusion lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/51/6970?source=related_link\">",
"      Castleman's disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/35/6712?source=related_link\">",
"      Clinical features and diagnosis of Merkel cell (neuroendocrine) carcinoma and sebaceous cell carcinoma of the skin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/23/34170?source=related_link\">",
"      Development of malignancy following solid organ transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/38/25194?source=related_link\">",
"      Epidemiology and etiologic associations of hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/55/7033?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of hepatitis B in the HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/32/30218?source=related_link\">",
"      Epidemiology, natural history, and diagnosis of hepatitis C in the HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/35/16954?source=related_link\">",
"      HIV and women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30202?source=related_link\">",
"      HIV infection and malignancy: Management considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/55/887?source=related_link\">",
"      Human papillomavirus associated head and neck cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/14/18665?source=related_link\">",
"      Preinvasive and invasive cervical neoplasia in HIV-infected women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36234?source=related_link\">",
"      Selecting antiretroviral regimens for the treatment naive HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/39/3703?source=related_link\">",
"      The role of Epstein-Barr virus in Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/53/26455?source=related_link\">",
"      Virology of human papillomavirus infections and the link to cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/27/30138?source=related_link\">",
"      Virology, epidemiology, and transmission of human herpesvirus 8 infection",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_36_27207="Hepatitis B vaccine: Drug information";
var content_f26_36_27207=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Hepatitis B vaccine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?10/38/10849?source=see_link\">",
"    see \"Hepatitis B vaccine: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/17/15639?source=see_link\">",
"    see \"Hepatitis B vaccine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F178984\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Engerix-B&reg;;",
"     </li>",
"     <li>",
"      Recombivax HB&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F178985\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Engerix-B&reg;;",
"     </li>",
"     <li>",
"      Recombivax HB&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F178999\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Vaccine, Inactivated (Viral)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F178987\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Primary immunization:",
"     </b>",
"     I.M.: 1 mL/dose (adult formulation) for 3 total doses administered at 0, 1, and 6 months",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Adult formulations of hepatitis B vaccine products differ by concentration (mcg/mL) but when dosed in terms of volume (mL), the dose of Engerix-B&reg; and Recombivax HB&reg; are the same (both 1 mL).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Alternate dosing schedules (selection of schedule should optimize compliance with vaccination):",
"     </i>",
"     All regimens use the adult formulation administered as one dose at the following intervals (three schedules presented):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     0, 1, and 4 months (CDC, 2005)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     0, 2, and 4 months (CDC, 2005)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     0, 12, and 24 months (CDC, 2005)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Bombings or similar mass casualty events:",
"     </b>",
"     I.M.: In persons without a reliable history of vaccination against HepB and who have no known contraindications to the vaccine, vaccination should begin within 24 hours (but no later than 7 days) following the event (CDC, 2008).",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F178994\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/17/15639?source=see_link\">",
"      see \"Hepatitis B vaccine: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Primary immunization:",
"     </b>",
"     I.M.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infants: 0.5 mL/dose (pediatric/adolescent formulation) for 3 total doses administered at 0, 1 and 6 months. Alternate dosing regimens are also available for children who begin vaccination &ge;1 year of age.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Doses are presented using the pediatric/adolescent formulations. Pediatric/adolescent formulations of hepatitis B vaccine products differ by concentration (mcg/mL). However, when dosed in terms of volume (mL), the dose of Engerix-B&reg; and Recombivax HB&reg; are the same (both 0.5 mL).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Combination vaccines (eg, vaccines containing HepB with DTaP, HIB) should not be used for the \"birth\" dose but may be used to complete the course beginning after the infant is &ge;6 weeks of age (CDC, 2005). Please see combination vaccine monographs for dose and schedule details.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants (HB",
"     <sub>",
"      s",
"     </sub>",
"     Ag-",
"     <b>",
"      negative",
"     </b>",
"     mothers):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     First dose: 0.5 mL at birth or before discharge (may be delayed in certain cases)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Second dose: 0.5 mL at 1-2 months of age",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Third dose: 0.5 mL at 6-18 months of age, but no sooner than 24 weeks of age",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Premature neonates &lt;2 kg may have the initial dose deferred up to 30 days of chronological age or at hospital discharge (CDC, 2005).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants (HB",
"     <sub>",
"      s",
"     </sub>",
"     Ag-",
"     <b>",
"      positive",
"     </b>",
"     mothers):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     First dose: 0.5 mL within first 12 hours of life, even if premature and regardless of birth weight (hepatitis immune globulin should also be administered at the same time at a different site)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Second dose: 0.5 mL at 1-2 months of age",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Third dose: 0.5 mL at 6 months of age but no sooner than 24 weeks of age",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Anti-HB",
"     <sub>",
"      s",
"     </sub>",
"     and HB",
"     <sub>",
"      s",
"     </sub>",
"     Ag levels should be checked at 9-18 months of age (ie, next well-child visit after series completion). If HB",
"     <sub>",
"      s",
"     </sub>",
"     Ag negative and anti-HB",
"     <sub>",
"      s",
"     </sub>",
"     levels &lt;10 mIU/mL, reimmunize with 3 doses and reassess 1-2 months after the third dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     In premature neonates &lt;2 kg, the birth dose should not be counted as part of the 3-dose vaccine series (CDC, 2005).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants (mother's HB",
"     <sub>",
"      s",
"     </sub>",
"     Ag status",
"     <b>",
"      unknown",
"     </b>",
"     ):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     First dose: 0.5 mL within 12 hours of birth even if premature and regardless of birth weight",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Second dose: 0.5 mL at 1-2 months of age",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Third dose: 0.5 mL at 6 months of age but no sooner than 24 weeks of age",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     If mother is later determined to be HB",
"     <sub>",
"      s",
"     </sub>",
"     Ag-positive, the infant should receive hepatitis immune globulin as soon as possible (no later than age 1 week).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     In premature neonates &lt;2 kg, the birth dose should not be counted as part of the 3-dose vaccine series (CDC, 2005).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children: 0.5 mL/dose (pediatric/adolescent formulation) administered at 0, 1, and 6 months (for 3 total doses). Alternate dosing regimens are also available for children who begin vaccination &ge;1 year of age.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Alternate dosing schedules (selection of schedule should optimize compliance with vaccination):",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children 1-10 years: 0.5 mL (pediatric/adolescent formulation) at the following intervals (two schedules presented):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     0, 2, and 4 months (CDC, 2005)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     0, 1, 2, and 12 months (Engerix-B&reg;)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children 5-10 years: 0.5 mL (pediatric/adolescent formulation) at 0, 12, and 24 months (Engerix-B&reg;)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children 11-15 years: 1 mL (adult formulation) at 0 and 4-6 months (Recombivax HB&reg;)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children 11-16 years: 0.5 mL (pediatric/adolescent formulation) at 0, 12, and 24 months (Engerix-B&reg;)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children 11-18 years: 0.5 mL (pediatric/adolescent formulation) at the following intervals (three schedules presented):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     0, 1, and 4 months (CDC, 2005)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     0, 2, and 4 months (CDC, 2005)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     0, 12, and 24 months (CDC, 2005)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children 11-18 years: 1 mL (adult formulation) at 0, 1, 2, and 12 months (Engerix-B&reg;)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Bombings or similar mass casualty events:",
"     </b>",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F178988\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F12674619\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults on dialysis:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Engerix-B&reg; 20 mcg/mL: Administer 2 mL per dose at 0, 1, 2, and 6 months",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Recombivax HB&reg; 40 mcg/mL: Administer 1 mL per dose at 0, 1, and 6 months",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Serologic testing is recommended 1-2 months after the final dose of the primary vaccine series and annually to determine the need for booster doses. Persons with anti-HB",
"     <sub>",
"      s",
"     </sub>",
"     concentrations of &lt;10 mIU/mL should be revaccinated with 3 doses of the vaccine (CDC, 2006).",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15897468\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F178967\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, suspension [adult, preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Engerix-B&reg;: Hepatitis B surface antigen 20 mcg/mL (1 mL) [contains aluminum, yeast protein, may contain natural rubber/natural latex in prefilled syringe]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Engerix-B&reg;: Hepatitis B surface antigen 20 mcg/mL (1 mL) [contains aluminum, yeast protein; vial]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Recombivax HB&reg;: Hepatitis B surface antigen 10 mcg/mL (1 mL) [contains aluminum, natural rubber/natural latex in packaging, yeast protein]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, suspension [dialysis formulation, preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Recombivax HB&reg;: Hepatitis B surface antigen 40 mcg/mL (1 mL) [contains aluminum, natural rubber/natural latex in packaging, yeast protein]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, suspension [pediatric/adolescent, preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Engerix-B&reg;: Hepatitis B surface antigen 10 mcg/0.5 mL (0.5 mL) [contains aluminum, yeast protein, may contain natural rubber/natural latex in prefilled syringe]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Recombivax HB&reg;: Hepatitis B surface antigen 5 mcg/0.5 mL (0.5 mL) [contains aluminum, natural rubber/natural latex in packaging, yeast protein]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F178954\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F178970\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Pediatric/adolescent formulations of hepatitis B vaccine products differ by concentration (mcg/mL). However, when dosed in terms of volume (mL), the dose of Engerix-B&reg; and Recombivax HB&reg; are the same (both 0.5 mL). Adult formulations of hepatitis B vaccine products also differ by concentration (mcg/mL), but when dosed in terms of volume (mL), the dose of Engerix-B&reg; and Recombivax HB&reg; are the same (both 1 mL). It is possible to interchange the vaccines for completion of a series or for booster doses; the antibody produced in response to each type of vaccine is comparable, however, the quantity of the vaccine will vary.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     I.M. injection only; in adults, the deltoid muscle is the preferred site; the anterolateral thigh is the recommended site in infants and young children. Not for gluteal administration. Shake well prior to withdrawal and use.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     For patients at risk of hemorrhage following intramuscular injection, hepatitis B vaccine may be administered subcutaneously although lower titers and/or increased incidence of local reactions may result. The ACIP recommends &ldquo;it should be administered intramuscularly if, in the opinion of the physician familiar with the patient's bleeding risk, the vaccine can be administered by this route with reasonable safety. If the patient receives antihemophilia or other similar therapy, intramuscular vaccination can be scheduled shortly after such therapy is administered. A fine needle (23 gauge or smaller) can be used for the vaccination and firm pressure applied to the site (without rubbing) for at least 2 minutes. The patient should be instructed concerning the risk of hematoma from the injection.&rdquo; Patients on anticoagulant therapy should be considered to have the same bleeding risks and treated as those with clotting factor disorders (CDC, 2011).",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;text-align:justify;\">",
"     Simultaneous administration of vaccines helps ensure the patients will be fully vaccinated by the appropriate age. Simultaneous administration of vaccines is defined as administering &gt;1 vaccine on the same day at different anatomic sites. The use of licensed combination vaccines is generally preferred over separate injections of the equivalent components. Separate vaccines should not be combined in the same syringe unless indicated by product specific labeling. Separate needles and syringes should be used for each injection. The ACIP prefers each dose of a specific vaccine in a series come from the same manufacturer when possible. Adolescents and adults should be vaccinated while seated or lying down. In general, preterm infants should be vaccinated at the same chronological age as full-term infants (CDC, 2011).",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;text-align:justify;\">",
"     Antipyretics have not been shown to prevent febrile seizures. Antipyretics may be used to treat fever or discomfort following vaccination (CDC, 2011). One study reported that routine prophylactic administration of acetaminophen to prevent fever prior to vaccination decreased the immune response of some vaccines; the clinical significance of this reduction in immune response has not been established (Prymula, 2009).",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Vaccination at the time of HB",
"      <sub>",
"       s",
"      </sub>",
"      Ag testing:",
"     </b>",
"     For persons in whom vaccination is recommended, the first dose of hepatitis B vaccine can be given after blood is drawn to test for HB",
"     <sub>",
"      s",
"     </sub>",
"     Ag.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F178968\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Immunization against infection caused by all known subtypes of hepatitis B virus (HBV)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     The Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination for the following (CDC, 2005; CDC, 2006; CDC, 2011):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     - All infants at birth",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     - All infants and children (post-birth dose; refer to recommended vaccination schedule)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     - All unvaccinated adults requesting protection from HBV infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     - All unvaccinated adults at risk for HBV infection such as those with:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Behavioral risks: Sexually-active persons with &gt;1 partner in a 6-month period; persons seeking evaluation or treatment for a sexually-transmitted disease; men who have sex with men; injection drug users",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Occupational risks: Healthcare and public safety workers with reasonably anticipated risk for exposure to blood or blood contaminated body fluids",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Medical risks: Persons with end-stage renal disease (including predialysis, hemodialysis, peritoneal dialysis, and home dialysis); persons with HIV infection; persons with chronic liver disease. Adults (19 through 59 years of age) with diabetes mellitus type 1 or type 2 should be vaccinated as soon as possible following diagnosis. Adults &ge;60 years with diabetes mellitus may also be vaccinated at the discretion of their treating clinician.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Other risks: Household contacts and sex partners of persons with chronic HBV infection; residents and staff of facilities for developmentally disabled persons; international travelers to regions with high or intermediate levels of endemic HBV infection",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     In addition, the ACIP recommends vaccination for any persons who are wounded in bombings or similar mass casualty events who have penetrating injuries or nonintact skin exposure, or who have contact with mucous membranes (exception - superficial contact with intact skin), and who cannot confirm receipt of a hepatitis B vaccination (CDC, 2008).",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F179005\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Engerix-B&reg; adult may be confused with Engerix-B&reg; pediatric/adolescent",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Recombivax HB&reg; may be confused with Comvax&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F178997\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      All serious adverse reactions must be reported to the U.S. Department of Health and Human Services (DHHS) Vaccine Adverse Event Reporting System (VAERS) at 1-800-822-7967 or online at",
"      <a href=\"https://vaers.hhs.gov/esub/index\" target=\"_blank\">",
"       https://vaers.hhs.gov/esub/index",
"      </a>",
"      .",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Frequency not defined. The most common adverse effects reported with both products included injection site reactions (&gt;10%).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Flushing, hypotension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Agitation, chills, dizziness, fatigue, fever (&ge;37.5&deg;C/100&deg;F),  headache, insomnia, irritability, lightheadedness, malaise, somnolence, vertigo",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Angioedema, petechiae, pruritus, rash, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, appetite decreased, constipation, cramps, diarrhea, dyspepsia, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Dysuria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Injection site reactions: Ecchymosis, erythema, induration, pain, nodule formation, soreness, swelling, tenderness, warmth",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Achiness, arthralgia, back pain, myalgia, neck pain, neck stiffness, paresthesia, shoulder pain, tingling, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Otic: Earache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Cough, pharyngitis, rhinitis, upper respiratory tract infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis, lymphadenopathy, flu-like syndrome",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Postmarketing and/or case reports: Allergic reactions, alopecia, anaphylaxis, apnea, Bell's palsy, bronchospasm, encephalitis, erythema nodosum, erythema multiforme, febrile seizure, Guillain-Barr&eacute; syndrome, herpes zoster, hypoesthesia, keratitis, liver enzymes increased, lupus-like syndrome, migraine, multiple sclerosis, muscle weakness, neuropathy, optic neuritis, palpitation, paralysis, paresis, polyarteritis nodosa, purpura, seizure, serum-sickness like syndrome (may be delayed days to weeks), Stevens-Johnson syndrome, SLE, syncope, tachycardia, thrombocytopenia, tinnitus, transverse myelitis, uveitis, vasculitis, visual disturbances",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F178973\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to yeast, hepatitis B vaccine, or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F178958\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anaphylactoid/hypersensitivity reactions: Immediate treatment (including epinephrine 1:1000) for anaphylactoid and/or hypersensitivity reactions should be available during vaccine use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Apnea: Apnea has been reported following I.M. vaccine administration in premature infants; consider risk versus benefit in infants born prematurely.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Syncope: Syncope has been reported with use of injectable vaccines and may be accompanied by transient visual disturbances, weakness, or tonic-clonic movements. Procedures should be in place to avoid injuries from falling and to restore cerebral perfusion if syncope occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Acute illness: Defer administration in patients with moderate or severe acute illness (with or without fever).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiopulmonary disease: Use with caution in patients with decreased cardiopulmonary function.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Multiple sclerosis: Use with caution in patients with multiple sclerosis; rare exacerbations of symptoms have been observed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Altered immunocompetence: Use with caution in severely immunocompromised patients (eg, patients receiving chemo/radiation therapy or other immunosuppressive therapy [including high-dose corticosteroids]); may have a reduced response to vaccination. In general, household and close contacts of persons with altered immunocompetence may receive all age appropriate vaccines.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Patients &gt;65 years of age may have lower response rates.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Infants &lt;2 kg:  Infants born to HBsAg-negative mothers and weighing &lt;2 kg at birth may have the initial dose deferred up to 30 days of chronological age or until hospital discharge. If the mothers HBsAg status at delivery is unknown or positive, hepatitis B vaccine and hepatitis B immune globulin should be administered within 12 hours of life and the first dose of the vaccine should not be counted as part of the vaccine series.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Vaccines:  In order to maximize vaccination rates, the ACIP recommends simultaneous administration of all age-appropriate vaccines (live or inactivated) for which a person is eligible at a single clinic visit, unless contraindications exist. The use of combination vaccines is generally preferred over separate injections, taking into consideration provider assessment, patient preference, and adverse events.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Latex: Packaging may contain natural latex rubber.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Effective immunity: Vaccination may not result in effective immunity in all patients. Response depends upon multiple factors (eg, type of vaccine, age of patient) and is improved by administering the vaccine at the recommended dose, route, and interval. Vaccines may not be effective if administered during periods of altered immune competence (CDC 60[2], 2011). Due to the long incubation period for hepatitis, unrecognized hepatitis B infection may be present prior to vaccination; immunization may not prevent infection in these patients.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299442\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F178962\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Belimumab: May diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fingolimod: May diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Immunosuppressants: May diminish the therapeutic effect of Vaccines (Inactivated).",
"     <b>",
"      Exceptions:",
"     </b>",
"     Cytarabine (Liposomal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F178964\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F178977\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted. The ACIP recommends HB",
"     <sub>",
"      s",
"     </sub>",
"     Ag testing for all pregnant women. Based on limited data, there is no apparent risk to the fetus when the hepatitis B vaccine is administered during pregnancy. Pregnancy itself is not a contraindication to vaccination; vaccination should be considered if otherwise indicated (CDC, 2006).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F178989\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F3344804\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inactivated virus vaccines do not affect the safety of breast-feeding for the mother or the infant. Breast-feeding infants should be vaccinated according to the recommended schedules (CDC, 2011). Infants born to HB",
"     <sub>",
"      s",
"     </sub>",
"     Ag-positive mothers may be breast-fed (CDC, 2005).",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F178976\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Injection",
"     </b>",
"     (Engerix-B Intramuscular)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mcg/0.5 mL (0.5 mL): $24.20",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mcg/mL (1 mL): $55.11",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Engerix-B Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mcg/0.5 mL (0.5 mL): $24.20",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mcg/mL (1 mL): $62.85",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Recombivax HB Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mcg/0.5 mL (0.5 mL): $28.59",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mcg/mL (1 mL): $73.31",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     40 mcg/mL (1 mL): $199.10",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F13908725\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Monitor for syncope for 15 minutes following administration. If seizure-like activity associated with syncope occurs, maintain patient in supine or Trendelenburg position to reestablish adequate cerebral perfusion.",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F178978\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Bio-Hep-B (IL);",
"     </li>",
"     <li>",
"      Engerix-B (AR, AT, AU, BB, BE, BG, BM, BR, BS, BZ, CH, CN, CR, CZ, DE, DK, DO, EC, FI, FR, GB, GR, GT, GY, HN, IE, IN, IT, JM, MX, NI, NL, NO, PA, PE, PK, PL, PT, PY, RU, SE, SR, SV, TR, TT, TW, UY, VE, ZA);",
"     </li>",
"     <li>",
"      Euvax B (PL);",
"     </li>",
"     <li>",
"      Fendrix (AT, BE, BG, CH, CZ, DE, DK, FI, FR, GB, GR, HN, IE, IT, NL, NO, PT, RU, SE, TR);",
"     </li>",
"     <li>",
"      Gen H-B-Vax (PL);",
"     </li>",
"     <li>",
"      Gen Hevac B Pasteur (PL);",
"     </li>",
"     <li>",
"      H-B-Vax II (AT, AU, BE, BG, CH, CZ, DE, DK, FI, FR, GB, GR, HN, IE, IT, NL, NO, PL, PT, RU, SE, TR, TW);",
"     </li>",
"     <li>",
"      HBvaxPRO (AT, BE, BG, CH, CZ, DE, DK, FI, FR, GB, GR, HN, IE, IT, NL, NO, NZ, PT, RU, SE, TR);",
"     </li>",
"     <li>",
"      Hbvaxpro (PL);",
"     </li>",
"     <li>",
"      Hepavax Gene (CO);",
"     </li>",
"     <li>",
"      Hepavax-Gene (PL);",
"     </li>",
"     <li>",
"      Shanvac-B (TW);",
"     </li>",
"     <li>",
"      Temrevac-HB (PH)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F178957\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Recombinant hepatitis B vaccine is a noninfectious subunit viral vaccine, which confers active immunity via formation of antihepatitis B antibodies. The vaccine is derived from hepatitis B surface antigen (HB",
"     <sub>",
"      s",
"     </sub>",
"     Ag) produced through recombinant DNA techniques from yeast cells. The portion of the hepatitis B gene which codes for HB",
"     <sub>",
"      s",
"     </sub>",
"     Ag is cloned into yeast which is then cultured to produce hepatitis B vaccine.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F178972\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Duration: Following a 3-dose series in children, up to 50% of patients will have low or undetectable anti-HB antibody 5-15 years postvaccination. However, anamnestic increases in anti-HB have been shown up to 23 years later suggesting a lifelong immune memory response.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part I: Immunization of Infants, Children, and Adolescents,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2005, 54(RR-16):1-23.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of Adults,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2006, 54(RR-16):1-25.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/36/27207/abstract-text/17159833/pubmed\" id=\"17159833\" target=\"_blank\">",
"        17159833",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Hepatitis B Virus: A Comprehensive Strategy for Eliminating Transmission in the United States Through Universal Childhood Vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP),&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 1991, 40(RR-13):23.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Recommendations of the Advisory Committee on Immunization Practices (ACIP): General Recommendations on Immunization,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2011, 60(2):1-64.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/36/27207/abstract-text/21293327/pubmed\" id=\"21293327\" target=\"_blank\">",
"        21293327",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Use of Hepatitis B Vaccination for Adults With Diabetes Mellitus: Recommendations of the Advisory Committee on Immunization Practices (ACIP),\"",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 2011, 60(50):1709-11.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/36/27207/abstract-text/22189894/pubmed\" id=\"22189894\" target=\"_blank\">",
"        22189894",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chapman LE, Sullivent EE, Grohskopf LA, et al, &ldquo;Recommendations for Postexposure Interventions to Prevent Infection With Hepatitis B Virus, Hepatitis C Virus, or Human  Immunodeficiency Virus, and Tetanus in Persons Wounded During Bombings and Other Mass-Casualty Events -- United States, 2008: Recommendations of the Centers for Disease Control and Prevention (CDC),&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2008, 57(RR-6):1-21.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/36/27207/abstract-text/18668022/pubmed\" id=\"18668022\" target=\"_blank\">",
"        18668022",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Cohen V, Jellinek SP, Teperikidis L, et al, &ldquo;Room-Temperature Storage of Medications Labeled for Refrigeration,&rdquo;",
"      <i>",
"       Am J Health-Syst Pharm",
"      </i>",
"      , 2007, 64(16):1711-15.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/36/27207/abstract-text/17687059/pubmed\" id=\"17687059\" target=\"_blank\">",
"        17687059",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gardner P and Schaffner W, &ldquo;Immunization of Adults,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1993, 328(17):1252-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/36/27207/abstract-text/8464436/pubmed\" id=\"8464436\" target=\"_blank\">",
"        8464436",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Prymula R, Siegrist CA, Chlibek R, et al, &ldquo;Effect of Prophylactic Paracetamol Administration at Time of Vaccination on Febrile Reactions and Antibody Responses in Children: Two Open-Label, Randomised Controlled Trials,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 2009, 374(9698):1339-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/36/27207/abstract-text/19837254/pubmed\" id=\"19837254\" target=\"_blank\">",
"        19837254",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Steering Committee on Quality Improvement and Management, Subcommittee on Febrile Seizures American Academy of Pediatrics, &ldquo;Febrile seizures: Clinical Practice Guideline for the Long-Term Management of the Child With Simple Febrile Seizures,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2008,  121(6):1281-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/36/27207/abstract-text/18519501/pubmed\" id=\"18519501\" target=\"_blank\">",
"        18519501",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Weinbaum CM, Williams I, Mast EE, et al, &ldquo;Recommendations for Identification and Public Health Management of Persons With Chronic Hepatitis B Virus Infection,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2008, 57(RR-8):1-20.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/36/27207/abstract-text/18802412/pubmed\" id=\"18802412\" target=\"_blank\">",
"        18802412",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8521 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.243-8D13A6BE0D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_36_27207=[""].join("\n");
var outline_f26_36_27207=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178984\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178985\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178999\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178987\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178994\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178988\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12674619\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15897468\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178967\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178954\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178970\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178968\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179005\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178997\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178973\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178958\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299442\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178962\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178964\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178977\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178989\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3344804\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178976\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13908725\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178978\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178957\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178972\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8521\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8521|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?10/38/10849?source=related_link\">",
"      Hepatitis B vaccine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/17/15639?source=related_link\">",
"      Hepatitis B vaccine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_36_27208="Endoscopic ultrasound in esophageal carcinoma";
var content_f26_36_27208=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Endoscopic ultrasound in esophageal carcinoma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/36/27208/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/36/27208/contributors\">",
"     Enrique Vazquez-Sequeiros, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/36/27208/contributors\">",
"     Maurits J Wiersema, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/36/27208/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/36/27208/contributors\">",
"     Douglas A Howell, MD, FASGE, FACG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/36/27208/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/36/27208/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/36/27208/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prognosis of esophageal cancer is strongly associated with its stage. As a result, accurate clinical staging is critical for selecting appropriate treatment options. Endoscopic ultrasonography (EUS) has a central role in the initial staging of esophageal carcinoma and may also be useful for detecting disease recurrence.",
"   </p>",
"   <p>",
"    This topic review will focus on the role of EUS in the care of patients with esophageal carcinoma. An overview of the diagnosis and staging of esophageal carcinoma is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/45/7898?source=see_link\">",
"     \"Diagnosis and staging of esophageal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PREOPERATIVE STAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial evaluation of the patient diagnosed with esophageal carcinoma centers on the assessment of operative risk and tumor stage. Comorbid conditions may preclude a patient with a potentially resectable tumor from undergoing surgery. Preoperative tumor staging is warranted in patients who are considered to be surgical candidates. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/30/34282?source=see_link\">",
"     \"Surgical oncologic principles for management of resectable esophageal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Staging usually begins with a CT scan to evaluate for the presence of metastatic disease. However, with increasing availability, positron emission tomography (PET) CT fusion scanning may be more accurate for the detection of stage IV disease, and can be used as an initial staging assessment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/45/7898?source=see_link\">",
"     \"Diagnosis and staging of esophageal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A more detailed evaluation of locoregional disease extent (T and N stage) should be obtained if distant metastases are not demonstrated. A number of studies have demonstrated that EUS is more accurate than transabdominal ultrasound (US), CT scan, magnetic resonance imaging (MRI), or PET scanning for locoregional staging of esophageal carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/1-16\">",
"     1-16",
"    </a>",
"    ]. A meta-analysis of diagnostic test characteristics made the following estimates for EUS, CT, and PET scanning, concluding that the three approaches were complementary [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/16\">",
"     16",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For EUS, the sensitivity and specificity for detecting celiac lymph node metastases were 85 percent (95% CI 72-99 percent) and 96 percent (95% CI 92-100 percent), respectively. Sensitivity and specificity for other regional lymph node metastases were 80 percent (95% CI 75-84 percent) and 70 percent (95% CI 65-75 percent), respectively.",
"     </li>",
"     <li>",
"      For CT, sensitivity and specificity for regional lymph node metastases were 50 percent (95% CI 41-60 percent) and 83 percent (95% CI 77-89 percent), respectively. For abdominal lymph node metastases, these values were 42 percent (95% CI 29-54 percent) and 93 percent (95% CI 86-100 percent), respectively. For distant metastases, these values were 52 percent (95% CI 33-71 percent) and 91 percent (95% CI 86-96 percent), respectively.",
"     </li>",
"     <li>",
"      For FDG-PET scanning, sensitivity and specificity for regional lymph node metastases were 57 percent (95% CI 43-70 percent) and 85 percent (95% CI 76-95 percent), respectively. For distant metastases, these values were 71 percent (95% CI 62-79 percent) and 93 percent (95% CI 89-97 percent), respectively.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Histologic correlates of the endoscopic ultrasound image",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dedicated echoendoscopes operating at frequencies of 7.5 and 12 MHz are able to visualize the esophageal wall as a five-layered structure (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef73301 \" href=\"UTD.htm?37/9/38035\">",
"     image 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      First hyperechoic layer: superficial mucosa",
"     </li>",
"     <li>",
"      Second hypoechoic layer: deep mucosa",
"     </li>",
"     <li>",
"      Third hyperechoic layer: submucosa",
"     </li>",
"     <li>",
"      Fourth hypoechoic layer: muscularis propria",
"     </li>",
"     <li>",
"      Fifth hyperechoic layer: adventitia",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The ability to visualize the five layers permits a detailed understanding of the degree of tumor infiltration into the wall layers, providing an assessment of the tumor stage (T stage) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef72915 graphicRef63620 graphicRef72321 graphicRef77939 graphicRef75810 \" href=\"UTD.htm?41/20/42314\">",
"     image 2A-E",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/17\">",
"     17",
"    </a>",
"    ]. However, one limitation of the standard dedicated echoendoscopes is that they operate at relatively low frequency and, as a result, cannot visualize the muscularis mucosa [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. High frequency miniprobes (20 MHz) (",
"    <a class=\"graphic graphic_picture graphicRef74641 \" href=\"UTD.htm?17/1/17424\">",
"     picture 1",
"    </a>",
"    ) provide a more detailed visualization, permitting delineation of nine layers in the esophageal wall [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      First and second layer: superficial mucosa (hyper and hypoechoic respectively)",
"     </li>",
"     <li>",
"      Third layer: lamina propria (hyperechoic)",
"     </li>",
"     <li>",
"      Fourth layer: muscularis mucosa (hypoechoic)",
"     </li>",
"     <li>",
"      Fifth layer: submucosa (hyperechoic)",
"     </li>",
"     <li>",
"      Sixth, seventh, and eighth layer: (hypo, hyper, and hypoechoic respectively) inner circular muscle and outer longitudinal muscle of the muscularis propria with intermuscular connective tissue",
"     </li>",
"     <li>",
"      Ninth layer: adventitia (hyperechoic)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This may have particular importance when evaluating superficial lesions for which nonsurgical therapy (such as endoscopic mucosal resection or photodynamic therapy) is being considered (see below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     EUS for T staging of superficial tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;EUS is the most accurate technique for locoregional staging of esophageal cancer, with an overall accuracy of EUS for T and N staging of 80 to 90 percent (",
"    <a class=\"graphic graphic_table graphicRef58757 \" href=\"UTD.htm?4/35/4668\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef62895 \" href=\"UTD.htm?13/38/13934\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef52078 \" href=\"UTD.htm?4/24/4494\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/14,20\">",
"     14,20",
"    </a>",
"    ]. While an earlier meta-analysis suggested that EUS may not be as accurate for T staging in patients with early esophageal cancer compared with those with more advanced esophageal cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/21\">",
"     21",
"    </a>",
"    ], a subsequent larger meta-analysis found that EUS was accurate for staging T1a and T1b tumors, with an area under the receiver operating characteristic curve of 0.93 to 0.96 [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The first meta-analysis included 12 studies with 292 patients with early esophageal adenocarcinoma. EUS had an accuracy of 67 percent for the evaluation of superficial (T1) lesions [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The subsequent meta-analysis included 19 studies with 1019 patients with superficial esophageal cancer (squamous cell carcinoma or adenocarcinoma) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/22\">",
"       22",
"      </a>",
"      ]. EUS had a sensitivity and specificity for diagnosing T1a tumors of 85 and 87 percent, respectively. For T1b tumors, the sensitivity and specificity were both 86 percent. The overall accuracy of EUS was 81 percent for squamous cell carcinoma and 84 percent for adenocarcinoma.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Consideration of nonsurgical therapy, such as endoscopic resection (ER) or photodynamic therapy (PDT), for curative treatment requires correct staging of early tumors. Lymph node metastases are unlikely to be present, and ER may be curative if the esophageal tumor does not invade the muscularis mucosa [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/23\">",
"     23",
"    </a>",
"    ]. By contrast, lymph node metastases may be present in up to 10 percent of patients with invasion into the muscularis mucosa [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. As a result, such patients may not be candidates for ER or PDT. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/54/4970?source=see_link\">",
"     \"Overview of endoscopic resection of gastrointestinal tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/60/20426?source=see_link\">",
"     \"Management of superficial esophageal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If the EUS identifies esophageal cancer that invades the muscularis mucosa, or if there is evidence of lymph node involvement, then surgical therapy is frequently recommended. On the other hand, if the EUS identifies only mucosal disease, ER can be considered to remove the tumor and precisely define the depth of invasion. The pathology result from the ER (particularly the presence or absence of lymphovascular invasion) can then be used to guide the final decision as to whether endoscopic therapy alone is sufficient or if surgery should be recommended. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/30/34282?source=see_link\">",
"     \"Surgical oncologic principles for management of resectable esophageal cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/31/39418?source=see_link\">",
"     \"Radiation therapy, chemoradiotherapy, neoadjuvant approaches, and postoperative adjuvant therapy for localized cancers of the esophagus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/60/20426?source=see_link\">",
"     \"Management of superficial esophageal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, some have suggested that EUS should not be used to determine which patients should go to surgery, and that instead, patients should undergo a careful endoscopic examination and ER without EUS [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/60/20426?source=see_link&amp;anchor=H4#H4\">",
"     \"Management of superficial esophageal cancer\", section on 'Accuracy of EUS in the staging evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although T1 lesions can be identified using echoendoscopes operating at 7.5 and 12 MHz, distinguishing subgroups of the T1 stage (muscularis mucosa",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    submucosal invasion) (",
"    <a class=\"graphic graphic_figure graphicRef64349 \" href=\"UTD.htm?16/57/17302\">",
"     figure 1",
"    </a>",
"    ) can be problematic with these instruments because the frequencies are too low to visualize the muscularis mucosa. High frequency catheters permit determination of the tumor extension into the muscularis mucosa with an accuracy as high as 84 percent when histology is used as the gold-standard [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/19\">",
"     19",
"    </a>",
"    ]. This improves the accuracy of T staging in superficial carcinomas (ie, distinguishing between T1 and T2 lesions), increasing from approximately 76 to 92 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/45/7898?source=see_link\">",
"     \"Diagnosis and staging of esophageal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite these advantages, high frequency catheters have some drawbacks. Their limited depth of penetration into surrounding tissues (approximately 3 cm) precludes adequate assessment of the N stage [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/26\">",
"     26",
"    </a>",
"    ]. As an example, in one report of 54 patients undergoing preoperative EUS, the accuracy of N staging in traversable tumors was significantly worse with the high frequency linear catheter than with the conventional radial-scanning echoendoscope (90 versus 48 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Obtaining an adequate acoustic coupling with the esophageal wall can also be problematic [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/26\">",
"     26",
"    </a>",
"    ]. The technique most commonly used to facilitate these examinations consists of attaching a latex condom to the distal end of the endoscope and then instilling water through the biopsy channel of the scope. This provides a fluid bath through which the catheter can image the infiltration of the tumor into the different layers [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/28\">",
"     28",
"    </a>",
"    ]. A balloon sheath (Olympus&reg; UM-BS20-26R, Olympus&reg; America Inc., Melville, NY) placed over the US catheter (Olympus&reg; UM-2R and UM-3R) has been specifically developed for this use [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/29\">",
"     29",
"    </a>",
"    ]. Combined use of the balloon sheathed catheter with a dual lumen gastroscope provides an efficient method of accurately staging patients with early esophageal carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     EUS for staging advanced tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The large caliber of dedicated radial echoendoscopes (12.7 mm in diameter) may preclude complete EUS staging in patients with stenotic esophageal tumors. This was illustrated in a series of 113 patients who underwent esophagectomy in whom the accuracy of EUS for T and N staging was much higher for traversable (81 and 86 percent, respectively) as compared to nontraversable tumors (28 and 72 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several options are available to improve accuracy in these settings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dilatation of the lumen to a diameter of 14 to 16 mm with either a Savary dilator or a pneumatic balloon may permit traversal of stenotic lesions in many cases [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/31\">",
"       31",
"      </a>",
"      ]. However, a perforation frequency of up to 24 percent has been described with this practice [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/32,33\">",
"       32,33",
"      </a>",
"      ]. The high perforation rate may in part be due to the blunt tips of the older instruments used in the reports cited above [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/32,33\">",
"       32,33",
"      </a>",
"      ]. Newer echoendoscopes appear to reduce the risk of perforation [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/31,32\">",
"       31,32",
"      </a>",
"      ]. Patients with severely stenotic tumors may be best served by serial, progressive dilation over several days rather than a single dilation when attempting to gain access across the tumor for purposes of staging. In one report, Savary dilation to 14 to 16 mm permitted passage of the echoendoscope in 85 to 100 percent of patients without complications [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/34\">",
"       34",
"      </a>",
"      ]; two additional dilators of incremental diameter were passed once resistance was encountered and the dilation was limited to &lt;13 mm in one-third of patients [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Ultrasound catheters introduced through the biopsy channel of the endoscope can traverse tight strictures due to their small caliber (3 mm in maximum diameter). Although this may improve the accuracy of T and N staging [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/35\">",
"       35",
"      </a>",
"      ], limited depth of penetration can lead to incomplete assessment of locoregional spread.",
"     </li>",
"     <li>",
"      A wire-guided echoendoscope without fiberoptics is available for staging stenotic tumors (Olympus&reg; MH-908). This probe measures 7 mm in diameter and can be advanced over a guide wire. In one series of 130 cases, complete endoscopic staging was accomplished by this method in 27 of 30 (90 percent) cases, compared to 60 of 100 (60 percent) cases before its introduction [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In summary, these techniques permit complete examination of stenotic tumors in most patients. The additional information that may be obtained must be balanced by the risk of perforation when dilation is undertaken. A direct comparison of these techniques to determine their comparative accuracy has not been performed. Our practice is to perform endoscopy with a standard gastroscope initially at the time of EUS. If the gastroscope cannot traverse the stenosis we do not dilate the lesion as we infrequently are able to pass the echoendoscope even with this intervention. In patients with circumferential stenosis permitting passage of a gastroscope but not the echoendoscope, judicious dilation is undertaken. We are particularly cautious when semi-circumferential involvement is present since the normal (and hence thinner) esophageal wall may be at increased risk of tearing in this setting, particularly if the proximal esophagus is dilated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Accuracy of EUS for determining unresectability",
"    </span>",
"    &nbsp;&mdash;&nbsp;The accuracy of EUS for determination of T4 stage is approximately 86 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/14\">",
"     14",
"    </a>",
"    ]. The presence of an advanced tumor (T4) at EUS typically results in palliative treatment or chemoradiation followed by restaging and surgical resection if possible.",
"   </p>",
"   <p>",
"    Unresectability is also suggested by EUS in patients with tumors arising above the level of the carina, with extension through the esophageal wall into the mediastinum. It may be difficult or impossible to obtain a safe margin of resection between the tumor and the trachea",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bifurcation in such patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/37\">",
"     37",
"    </a>",
"    ]. Below the carina, extension into adjacent structures such as the pleura, aorta, diaphragm, and liver represents T4 disease, precluding surgical resection with a curative intent without neoadjuvant chemoradiation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     EUS for preoperative lymph node staging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endosonographic criteria that are suggestive of malignant involvement of visible lymph nodes include a width greater than 10 mm, round shape, smooth border, and echo-poor pattern (",
"    <a class=\"graphic graphic_table graphicRef66591 \" href=\"UTD.htm?9/12/9419\">",
"     table 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef57813 \" href=\"UTD.htm?14/25/14739\">",
"     image 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. Of these, an echo-poor pattern and width &gt;10 mm appear to be the most specific for malignancy. When all four suspicious features are present in a visualized lymph node, there is an 80 to 100 percent chance of metastatic involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. However, only 25 percent of malignant nodes will have all of these features. These results demonstrate the limitations of EUS criteria for preoperative determination of lymph node staging.",
"   </p>",
"   <p>",
"    As noted above, EUS has an accuracy of more than 80 percent for detecting malignant nodes in the cervical paraesophageal, right recurrent laryngeal, left paratracheal, upper and lower paraesophageal, infra-aortic, infracarinal, lower posterior mediastinal, and perigastric regions. Greater numbers of malignant-appearing periesophageal lymph nodes detected by EUS predicted worse survival [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/40\">",
"     40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/45/7898?source=see_link\">",
"     \"Diagnosis and staging of esophageal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The demonstration of clinically suspicious lymph nodes may support the selection of induction chemoradiotherapy over surgery alone, particularly in a patient with T2 disease [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/31/39418?source=see_link\">",
"     \"Radiation therapy, chemoradiotherapy, neoadjuvant approaches, and postoperative adjuvant therapy for localized cancers of the esophagus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Endoscopic ultrasound-guided fine-needle aspiration biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;EUS FNA may improve the accuracy of N staging by providing cytologic confirmation of metastatic disease from accessible nodes, as long as the primary tumor is not in the pathway of the aspiration needle. EUS FNA cytology results may not be reliable if the needle has to traverse the primary tumor.",
"   </p>",
"   <p>",
"    Sensitivity, specificity, and accuracy of EUS FNA for locoregional lymph nodes are all over 85 percent when surgical resection specimen or cytology results are considered as the gold-standard [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/42-44\">",
"     42-44",
"    </a>",
"    ]. The accuracy of EUS FNA for esophageal cancer staging appears to be similar to that reported for other gastrointestinal malignancies (",
"    <a class=\"graphic graphic_table graphicRef73448 \" href=\"UTD.htm?35/10/36011\">",
"     table 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/45-48\">",
"     45-48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/30/3561?source=see_link\">",
"     \"Endoscopic ultrasound-guided fine-needle aspiration biopsy in the gastrointestinal tract\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    EUS FNA appears to improve the accuracy of nodal staging beyond that achieved by EUS alone. Most of these reports involve celiac nodes. In three separate series, the sensitivity of EUS FNA for celiac lymph nodes was 88 to 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/45,46,48\">",
"     45,46,48",
"    </a>",
"    ]. In one of these reports, EUS FNA detected 15 of 17 cases of histologically confirmed celiac nodal involvement; however, radial EUS failed to find abnormalities in six cases [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One study from our institution compared lymph node staging using EUS alone in a historical cohort of 33 patients versus our more recent practice in 31 patients who underwent EUS FNA of non peritumoral lymph nodes for preoperative lymph node staging [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/47\">",
"     47",
"    </a>",
"    ]. Compared to EUS, EUS FNA was associated with significantly better sensitivity (63 versus 93 percent) and accuracy (70 versus 93 percent). A comparison of specificity was limited in this study, since only one patient underwent a biopsy for which benign pathology was reported. EUS FNA was less costly than CT FNA and surgery. The cost-saving was principally a result of a reduction in unnecessary surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These results were supported by a prospective study conducted at our institution that compared the performance characteristics of CT, EUS, and EUS FNA for preoperative lymph node staging of esophageal carcinoma in 125 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/50\">",
"     50",
"    </a>",
"    ]. EUS FNA was more sensitive than CT (83 versus 29 percent) and more accurate than CT (87 versus 51 percent) or EUS (87 versus 74 percent) for nodal staging (",
"    <a class=\"graphic graphic_table graphicRef73600 \" href=\"UTD.htm?9/40/9867\">",
"     table 6",
"    </a>",
"    ). Direct surgical resection was contraindicated in 77 percent of patients due to detection of advanced",
"    <span class=\"nowrap\">",
"     locoregional/metastatic",
"    </span>",
"    disease.",
"   </p>",
"   <p>",
"    Optimal criteria for identifying malignant lymph nodes based upon EUS criteria and for helping to select patients for whom EUS FNA is required continue to evolve. Initial experience suggests that a selective approach based upon modified EUS criteria was cost-saving comparing with an approach of routine FNA [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/51\">",
"     51",
"    </a>",
"    ]. Furthermore, the modified EUS criteria (four standard criteria plus EUS identified celiac lymph nodes, &gt;5 lymph nodes, or EUS",
"    <span class=\"nowrap\">",
"     T3/4",
"    </span>",
"    tumor) were more accurate than standard criteria (hypoechoic, smooth border, round, or width &gt;5 mm) at identifying malignant lymph nodes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Interobserver variation and EUS learning curve for esophageal carcinoma staging",
"    </span>",
"    &nbsp;&mdash;&nbsp;The accuracy of EUS is operator dependent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/52\">",
"     52",
"    </a>",
"    ]. The available evidence suggests that interobserver reliability (different observers staging the same patients) is influenced by experience and tumor stage [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/53-56\">",
"     53-56",
"    </a>",
"    ]. As a general rule, there is good agreement among experienced endosonographers (defined as &gt;50 EUS examinations in patients with esophageal cancer) for both T and N stage, except for T2 tumors in which agreement was poor. Interobserver reliability was lower when inexperienced endosonographers (&lt;20 EUS examinations in patients with esophageal cancer) were tested. Technical factors, including balloon overinflation causing a blurring of the distinction between the esophageal wall layers, tangential imaging, and inadequate use of higher scanning frequencies (12 MHz), may be responsible for staging errors among inexperienced endosonographers [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/54,56,57\">",
"     54,56,57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among expert endosonographers (&gt;75 esophageal cancer examinations) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/58\">",
"     58",
"    </a>",
"    ], overstaging of esophageal carcinomas is more frequent than understaging, occurring in 8 to 14 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/59\">",
"     59",
"    </a>",
"    ]. This is particularly evident in T2 lesions, and may be attributed to peritumoral inflammation leading to an overestimation of mural penetration [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/59\">",
"     59",
"    </a>",
"    ]. In contrast, understaging occurs in 3 to 15 percent of cases, and is frequently associated with T3 tumors with microscopic infiltration of the adventitia that is beyond the resolution capabilities of the currently available echoendoscopes [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/8,56\">",
"     8,56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     RESTAGING AFTER CHEMORADIATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;One of the most controversial areas in oncology is the optimal treatment of potentially resectable esophageal cancer, in particular, the benefit of preoperative chemoradiotherapy over surgery alone. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/31/39418?source=see_link\">",
"     \"Radiation therapy, chemoradiotherapy, neoadjuvant approaches, and postoperative adjuvant therapy for localized cancers of the esophagus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/30/34282?source=see_link\">",
"     \"Surgical oncologic principles for management of resectable esophageal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients who receive preoperative chemoradiotherapy, it is frequently desirable to evaluate the response to treatment prior to recommending tumor resection. Unfortunately, the accuracy of EUS is poor in this setting (",
"    <a class=\"graphic graphic_table graphicRef64046 \" href=\"UTD.htm?21/7/21627\">",
"     table 7",
"    </a>",
"    ). A possible explanation for the discrepancy between endoscopic and subsequent pathologic staging is that EUS may not be able to differentiate between post-treatment",
"    <span class=\"nowrap\">",
"     inflammation/fibrosis",
"    </span>",
"    and residual tumor.",
"   </p>",
"   <p>",
"    This subject is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/45/7898?source=see_link&amp;anchor=H10#H10\">",
"     \"Diagnosis and staging of esophageal cancer\", section on 'EUS restaging after neoadjuvant chemoradiotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     DETECTION OF LOCOREGIONAL RECURRENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who present with symptoms or signs worrisome for locoregional recurrence may have a negative endoscopic and radiographic evaluation. In this setting, EUS is extremely accurate (sensitivity &gt;92 percent and specificity &gt;96 percent) for detecting locoregional relapse, and it should be considered in the work-up of such patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/60-62\">",
"     60-62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The benefit of EUS for surveillance of resected patients has also been evaluated. In one series of 45 patients who had undergone resection for localized esophageal carcinoma, EUS examination was performed every six months for a period of two years [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27208/abstract/61\">",
"     61",
"    </a>",
"    ]. The positive predictive value of an abnormal EUS for tumor recurrence was 92 percent, and two-thirds of patients who had tumor relapse documented by EUS were asymptomatic at the time of diagnosis. Although EUS may be an important tool for postoperative surveillance, it is unclear if early detection of tumor recurrence improves survival. In patients with signs or symptoms suspicious for recurrence, EUS with FNA should be performed to establish a diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;EUS is the most accurate method for locoregional staging of esophageal carcinoma. EUS should be performed in patients being considered for surgery once distant metastases have been excluded by CT",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    PET scan. The addition of EUS FNA has further improved lymph node staging accuracy and should be performed routinely when confirmation of metastatic lymphadenopathy will alter patient therapy.",
"   </p>",
"   <p>",
"    Limitations caused by stenotic tumors precluding echoendoscope passage and therefore complete staging are being overcome by smaller caliber instruments. Reports comparing EUS with PET support the superior performance of EUS in locoregional staging. Although EUS has a limited role in restaging patients post chemotherapy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    radiation therapy, it is the most sensitive technique for detecting locoregional tumor recurrence.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/1\">",
"      Flamen P, Lerut A, Van Cutsem E, et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 2000; 18:3202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/2\">",
"      Keswani RN, Early DS, Edmundowicz SA, et al. Routine positron emission tomography does not alter nodal staging in patients undergoing EUS-guided FNA for esophageal cancer. Gastrointest Endosc 2009; 69:1210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/3\">",
"      Tio TL, Coene PP, den Hartog Jager FC, Tytgat GN. Preoperative TNM classification of esophageal carcinoma by endosonography. Hepatogastroenterology 1990; 37:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/4\">",
"      Dittler HJ, Bollschweiler E, Siewert JR. [What is the value of endosonography in the preoperative staging of esophageal carcinoma?]. Dtsch Med Wochenschr 1991; 116:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/5\">",
"      Vilgrain V, Mompoint D, Palazzo L, et al. Staging of esophageal carcinoma: comparison of results with endoscopic sonography and CT. AJR Am J Roentgenol 1990; 155:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/6\">",
"      Botet JF, Lightdale CJ, Zauber AG, et al. Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT. Radiology 1991; 181:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/7\">",
"      Grimm H, Binmoeller KF, Hamper K, et al. Endosonography for preoperative locoregional staging of esophageal and gastric cancer. Endoscopy 1993; 25:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/8\">",
"      R&ouml;sch T, Lorenz R, Zenker K, et al. Local staging and assessment of resectability in carcinoma of the esophagus, stomach, and duodenum by endoscopic ultrasonography. Gastrointest Endosc 1992; 38:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/9\">",
"      Quint LE, Glazer GM, Orringer MB. Esophageal imaging by MR and CT: study of normal anatomy and neoplasms. Radiology 1985; 156:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/10\">",
"      Petrillo R, Balzarini L, Bidoli P, et al. Esophageal squamous cell carcinoma: MRI evaluation of mediastinum. Gastrointest Radiol 1990; 15:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/11\">",
"      Takashima S, Takeuchi N, Shiozaki H, et al. Carcinoma of the esophagus: CT vs MR imaging in determining resectability. AJR Am J Roentgenol 1991; 156:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/12\">",
"      Lehr L, Rupp N, Siewert JR. Assessment of resectability of esophageal cancer by computed tomography and magnetic resonance imaging. Surgery 1988; 103:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/13\">",
"      Koch J, Halvorsen RA Jr. Staging of esophageal cancer: computed tomography, magnetic resonance imaging, and endoscopic ultrasound. Semin Roentgenol 1994; 29:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/14\">",
"      R&ouml;sch T. Endosonographic staging of esophageal cancer: a review of literature results. Gastrointest Endosc Clin N Am 1995; 5:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/15\">",
"      Lowe VJ, Booya F, Fletcher JG, et al. Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer. Mol Imaging Biol 2005; 7:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/16\">",
"      van Vliet EP, Heijenbrok-Kal MH, Hunink MG, et al. Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer 2008; 98:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/17\">",
"      Kimmey MB, Martin RW, Haggitt RC, et al. Histologic correlates of gastrointestinal ultrasound images. Gastroenterology 1989; 96:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/18\">",
"      Hasegawa N, Niwa Y, Arisawa T, et al. Preoperative staging of superficial esophageal carcinoma: comparison of an ultrasound probe and standard endoscopic ultrasonography. Gastrointest Endosc 1996; 44:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/19\">",
"      Murata Y, Suzuki S, Ohta M, et al. Small ultrasonic probes for determination of the depth of superficial esophageal cancer. Gastrointest Endosc 1996; 44:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/20\">",
"      Chandawarkar RY, Kakegawa T, Fujita H, et al. Endosonography for preoperative staging of specific nodal groups associated with esophageal cancer. World J Surg 1996; 20:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/21\">",
"      Young PE, Gentry AB, Acosta RD, et al. Endoscopic ultrasound does not accurately stage early adenocarcinoma or high-grade dysplasia of the esophagus. Clin Gastroenterol Hepatol 2010; 8:1037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/22\">",
"      Thosani N, Singh H, Kapadia A, et al. Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers: a systematic review and meta-analysis. Gastrointest Endosc 2012; 75:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/23\">",
"      Tajima Y, Nakanishi Y, Ochiai A, et al. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors. Cancer 2000; 88:1285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/24\">",
"      Tio TL. Diagnosis and staging of esophageal carcinoma by endoscopic ultrasonography. Endoscopy 1998; 30 Suppl 1:A33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/25\">",
"      Pouw RE, Heldoorn N, Herrero LA, et al. Do we still need EUS in the workup of patients with early esophageal neoplasia? A retrospective analysis of 131 cases. Gastrointest Endosc 2011; 73:662.",
"     </a>",
"    </li>",
"    <li>",
"     Rosch T, Classen M. Pitfalls in endosonographic imaging. In: Gastrointestinal endosonography, Van Dam, Sivak (Eds), WB Saunders Company, 1999. p.123.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/27\">",
"      Nesje LB, Svanes K, Viste A, et al. Comparison of a linear miniature ultrasound probe and a radial-scanning echoendoscope in TN staging of esophageal cancer. Scand J Gastroenterol 2000; 35:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/28\">",
"      Wallace MB, Hoffman BJ, Sahai AS, et al. Imaging of esophageal tumors with a water-filled condom and a catheter US probe. Gastrointest Endosc 2000; 51:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/29\">",
"      Fockens P, van Dullemen HM, Tytgat GN. Endosonography of stenotic esophageal carcinomas: preliminary experience with an ultra-thin, balloon-fitted ultrasound probe in four patients. Gastrointest Endosc 1994; 40:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/30\">",
"      Vazquez-Sequeiros E, Wiersema MJ. High-frequency US catheter-based staging of early esophageal tumors. Gastrointest Endosc 2002; 55:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/31\">",
"      Catalano MF, Van Dam J, Sivak MV Jr. Malignant esophageal strictures: staging accuracy of endoscopic ultrasonography. Gastrointest Endosc 1995; 41:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/32\">",
"      Kallimanis GE, Gupta PK, al-Kawas FH, et al. Endoscopic ultrasound for staging esophageal cancer, with or without dilation, is clinically important and safe. Gastrointest Endosc 1995; 41:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/33\">",
"      Van Dam J, Rice TW, Catalano MF, et al. High-grade malignant stricture is predictive of esophageal tumor stage. Risks of endosonographic evaluation. Cancer 1993; 71:2910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/34\">",
"      Wallace MB, Hawes RH, Sahai AV, et al. Dilation of malignant esophageal stenosis to allow EUS guided fine-needle aspiration: safety and effect on patient management. Gastrointest Endosc 2000; 51:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/35\">",
"      Menzel J, Hoepffner N, Nottberg H, et al. Preoperative staging of esophageal carcinoma: miniprobe sonography versus conventional endoscopic ultrasound in a prospective histopathologically verified study. Endoscopy 1999; 31:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/36\">",
"      Mallery S, Van Dam J. Increased rate of complete EUS staging of patients with esophageal cancer using the nonoptical, wire-guided echoendoscope. Gastrointest Endosc 1999; 50:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/37\">",
"      Dittler HJ. Assessment of resectability of gastrointestinal cancers by endoscopic ultrasonography. Gastrointest Endosc Clin N Am 1995; 5:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/38\">",
"      Catalano MF, Sivak MV Jr, Rice T, et al. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc 1994; 40:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/39\">",
"      Bhutani MS, Hawes RH, Hoffman BJ. A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration for diagnosis of malignant lymph node invasion. Gastrointest Endosc 1997; 45:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/40\">",
"      Chen J, Xu R, Hunt GC, et al. Influence of the number of malignant regional lymph nodes detected by endoscopic ultrasonography on survival stratification in esophageal adenocarcinoma. Clin Gastroenterol Hepatol 2006; 4:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/41\">",
"      Rice TW, Blackstone EH, Adelstein DJ, et al. Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinoma. J Thorac Cardiovasc Surg 2003; 125:1091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/42\">",
"      Wiersema MJ, Vilmann P, Giovannini M, et al. Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology 1997; 112:1087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/43\">",
"      Giovannini M, Seitz JF, Monges G, et al. Fine-needle aspiration cytology guided by endoscopic ultrasonography: results in 141 patients. Endoscopy 1995; 27:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/44\">",
"      Eloubeidi MA, Wallace MB, Reed CE, et al. The utility of EUS and EUS-guided fine needle aspiration in detecting celiac lymph node metastasis in patients with esophageal cancer: a single-center experience. Gastrointest Endosc 2001; 54:714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/45\">",
"      Reed CE, Mishra G, Sahai AV, et al. Esophageal cancer staging: improved accuracy by endoscopic ultrasound of celiac lymph nodes. Ann Thorac Surg 1999; 67:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/46\">",
"      Giovannini M, Monges G, Seitz JF, et al. Distant lymph node metastases in esophageal cancer: impact of endoscopic ultrasound-guided biopsy. Endoscopy 1999; 31:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/47\">",
"      Vazquez-Sequeiros E, Norton ID, Clain JE, et al. Impact of EUS-guided fine-needle aspiration on lymph node staging in patients with esophageal carcinoma. Gastrointest Endosc 2001; 53:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/48\">",
"      Catalano MF, Alcocer E, Chak A, et al. Evaluation of metastatic celiac axis lymph nodes in patients with esophageal carcinoma: accuracy of EUS. Gastrointest Endosc 1999; 50:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/49\">",
"      Harewood GC, Wiersema MJ. A cost analysis of endoscopic ultrasound in the evaluation of esophageal cancer. Am J Gastroenterol 2002; 97:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/50\">",
"      Vazquez-Sequeiros E, Wiersema MJ, Clain JE, et al. Impact of lymph node staging on therapy of esophageal carcinoma. Gastroenterology 2003; 125:1626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/51\">",
"      Vazquez-Sequeiros E, Levy MJ, Clain JE, et al. Routine vs. selective EUS-guided FNA approach for preoperative nodal staging of esophageal carcinoma. Gastrointest Endosc 2006; 63:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/52\">",
"      van Vliet EP, Eijkemans MJ, Poley JW, et al. Staging of esophageal carcinoma in a low-volume EUS center compared with reported results from high-volume centers. Gastrointest Endosc 2006; 63:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/53\">",
"      Catalano MF, Sivak MV Jr, Bedford RA, et al. Observer variation and reproducibility of endoscopic ultrasonography. Gastrointest Endosc 1995; 41:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/54\">",
"      Burtin P, Berg P, Bour B, et al. [Evaluation of the teaching of echo-endoscopy. Application to the assessment of invasiveness of cancer of the esophagus and the cardia]. Gastroenterol Clin Biol 1995; 19:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/55\">",
"      Palazzo L, Burtin P. Interobserver variation in tumor staging. Gastrointest Endosc Clin N Am 1995; 5:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/56\">",
"      Fockens P, Van den Brande JH, van Dullemen HM, et al. Endosonographic T-staging of esophageal carcinoma: a learning curve. Gastrointest Endosc 1996; 44:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/57\">",
"      Massari M, Cioffi U, De Simone M, et al. Endoscopic ultrasonography for preoperative staging of esophageal carcinoma. Surg Laparosc Endosc 1997; 7:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/58\">",
"      Schlick T, Heintz A, Junginger T. The examiner's learning effect and its influence on the quality of endoscopic ultrasonography in carcinoma of the esophagus and gastric cardia. Surg Endosc 1999; 13:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/59\">",
"      Souquet JC, Napoleon B, Pujol B, et al. Endosonography-guided treatment of esophageal carcinoma. Endoscopy 1992; 24 Suppl 1:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/60\">",
"      Catalano MF, Sivak MV Jr, Rice TW, Van Dam J. Postoperative screening for anastomotic recurrence of esophageal carcinoma by endoscopic ultrasonography. Gastrointest Endosc 1995; 42:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/61\">",
"      Fockens P, Manshanden CG, van Lanschot JJ, et al. Prospective study on the value of endosonographic follow-up after surgery for esophageal carcinoma. Gastrointest Endosc 1997; 46:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27208/abstract/62\">",
"      M&uuml;ller C, K&auml;hler G, Scheele J. Endosonographic examination of gastrointestinal anastomoses with suspected locoregional tumor recurrence. Surg Endosc 2000; 14:45.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2663 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-FE8AB3007C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_36_27208=[""].join("\n");
var outline_f26_36_27208=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PREOPERATIVE STAGING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Histologic correlates of the endoscopic ultrasound image",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      EUS for T staging of superficial tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      EUS for staging advanced tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Accuracy of EUS for determining unresectability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      EUS for preoperative lymph node staging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Endoscopic ultrasound-guided fine-needle aspiration biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Interobserver variation and EUS learning curve for esophageal carcinoma staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      RESTAGING AFTER CHEMORADIATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      DETECTION OF LOCOREGIONAL RECURRENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2663\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2663|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?37/9/38035\" title=\"diagnostic image 1\">",
"      EUS five layer pattern",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?19/1/19478\" title=\"diagnostic image 2A\">",
"      Esophageal tumor staging EUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?8/44/8901\" title=\"diagnostic image 2B\">",
"      T1 esophageal cancer EUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?2/4/2116\" title=\"diagnostic image 2C\">",
"      T2 esophageal cancer EUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?41/32/42496\" title=\"diagnostic image 2D\">",
"      T3 esophageal cancer EUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?2/2/2081\" title=\"diagnostic image 2E\">",
"      T4 esophageal cancer EUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?14/25/14739\" title=\"diagnostic image 3\">",
"      Periesophageal lymph nodes EUS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2663|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/57/17302\" title=\"figure 1\">",
"      Depth invasion esophageal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2663|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/1/17424\" title=\"picture 1\">",
"      High frequency EUS probe",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2663|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/35/4668\" title=\"table 1\">",
"      T stage esophageal cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/38/13934\" title=\"table 2\">",
"      TNM staging esoph SCC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/24/4494\" title=\"table 3\">",
"      TNM staging esoph adenoCA including EGJ",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/12/9419\" title=\"table 4\">",
"      EUS criteria lymph nodes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/10/36011\" title=\"table 5\">",
"      Lymph node staging EUS FNA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/40/9867\" title=\"table 6\">",
"      CT EUS and EUS-FNA for esoph cancer staging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/7/21627\" title=\"table 7\">",
"      Accuracy EUS post chemo",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/45/7898?source=related_link\">",
"      Diagnosis and staging of esophageal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/30/3561?source=related_link\">",
"      Endoscopic ultrasound-guided fine-needle aspiration biopsy in the gastrointestinal tract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/60/20426?source=related_link\">",
"      Management of superficial esophageal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/54/4970?source=related_link\">",
"      Overview of endoscopic resection of gastrointestinal tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/31/39418?source=related_link\">",
"      Radiation therapy, chemoradiotherapy, neoadjuvant approaches, and postoperative adjuvant therapy for localized cancers of the esophagus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/30/34282?source=related_link\">",
"      Surgical oncologic principles for management of resectable esophageal cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_36_27209="Clinical manifestations and diagnosis of acute interstitial nephritis";
var content_f26_36_27209=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of acute interstitial nephritis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/36/27209/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/36/27209/contributors\">",
"     Manuel Praga, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/36/27209/contributors\">",
"     Gerald B Appel, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/36/27209/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/36/27209/contributors\">",
"     Paul M Palevsky, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/36/27209/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/36/27209/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/36/27209/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute interstitial nephritis (AIN) is a renal lesion that causes a decline in creatinine clearance and is characterized by an inflammatory infiltrate in the kidney interstitium [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/1\">",
"     1",
"    </a>",
"    ]. It is most often induced by drug therapy. AIN is also caused by autoimmune disorders or other systemic disease (eg, SLE, Sj&ouml;gren's syndrome, sarcoidosis), a variety of infections remote to the kidney (eg, Legionella, leptospirosis and streptococcal organisms), and TINU syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/2-10\">",
"     2-10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An overview of the clinical manifestations and diagnosis of acute interstitial nephritis is presented in this topic review. The treatment of acute interstitial nephritis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/28/34245?source=see_link\">",
"     \"Treatment of acute interstitial nephritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Interstitial nephritis associated with systemic lupus erythematosus, sarcoidosis, the TINU syndrome, and Sj&ouml;gren's syndrome is also discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/3/27706?source=see_link&amp;anchor=H15#H15\">",
"     \"Diagnosis and classification of renal disease in systemic lupus erythematosus\", section on 'Tubulointerstitial nephritis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/31/40438?source=see_link&amp;anchor=H6#H6\">",
"     \"Renal disease in sarcoidosis\", section on 'Granulomatous interstitial nephritis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/0/20486?source=see_link\">",
"     \"Tubulointerstitial nephritis and uveitis (TINU syndrome)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/12/20677?source=see_link\">",
"     \"Renal disease in Sj&ouml;gren's syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In initial reports, the vast majority of cases of AIN resulted from exposure to beta-lactam antibiotics, particularly methicillin. More recently, drugs other than antibiotics as well as infections and other underlying conditions have been recognized as clinically significant causes.",
"   </p>",
"   <p>",
"    The distribution of causes of acute interstitial nephritis has been reported as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/6,9,11,12\">",
"     6,9,11,12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Drugs, with antibiotics responsible for one-third of these cases &mdash; more than 75 percent",
"     </li>",
"     <li>",
"      Infections &mdash; 5 to 10 percent",
"     </li>",
"     <li>",
"      Tubulointerstitial nephritis and uveitis (TINU) syndrome &mdash; 5 to 10 percent",
"     </li>",
"     <li>",
"      Systemic disease including sarcoidosis, Sj&ouml;gren's syndrome, systemic lupus erythematosus and others &mdash; 10 to 15 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Virtually any drug can cause AIN although only a few have been reported with any frequency. While there are single case reports of many drugs apparently causing AIN, we generally only consider a case report of a previously unreported drug as likely to reflect a real effect if there is biopsy-proven AIN and the patient was not taking any other drugs that might cause AIN.",
"   </p>",
"   <p>",
"    On the other hand, it may be difficult to identify the culprit drug in some patients with biopsy-proven AIN, especially among patients who are taking multiple medications and may not recall which agents are newly started.",
"   </p>",
"   <p>",
"    AIN was particularly common with methicillin, occurring in up to 17 percent of patients who had been treated for more than 10 days [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/5,13,14\">",
"     5,13,14",
"    </a>",
"    ]. Methicillin is no longer available in the United States.",
"   </p>",
"   <p>",
"    The most common drug causes of AIN now include [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/2-4,14-22\">",
"     2-4,14-22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Nonsteroidal antiinflammatory agents (NSAIDs), including selective COX-2 inhibitors",
"     </li>",
"     <li>",
"      Penicillins and cephalosporins",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"       Rifampin",
"      </a>",
"     </li>",
"     <li>",
"      Antimicrobial sulfonamides, including",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"       trimethoprim-sulfamethoxazole",
"      </a>",
"     </li>",
"     <li>",
"      Diuretics, including loop diuretics such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/9/43158?source=see_link\">",
"       bumetanide",
"      </a>",
"      , and thiazide-type diuretics",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"       Ciprofloxacin",
"      </a>",
"      and, perhaps to a lesser degree, other quinolones",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/54/2921?source=see_link\">",
"       Cimetidine",
"      </a>",
"      (only rare cases have been described with other H-2 blockers such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/56/42888?source=see_link\">",
"       ranitidine",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/23,24\">",
"       23,24",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/40/25223?source=see_link\">",
"       Allopurinol",
"      </a>",
"     </li>",
"     <li>",
"      Proton pump inhibitors such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/62/26601?source=see_link\">",
"       omeprazole",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?3/14/3305?source=see_link\">",
"       lansoprazole",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/36/25161?source=see_link\">",
"       Indinavir",
"      </a>",
"     </li>",
"     <li>",
"      5-aminosalicylates (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/44/22215?source=see_link\">",
"       mesalamine",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The development of drug-induced AIN is not dose-dependent and recurrence or exacerbation can occur with a second exposure to the same or a related drug [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple organisms have been associated with AIN including Legionella, Leptospira, Cytomegalovirus Streptococcus, Mycobacterium tuberculosis, Corynebacterium diphtheriae, Epstein-Barr virus, Yersinia, polyomavirus, and others [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/10,26-28\">",
"     10,26-28",
"    </a>",
"    ]. A histologic variant of AIN that is characterized by granuloma formation has been associated with Mycobacterium, fungi (histoplasmosis, coccidiomycosis), bacteria (brucella, chlamydia), spirochetes (Francisella, treponema) and parasites (leishmania, toxoplasma) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H853752222\">",
"     'Histology'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Initial reports suggested that organisms such as Legionella, Leptospira, Cytomegalovirus and Streptococcus primarily invaded organs remote from the kidney and exerted an inflammatory response in the kidney without invading the kidney [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. However, more recent reports describe the identification of organism-specific antigens or DNA in kidney proximal tubule cells of patients with AIN [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/26,30-32\">",
"     26,30-32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Associated with systemic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Numerous systemic disorders have been associated with AIN. These primarily include systemic lupus erythematosus (SLE), sarcoidosis, and Sj&ouml;gren's syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/3/27706?source=see_link&amp;anchor=H15#H15\">",
"     \"Diagnosis and classification of renal disease in systemic lupus erythematosus\", section on 'Tubulointerstitial nephritis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/31/40438?source=see_link&amp;anchor=H6#H6\">",
"     \"Renal disease in sarcoidosis\", section on 'Granulomatous interstitial nephritis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/12/20677?source=see_link\">",
"     \"Renal disease in Sj&ouml;gren's syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with SLE and granulomatosis with polyangiitis (Wegener&rsquo;s) often have an interstitial nephritis accompanying the characteristic glomerular disease and may rarely present with AIN even in the absence of glomerular disease.",
"   </p>",
"   <p>",
"    Relatively rare causes of AIN include IgG4-related disease [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/33,34\">",
"     33,34",
"    </a>",
"    ] and hypocomplementemic tubulointerstitial nephritis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/35-37\">",
"     35-37",
"    </a>",
"    ]. IgG4-related disease is a systemic disorder that was initially described in 2003 and reported to cause tubulointerstitial nephritis in 2004 [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/38-41\">",
"     38-41",
"    </a>",
"    ]. IgG4-related disease is characterized by the infiltration of multiple organs by a lymphoplasmacytic infiltrate that is rich in IgG4-positive plasma cells, resulting in diverse clinical manifestations including autoimmune pancreatitis, enlarged lacrimal and salivary glands and periorbital tissue and tubulointerstitial nephritis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/55/13178?source=see_link\">",
"     \"Overview of IgG4-related disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Kidneys are reportedly involved in approximately 30 percent of cases of IgG4-related disease [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/33,42\">",
"     33,42",
"    </a>",
"    ]. Tubulointerstitial nephritis is the most commonly associated renal lesion although glomerular lesions (mostly membranous nephropathy) have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/42-44\">",
"     42-44",
"    </a>",
"    ]. In a case series from Japan, among 153 patients with IgG4-related disease, 23 patients (15 percent) had tubulointerstitial nephritis and two patients had a concurrent membranous nephropathy lesion [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/42\">",
"     42",
"    </a>",
"    ]. The clinical and laboratory features that characterize IgG4-related tubulointerstitial nephritis are described below. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Clinical features'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Hypocomplementemic tubulointerstitial nephritis, described in a small case series [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/36\">",
"     36",
"    </a>",
"    ] and a number of case reports, is characterized by massive tubulointerstitial deposits and lymphoid or plasma cell infiltration observed on kidney biopsy, and systemic hypocomplementemia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/35-37\">",
"     35-37",
"    </a>",
"    ]. It is possible that many of the early reports of hypocomplementemic tubulointerstitial nephritis were due to IgG4-related disease, which is also characterized by lymphoplasmacytic infiltrates and systemic hypocomplementemia, since IgG4 immunostaining was not available at the time of the initial reports [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/36\">",
"     36",
"    </a>",
"    ] and personal communication. However, both IgG4-positive and IgG4-negative cases of hypocomplementemic interstitial nephritis have since been diagnosed at the same institution that reported the defining case series, suggesting that these diseases should be considered as distinct entities.",
"   </p>",
"   <p>",
"    A rare cause of AIN is anti-tubular basement membrane (TBM) antibodies, leading to linear staining on immunofluorescence microscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/45-48\">",
"     45-48",
"    </a>",
"    ]. This can occur in the presence or absence of concurrent anti-glomerular basement membrane antibodies [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/45,46\">",
"     45,46",
"    </a>",
"    ] and has been described in patients with membranous nephropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/48\">",
"     48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/19/4409?source=see_link&amp;anchor=H9#H9\">",
"     \"Pathogenesis and diagnosis of anti-GBM antibody (Goodpasture's) disease\", section on 'Renal biopsy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/54/19306?source=see_link\">",
"     \"Causes and diagnosis of membranous nephropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H451377303\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;With AIN from any cause, patients may present with nonspecific signs and symptoms of acute renal dysfunction. These may include the acute or subacute onset of nausea, vomiting, malaise. However many patients are asymptomatic [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/10\">",
"     10",
"    </a>",
"    ]. Patients may be oliguric; in retrospective study that included 60 cases of AIN (92 percent of which were drug-induced with remainder idiopathic) oliguria was present among 51 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/11\">",
"     11",
"    </a>",
"    ]. Gross hematuria occurs in approximately 5 percent of individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients usually do not have significant proteinuria and nephrotic syndrome occurs in fewer than 1 percent of patients with AIN [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients may present with symptoms related to the cause of the AIN. Classically, patients with drug-induced AIN were reported to have symptoms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    signs of an allergic-type reaction, including rash, fever, and eosinophilia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/49\">",
"     49",
"    </a>",
"    ]. However, in a more recent review of three series that totaled 128 patients with AIN (of whom 70 percent had drug-induced disease), these findings of a typical allergic response were relatively less common at presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/9\">",
"     9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Rash &mdash; 15 percent",
"     </li>",
"     <li>",
"      Fever &mdash; 27 percent",
"     </li>",
"     <li>",
"      Eosinophilia &mdash; 23 percent",
"     </li>",
"     <li>",
"      Triad of rash, fever, and eosinophilia &mdash; 10 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A similar incidence of findings was reported in two retrospective series, which collected a total of 121 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. Rash, fever, eosinophilia and the triad were observed in 22, 36, 35 and 11 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/11\">",
"     11",
"    </a>",
"    ]. Arthralgias were observed in 45 percent of the patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thus, the originally described classic triad is less commonly observed than initially reported. This is probably due to the absence of cases of methicillin-induced AIN, and (perhaps) the increased inclusion of cases not directly resulting from an allergic response [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/10\">",
"     10",
"    </a>",
"    ]. In addition, some agents such as NSAIDs are less commonly associated with fever, rash and eosinophilia compared with other agents [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/51,52\">",
"     51,52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The onset of drug-induced AIN following drug exposure typically ranges from three to five days (as occurs with a second exposure to an offending drug) to as long as several weeks to many months (as occurs following a first exposure to an offending drug) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. However, the latent period may be as short as one day with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/3\">",
"     3",
"    </a>",
"    ] or as long as 18 months with an NSAID [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients who have AIN that is not related to a drug may have symptoms related to an associated infection, or systemic condition such as SLE, sarcoidosis, the TINU syndrome and Sj&ouml;gren's syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/3/27706?source=see_link&amp;anchor=H15#H15\">",
"     \"Diagnosis and classification of renal disease in systemic lupus erythematosus\", section on 'Tubulointerstitial nephritis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/31/40438?source=see_link&amp;anchor=H6#H6\">",
"     \"Renal disease in sarcoidosis\", section on 'Granulomatous interstitial nephritis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/0/20486?source=see_link\">",
"     \"Tubulointerstitial nephritis and uveitis (TINU syndrome)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/12/20677?source=see_link\">",
"     \"Renal disease in Sj&ouml;gren's syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with IgG4-related interstitial nephritis may have extrarenal signs and symptoms. In a series of 23 patients, fever, arthralgias, skin lesions and edema were present in 3, 5, 1 and 2 patients, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Overall, 96 percent of patients with IgG4-related AIN had extrarenal lesions including sialadenitis in 19 (82 percent), lymphadenopathy in 10 (44 percent), autoimmune pancreatitis in 9 (39 percent) dacryoadenitis in 7 (30 percent) and lung lesions (interstitial pneumonia and nodular lesions) in 6 (26 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H853751738\">",
"    <span class=\"h2\">",
"     Tubulointerstitial nephritis and uveitis (TINU) syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some patients with interstitial nephritis have the tubulointerstitial nephritis and uveitis TINU syndrome. Patients present with interstitial nephritis and uveitis, and occasionally with systemic findings including, fever, weight loss, fatigue, malaise, anorexia, asthenia, abdominal and flank pain, arthralgias, myalgias, headache, polyuria",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    nocturia. The TINU syndrome is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/0/20486?source=see_link\">",
"     \"Tubulointerstitial nephritis and uveitis (TINU syndrome)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Laboratory and radiographic findings",
"    </span>",
"   </p>",
"   <p>",
"    In general, patients with acute interstitial nephritis present with some combination of the following laboratory findings, with some variation based upon the underlying cause [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/2-4,9,50\">",
"     2-4,9,50",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Virtually all patients have a rise in the plasma creatinine concentration on presentation [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/50,51\">",
"       50,51",
"      </a>",
"      ]. If AIN is drug-induced, the increase in creatinine is temporally related to administration of the offending drug. AKI may be severe; in two retrospective series, among 121 patients who presented with AIN, 40 percent required dialysis [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/50,51\">",
"       50,51",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Eosinophilia and eosinophiluria. Eosinophiluria is considered to be present when eosinophils account for",
"      <strong>",
"       more than 1 percent",
"      </strong>",
"      of urinary white cells by Hansel's stain [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/5,53\">",
"       5,53",
"      </a>",
"      ]. However, with disease-induced by NSAIDs, eosinophilia and eosinophiluria are less commonly observed than in cases induced by other drugs [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/51,52\">",
"       51,52",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      A urine sediment that usually reveals white cells, red cells, and white cell casts (",
"      <a class=\"graphic graphic_picture graphicRef54319 graphicRef68147 \" href=\"UTD.htm?27/1/27669\">",
"       picture 1A-B",
"      </a>",
"      ). Red blood cell casts, which are typically seen in glomerulonephritis, have also been described in AIN although this is rare [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A variable degree of proteinuria which can range from none or minimal to &gt;1",
"      <span class=\"nowrap\">",
"       g/day.",
"      </span>",
"      In two retrospective series that included a total of 121 patients, the mean and median protein excretions were 0.9&plusmn;1.1",
"      <span class=\"nowrap\">",
"       g/day",
"      </span>",
"      (range 0 to 6",
"      <span class=\"nowrap\">",
"       g/day)",
"      </span>",
"      and 0.70",
"      <span class=\"nowrap\">",
"       g/day",
"      </span>",
"      (interquartile range 0.39 to 1.0",
"      <span class=\"nowrap\">",
"       g/day),",
"      </span>",
"      respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/50,51\">",
"       50,51",
"      </a>",
"      ]. Older individuals may be more likely to have significant proteinuria [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/55\">",
"       55",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Occasional patients will have nephrotic range proteinuria [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/2,3,11\">",
"       2,3,11",
"      </a>",
"      ]. Concurrent nephrotic syndrome due to minimal change disease or membranous nephropathy can rarely be seen with NSAIDs, and in selected cases induced by",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"       ampicillin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"       rifampin",
"      </a>",
"      , interferon, or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/56/42888?source=see_link\">",
"       ranitidine",
"      </a>",
"      &nbsp;(",
"      <a class=\"graphic graphic_picture graphicRef52666 \" href=\"UTD.htm?3/6/3175\">",
"       picture 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/11,23,52,56,57\">",
"       11,23,52,56,57",
"      </a>",
"      ]. In one study cited above however, although proteinuria was significantly higher among NSAID-induced AIN as compared with other types of drug-induced AIN, nephrotic range proteinuria was rare [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/51\">",
"       51",
"      </a>",
"      ]. In addition, although these and other drugs may induce heavy proteinuria [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/13\">",
"       13",
"      </a>",
"      ], an underlying disease (such as diabetic nephropathy or glomerulonephritis due to bacterial endocarditis) may be responsible for at least part of the proteinuria in some patients.",
"     </li>",
"     <li>",
"      Signs of tubulointerstitial damage, such as the Fanconi syndrome and renal tubular acidosis [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Fractional excretion of sodium above 1 percent which is in part indicative of tubular damage [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/2\">",
"       2",
"      </a>",
"      ]. Calculators for the FENa are available using either standard units (",
"      <a class=\"calc calc_professional\" href=\"UTD.htm?25/13/25809?source=see_link\">",
"       calculator 1",
"      </a>",
"      ) or SI units (",
"      <a class=\"calc calc_professional\" href=\"UTD.htm?24/28/25025?source=see_link\">",
"       calculator 2",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/17/8472?source=see_link&amp;anchor=H3#H3\">",
"       \"Fractional excretion of sodium, urea, and other molecules in acute kidney injury (acute renal failure)\", section on 'FENa in acute kidney injury'",
"      </a>",
"      .) However lower values may be seen, particularly in patients who are nonoliguric and have less severe renal failure [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/58,59\">",
"       58,59",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients with IgG4-related disease or hypocomplementemic interstitial nephritis may have low serum complement concentrations. In a series cited above, among 23 patients, complement C3, C4 or both were reduced in 16 [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/42\">",
"       42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients with IgG4-related disease usually have elevated serum total IgG",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      IgG4 levels or hypergammaglobulinemia [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/42\">",
"       42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      There are no radiographic findings that are diagnostic for AIN. Radiographic findings including marked enlargement of kidneys with low-attenuation lesions may be seen among patients with IgG4-related AIN [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Microbiologic features unique to different culprit organisms are presented separately. (See appropriate topic reviews)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute interstitial nephritis (AIN) should be suspected in a patient who presents with an elevated serum creatinine and a urinalysis that shows white cells, white cell casts, and, in some cases, eosinophiluria. Drug-induced AIN should be suspected when the onset of characteristic laboratory findings is temporally related to the initiation of a new drug, particularly one that has been previously reported to cause AIN. However, occasional patients have a bland sediment with few cells or casts [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/17\">",
"     17",
"    </a>",
"    ]. Thus, a relatively normal urinalysis should not exclude the diagnosis.",
"   </p>",
"   <p>",
"    A definitive diagnosis of AIN is made by renal biopsy. It is often considered unnecessary to make a definitive diagnosis, such as among patients who have clearly documented onset of renal failure after initiation of a common culprit drug, and who improve immediately upon stopping the offending agent.",
"   </p>",
"   <p>",
"    We suggest a kidney biopsy for the following patients who are suspected of having AIN:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients who have a characteristic urinalysis for AIN but are not being treated with a drug known to cause AIN.",
"     </li>",
"     <li>",
"      Patients who are being treated with a drug known to cause AIN but do not have a characteristic urinalysis. Some of the drugs that cause AIN can produce other forms of acute kidney injury. As an example, NSAIDs can exacerbate prerenal disease by inhibiting the production of vasodilator prostaglandins [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/52\">",
"       52",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/0/24582?source=see_link\">",
"       \"NSAIDs: Acute kidney injury (acute renal failure) and nephrotic syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients who are being considered for treatment with glucocorticoids for AIN (usually drug-induced). Among selected patients (such as those at high risk of complications of a biopsy or who do not wish to undergo a biopsy), glucocorticoids may be initiated in the absence of a biopsy. However among such patients who do not improve after the first five to seven days of steroid treatment, most should have a biopsy in order to exclude other diagnosis or the presence of severe interstitial fibrosis.",
"     </li>",
"     <li>",
"      Patients with putative drug-related AIN who are not treated with glucocorticoids initially and do not have a spontaneous recovery following cessation of drug therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/2,50\">",
"       2,50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients who present with advanced renal failure, providing the onset of renal failure is known to be relatively recent (ie, within three months).",
"     </li>",
"     <li>",
"      Patients with any features (such as high grade proteinuria) that cause the diagnosis of AIN to be uncertain.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients who have a characteristic urinalysis for AIN but do not have an elevated creatinine may also be considered for biopsy but such patients rarely come to medical attention since the urinalysis is usually only performed after the detection of a increased serum creatinine.",
"   </p>",
"   <p>",
"    The approach to the treatment of patients diagnosed with AIN, TINU, and renal sarcoidosis is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/28/34245?source=see_link\">",
"     \"Treatment of acute interstitial nephritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/31/40438?source=see_link\">",
"     \"Renal disease in sarcoidosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/0/20486?source=see_link\">",
"     \"Tubulointerstitial nephritis and uveitis (TINU syndrome)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H853752222\">",
"    <span class=\"h2\">",
"     Histology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major histologic changes are interstitial edema and a marked interstitial infiltrate consisting primarily of T lymphocytes and monocytes (",
"    <a class=\"graphic graphic_picture graphicRef66763 graphicRef64378 graphicRef78206 graphicRef55002 graphicRef67591 \" href=\"UTD.htm?43/18/44330\">",
"     picture 3A-E",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/2,9\">",
"     2,9",
"    </a>",
"    ]. Eosinophils, plasma cells, and neutrophils also may be found. The classic lesion of \"tubulitis\" is found when inflammatory cells invade the tubular basement membrane.",
"   </p>",
"   <p>",
"    Some histologic features may suggest particular variants of AIN. As an example, granuloma formation is particularly characteristic of sarcoidosis although it may be seen in any form of AIN [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/60\">",
"     60",
"    </a>",
"    ]. Granuloma formation also suggests a greater likelihood of infection-induced AIN compared with AIN without granulomas. In a review of 40 biopsies of patients with granulomatous renal disease (including 37 patients with interstitial nephritis, 2 with associated pauci-immune crescentic glomerulonephritis and 1 with vasculitis), sarcoidosis was present in 20 patients (50 percent) and drug-induced and Mycobacterium infection present in 7 (18 percent) and 5 (13 percent), respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/61\">",
"     61",
"    </a>",
"    ]. As described above, other infections that have been associated with granulomatous AIN include fungi (histoplasmosis, coccidiomycosis), bacteria (brucella, chlamydia), spirochetes (Francisella, treponema) and parasites (leishmania, toxoplasma) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Infections'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Characteristic histologic features that suggest IgG4-related disease include the presence of tubular basement membrane immune complex deposits and an increase in IgG4-positive plasma cells in the interstitium [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with interstitial nephritis related to lupus usually have concurrent glomerular lesions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/3/27706?source=see_link&amp;anchor=H15#H15\">",
"     \"Diagnosis and classification of renal disease in systemic lupus erythematosus\", section on 'Tubulointerstitial nephritis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H451377245\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of AIN includes all other causes of acute kidney injury. The diagnostic approach to the patient with acute kidney injury from any cause is presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/60/35785?source=see_link\">",
"     \"Diagnostic approach to the patient with acute kidney injury (acute renal failure) or chronic kidney disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In general, the urinary findings will distinguish AIN from other causes of acute kidney injury. The urinalysis, for example, typically shows granular and epithelial cell casts and free epithelial cells in acute tubular necrosis; red cell casts as well as red and white cells in acute glomerulonephritis; and few if any abnormalities in prerenal disease and obstruction.",
"   </p>",
"   <p>",
"    Among patients with a predominance of white blood cells and white blood cell casts, renal atheroemboli should be considered, particularly among elderly patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/62\">",
"     62",
"    </a>",
"    ]. Similarly to AIN, renal atheroemboli may present with eosinophiluria, eosinophilia and skin lesions. However, the skin lesions associated with atheroemboli are more commonly reticular (livedo reticularis) with digital infarcts, whereas the characteristic rash associated with AIN is a diffuse maculopapular one. The history may also distinguish between AIN and renal atheroemboli since the majority of cases of atheroemboli are preceded by an endovascular procedure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/13/13528?source=see_link\">",
"     \"Clinical presentation, evaluation, and treatment of renal atheroemboli\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/13/13528?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical presentation, evaluation, and treatment of renal atheroemboli\", section on 'Risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Among patients who have a completely negative sediment, obstruction should be considered as part of the differential diagnosis. Imaging studies (usually an ultrasound) generally exclude the presence of obstruction, except in rare cases when the diagnosis of AKI is made within the first two to three days. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/38/25190?source=see_link&amp;anchor=H8#H8\">",
"     \"Diagnosis of urinary tract obstruction and hydronephrosis\", section on 'Diagnosis'",
"    </a>",
"    .) In all patients, imaging should be done prior to renal biopsy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H451377368\">",
"    <span class=\"h1\">",
"     ESTABLISHING THE CAUSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once a diagnosis of acute interstitial nephritis is made by biopsy, the underlying cause should be determined. As discussed above, the vast majority of cases of AIN are caused by a drug. A careful review of medications, including the timing of initiation in relation to the onset of AKI may reveal the likely culprit agent.",
"   </p>",
"   <p>",
"    Less commonly a drug is not identified. Among such patients, a histologic diagnosis of AIN should provoke a search for underlying infection and systemic disorders including systemic lupus erythematosus (SLE), sarcoidosis, Sj&ouml;gren's syndrome, tubulointerstitial nephritis and uveitis (TINU) syndrome, and ANCA-associated vasculitis.",
"   </p>",
"   <p>",
"    In some cases, histologic features may suggest the underlying disease that is associated with AIN. As an example, granulomas are more likely to be seen in patients with sarcoidosis than in other forms of AIN. Additionally, AIN related to SLE may be accompanied by characteristic glomerular lesions. IgG4-related disease may be suggested by the presence of tubular basement membrane immune complex deposits and an increase in IgG4-positive plasma cells in the interstitium [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/34\">",
"     34",
"    </a>",
"    ]. However, testing for IgG-4 specific plasma cells is not routinely performed at most centers.",
"   </p>",
"   <p>",
"    Such histologic features are not diagnostic and in general the etiology of non drug-related AIN must be established by means other than the renal biopsy. Among patients who have AIN that is not believed to be related to a drug, we perform the following tests:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chest x-ray to evaluate for sarcoidosis, tuberculosis and other infections. Among patients in whom the chest radiograph is nondiagnostic, a high resolution chest CT should be obtained to evaluate for sarcoidosis.",
"     </li>",
"     <li>",
"      Serum levels of angiotensin converting enzyme and measurement of serum calcium and urinary calcium excretion to evaluate for sarcoidosis.",
"     </li>",
"     <li>",
"      A PPD to exclude tuberculosis, particularly in granulomatous AIN.",
"     </li>",
"     <li>",
"      Serologic tests to exclude histoplasmosis, coccidiomycosis, toxoplasmosis, EBV. Urinary antigen test to exclude legionella infection and urine culture to exclude leptospirosis.",
"     </li>",
"     <li>",
"      ANCA to exclude ANCA-associated vasculitides.",
"     </li>",
"     <li>",
"      ANA and dsDNA to exclude SLE.",
"     </li>",
"     <li>",
"      C3 and C4 to evaluate for SLE and IgG-4-related disease and hypocomplementemic AIN. These tests, however, neither diagnose nor exclude these disorders.",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Anti-Ro/SSA,",
"      </span>",
"      <span class=\"nowrap\">",
"       anti-La/SSb",
"      </span>",
"      antibodies, C-reactive protein, and rheumatoid factor to exclude Sj&ouml;gren's syndrome.",
"     </li>",
"     <li>",
"      Serum protein electrophoresis.",
"     </li>",
"     <li>",
"      The diagnostic evaluation of a particular infection-related AIN should be guided by extrarenal clinical manifestations.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?15/22/15713?source=see_link\">",
"       \"Patient information: Acute interstitial nephritis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute interstitial nephritis (AIN) is a renal lesion that causes a decline in creatinine clearance and is characterized by an inflammatory infiltrate in the kidney interstitium. Drugs, particularly antibiotics, are the most common cause of AIN. Other causes include autoimmune disorders, infections, sarcoidosis and TINU syndrome. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Drugs that most commonly cause AIN are NSAIDs (including selective COX-2 inhibitors), penicillins and cephalosporins,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"       rifampin",
"      </a>",
"      , antimicrobial sulfonamides,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"       ciprofloxacin",
"      </a>",
"      and other quinolones, diuretics,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/54/2921?source=see_link\">",
"       cimetidine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/40/25223?source=see_link\">",
"       allopurinol",
"      </a>",
"      , proton pump inhibitors,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/36/25161?source=see_link\">",
"       indinavir",
"      </a>",
"      and 5-aminosalicylates (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/44/22215?source=see_link\">",
"       mesalamine",
"      </a>",
"      ). Many other drugs can occasionally cause AIN. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Drugs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infections that have been associated with AIN include Legionella, Leptospira, Cytomegalovirus and Streptococcus. Other less commonly associated organisms include Corynebacterium diphtheriae, Epstein-Barr virus, Yersinia and Polyomavirus. Mycobacterium infection is associated with a granulomatous variant of AIN. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Infections'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Autoimmune disorders that have been associated with AIN include sarcoidosis, Sj&ouml;gren&rsquo;s syndrome, systemic lupus erythematosus and granulomatosis with polyangiitis (Wegener&rsquo;s). Rare causes of AIN are IgG4-related disease, anti-tubular basement membrane (TBM) antibodies, hypocomplementemic tubulointerstitial nephritis and the TINU syndrome. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Associated with systemic disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with AIN present with nonspecific signs and symptoms associated with acute kidney injury. Signs and symptoms of an allergic-type reaction may be present including rash, fever, and eosinophilia, although only 10 percent of patients have the triad of rash, fever, and eosinophilia. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients generally present with a rise in the plasma creatinine concentration, which (if drug-induced) is temporally related to administration of the offending drug. Urine sediment usually reveals white cells, red cells, and white cell casts. Urinary eosinophils may be present but lack the specificity and sensitivity to either exclude or diagnose AIN. Protein excretion is usually only mildly or moderately increased. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Laboratory and radiographic findings'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/39/34418?source=see_link\">",
"       \"The significance of urinary eosinophils\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      AIN should be suspected in a patient who presents with an elevated serum creatinine and a urinalysis that shows white cells, white cell casts, and, in some cases, eosinophiluria. Drug-induced AIN should be suspected when the onset of characteristic laboratory findings are temporally related to the initiation of a new drug, particularly one that has been previously reported to cause AIN. A definitive diagnosis of AIN is made by renal biopsy. We suggest a kidney biopsy for the following patients who are suspected of having AIN. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnosis'",
"      </a>",
"      above.):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Patients who have a characteristic urinalysis for AIN but are not being treated with a drug known to cause AIN.",
"     </li>",
"     <li>",
"      Patients who are being treated with a drug known to cause AIN but do not have a characteristic urinalysis. Some of the drugs that cause AIN can produce other forms of acute kidney injury. As an example, NSAIDs can exacerbate prerenal disease by inhibiting the production of vasodilator prostaglandins [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/52\">",
"       52",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/0/24582?source=see_link\">",
"       \"NSAIDs: Acute kidney injury (acute renal failure) and nephrotic syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients who are being considered for treatment with glucocorticoids for AIN (usually drug-induced). Among selected patients (such as those at high risk of complications of a biopsy or who do not wish to undergo a biopsy), glucocorticoids may be initiated in the absence of a biopsy. However among such patients who do not improve after the first five to seven days of steroid treatment, most should have a biopsy in order to exclude other diagnosis or the presence of severe interstitial fibrosis.",
"     </li>",
"     <li>",
"      Patients with putative drug-related AIN who are not treated with glucocorticoids initially and do not have a spontaneous recovery following cessation of drug therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27209/abstract/2,50\">",
"       2,50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients who present with advanced renal failure, providing the onset of renal failure is known to be relatively recent (ie, within three months).",
"     </li>",
"     <li>",
"      Patients with any features (such as high grade proteinuria) that cause the diagnosis of AIN to be uncertain.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Patients who have a histologic diagnosis of AIN and are not on a drug known to cause AIN should be evaluated for an underlying etiology. (See",
"      <a class=\"local\" href=\"#H451377368\">",
"       'Establishing the cause'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Rossert JA, Fischer EA. Acute interstitial nephritis. In: Comprehensive Clinical Nephrology, 2, Johnson RJ, Feehally J.  (Eds), Elsevier Limited, Philadelphia 2003. Vol 1, p.769.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/2\">",
"      Neilson EG. Pathogenesis and therapy of interstitial nephritis. Kidney Int 1989; 35:1257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/3\">",
"      Ten RM, Torres VE, Milliner DS, et al. Acute interstitial nephritis: immunologic and clinical aspects. Mayo Clin Proc 1988; 63:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/4\">",
"      Michel DM, Kelly CJ. Acute interstitial nephritis. J Am Soc Nephrol 1998; 9:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/5\">",
"      Rossert J. Drug-induced acute interstitial nephritis. Kidney Int 2001; 60:804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/6\">",
"      Schwarz A, Krause PH, Kunzendorf U, et al. The outcome of acute interstitial nephritis: risk factors for the transition from acute to chronic interstitial nephritis. Clin Nephrol 2000; 54:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/7\">",
"      Yang CW, Wu MS, Pan MJ, et al. The Leptospira outer membrane protein LipL32 induces tubulointerstitial nephritis-mediated gene expression in mouse proximal tubule cells. J Am Soc Nephrol 2002; 13:2037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/8\">",
"      Tsai JD, Lee HC, Lin CC, et al. Epstein-Barr virus-associated acute renal failure: diagnosis, treatment, and follow-up. Pediatr Nephrol 2003; 18:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/9\">",
"      Baker RJ, Pusey CD. The changing profile of acute tubulointerstitial nephritis. Nephrol Dial Transplant 2004; 19:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/10\">",
"      Kodner CM, Kudrimoti A. Diagnosis and management of acute interstitial nephritis. Am Fam Physician 2003; 67:2527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/11\">",
"      Praga M, Gonz&aacute;lez E. Acute interstitial nephritis. Kidney Int 2010; 77:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/12\">",
"      Buysen JG, Houthoff HJ, Krediet RT, Arisz L. Acute interstitial nephritis: a clinical and morphological study in 27 patients. Nephrol Dial Transplant 1990; 5:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/13\">",
"      Nolan CM, Abernathy RS. Nephropathy associated with methicillin therapy. Prevalence and determinants in patients with staphylococcal bacteremia. Arch Intern Med 1977; 137:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/14\">",
"      Galpin JE, Shinaberger JH, Stanley TM, et al. Acute interstitial nephritis due to methicillin. Am J Med 1978; 65:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/15\">",
"      Nessi R, Bonoldi GL, Redaelli B, di Filippo G. Acute renal failure after rifampicin: a case report and survey of the literature. Nephron 1976; 16:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/16\">",
"      Allon M, Lopez EJ, Min KW. Acute renal failure due to ciprofloxacin. Arch Intern Med 1990; 150:2187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/17\">",
"      Lo WK, Rolston KV, Rubenstein EB, Bodey GP. Ciprofloxacin-induced nephrotoxicity in patients with cancer. Arch Intern Med 1993; 153:1258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/18\">",
"      World MJ, Stevens PE, Ashton MA, Rainford DJ. Mesalazine-associated interstitial nephritis. Nephrol Dial Transplant 1996; 11:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/19\">",
"      Torpey N, Barker T, Ross C. Drug-induced tubulo-interstitial nephritis secondary to proton pump inhibitors: experience from a single UK renal unit. Nephrol Dial Transplant 2004; 19:1441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/20\">",
"      Esteve JB, Launay-Vacher V, Brocheriou I, et al. COX-2 inhibitors and acute interstitial nephritis: case report and review of the literature. Clin Nephrol 2005; 63:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/21\">",
"      Hoppes T, Prikis M, Segal A. Four cases of nafcillin-associated acute interstitial nephritis in one institution. Nat Clin Pract Nephrol 2007; 3:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/22\">",
"      Wang YC, Lin YF, Chao TK, et al. Acute interstitial nephritis with prominent eosinophil infiltration. Clin Nephrol 2009; 71:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/23\">",
"      Gaughan WJ, Sheth VR, Francos GC, et al. Ranitidine-induced acute interstitial nephritis with epithelial cell foot process fusion. Am J Kidney Dis 1993; 22:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/24\">",
"      Neelakantappa K, Gallo GR, Lowenstein J. Ranitidine-associated interstitial nephritis and Fanconi syndrome. Am J Kidney Dis 1993; 22:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/25\">",
"      Schubert C, Bates WD, Moosa MR. Acute tubulointerstitial nephritis related to antituberculous drug therapy. Clin Nephrol 2010; 73:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/26\">",
"      Chang JF, Peng YS, Tsai CC, et al. A possible rare cause of renal failure in streptococcal infection. Nephrol Dial Transplant 2011; 26:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/27\">",
"      Ellis D, Fried WA, Yunis EJ, Blau EB. Acute interstitial nephritis in children: a report of 13 cases and review of the literature. Pediatrics 1981; 67:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/28\">",
"      Dharmarajan TS, Yoo J, Russell RO, Boateng YA. Acute post streptococcal interstitial nephritis in an adult and review of the literature. Int Urol Nephrol 1999; 31:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/29\">",
"      Agrawal V, Crisi GM, D'Agati VD, Freda BJ. Renal sarcoidosis presenting as acute kidney injury with granulomatous interstitial nephritis and vasculitis. Am J Kidney Dis 2012; 59:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/30\">",
"      Hung CC, Chang CT, Chen KH, et al. Upregulation of chemokine CXCL1/KC by leptospiral membrane lipoprotein preparation in renal tubule epithelial cells. Kidney Int 2006; 69:1814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/31\">",
"      Farr RW. Leptospirosis. Clin Infect Dis 1995; 21:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/32\">",
"      Baksh FK, Finkelstein SD, Swalsky PA, et al. Molecular genotyping of BK and JC viruses in human polyomavirus-associated interstitial nephritis after renal transplantation. Am J Kidney Dis 2001; 38:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/33\">",
"      Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012; 366:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/34\">",
"      Raissian Y, Nasr SH, Larsen CP, et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol 2011; 22:1343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/35\">",
"      Vaseemuddin M, Schwartz MM, Dunea G, Kraus MA. Idiopathic hypocomplementemic immune-complex-mediated tubulointerstitial nephritis. Nat Clin Pract Nephrol 2007; 3:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/36\">",
"      Kambham N, Markowitz GS, Tanji N, et al. Idiopathic hypocomplementemic interstitial nephritis with extensive tubulointerstitial deposits. Am J Kidney Dis 2001; 37:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/37\">",
"      Gupta A, Jothy S, Somerville P, Zaltzman JS. Hypocomplementemic immune complex tubulointerstitial nephritis. NDT Plus 2010; 3:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/38\">",
"      Uchiyama-Tanaka Y, Mori Y, Kimura T, et al. Acute tubulointerstitial nephritis associated with autoimmune-related pancreatitis. Am J Kidney Dis 2004; 43:e18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/39\">",
"      Takeda S, Haratake J, Kasai T, et al. IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis. Nephrol Dial Transplant 2004; 19:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/40\">",
"      Saeki T, Saito A, Yamazaki H, et al. Tubulointerstitial nephritis associated with IgG4-related systemic disease. Clin Exp Nephrol 2007; 11:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/41\">",
"      Saeki T, Nishi S, Ito T, et al. Renal lesions in IgG4-related systemic disease. Intern Med 2007; 46:1365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/42\">",
"      Saeki T, Nishi S, Imai N, et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int 2010; 78:1016.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/43\">",
"      Fervenza FC, Downer G, Beck LH Jr, Sethi S. IgG4-related tubulointerstitial nephritis with membranous nephropathy. Am J Kidney Dis 2011; 58:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/44\">",
"      Cornell LD. IgG4-related kidney disease. Curr Opin Nephrol Hypertens 2012; 21:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/45\">",
"      Andres G, Brentjens J, Kohli R, et al. Histology of human tubulo-interstitial nephritis associated with antibodies to renal basement membranes. Kidney Int 1978; 13:480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/46\">",
"      Paueksakon P, Revelo M, Lee SM, et al. Acute renal failure in a 64-year-old white man. Am J Kidney Dis 2000; 36:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/47\">",
"      Clayman MD, Michaud L, Brentjens J, et al. Isolation of the target antigen of human anti-tubular basement membrane antibody-associated interstitial nephritis. J Clin Invest 1986; 77:1143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/48\">",
"      Katz A, Fish AJ, Santamaria P, et al. Role of antibodies to tubulointerstitial nephritis antigen in human anti-tubular basement membrane nephritis associated with membranous nephropathy. Am J Med 1992; 93:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/49\">",
"      Baldwin DS, Levine BB, McCluskey RT, Gallo GR. Renal failure and interstitial nephritis due to penicillin and methicillin. N Engl J Med 1968; 279:1245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/50\">",
"      Clarkson MR, Giblin L, O'Connell FP, et al. Acute interstitial nephritis: clinical features and response to corticosteroid therapy. Nephrol Dial Transplant 2004; 19:2778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/51\">",
"      Gonz&aacute;lez E, Guti&eacute;rrez E, Galeano C, et al. Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int 2008; 73:940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/52\">",
"      Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1984; 310:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/53\">",
"      Nolan CR 3rd, Anger MS, Kelleher SP. Eosinophiluria--a new method of detection and definition of the clinical spectrum. N Engl J Med 1986; 315:1516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/54\">",
"      Sigala JF, Biava CG, Hulter HN. Red blood cell casts in acute interstitial nephritis. Arch Intern Med 1978; 138:1419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/55\">",
"      Haas M, Spargo BH, Wit EJ, Meehan SM. Etiologies and outcome of acute renal insufficiency in older adults: a renal biopsy study of 259 cases. Am J Kidney Dis 2000; 35:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/56\">",
"      Neugarten J, Gallo GR, Baldwin DS. Rifampin-induced nephrotic syndrome and acute interstitial nephritis. Am J Nephrol 1983; 3:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/57\">",
"      Averbuch SD, Austin HA 3rd, Sherwin SA, et al. Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte a interferon therapy for mycosis fungoides. N Engl J Med 1984; 310:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/58\">",
"      Saha H, Mustonen J, Helin H, Pasternack A. Limited value of the fractional excretion of sodium test in the diagnosis of acute renal failure. Nephrol Dial Transplant 1987; 2:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/59\">",
"      Lins RL, Verpooten GA, De Clerck DS, De Broe ME. Urinary indices in acute interstitial nephritis. Clin Nephrol 1986; 26:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/60\">",
"      Joss N, Morris S, Young B, Geddes C. Granulomatous interstitial nephritis. Clin J Am Soc Nephrol 2007; 2:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/61\">",
"      Javaud N, Belenfant X, Stirnemann J, et al. Renal granulomatoses: a retrospective study of 40 cases and review of the literature. Medicine (Baltimore) 2007; 86:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27209/abstract/62\">",
"      Espejo B, Herrero JC, Torres A, et al. [Immunoallergic interstitial nephritis vs. cholesterol atheroembolism. Differentiating characteristics]. Nefrologia 2003; 23:125.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7234 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-4D6C774D8A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_36_27209=[""].join("\n");
var outline_f26_36_27209=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Associated with systemic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H451377303\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H853751738\">",
"      Tubulointerstitial nephritis and uveitis (TINU) syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Laboratory and radiographic findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H853752222\">",
"      Histology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H451377245\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H451377368\">",
"      ESTABLISHING THE CAUSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/7234\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7234|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/51/25393\" title=\"picture 1A\">",
"      White blood cell cast I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/49/34591\" title=\"picture 1B\">",
"      White blood cell cast II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/6/3175\" title=\"picture 2\">",
"      Acute ISN and minimal change",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/10/13479\" title=\"picture 3A\">",
"      Acute ISN Low power",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/17/9493\" title=\"picture 3B\">",
"      Acute ISN Light I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/59/17332\" title=\"picture 3C\">",
"      Acute ISN Light II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?12/41/12950\" title=\"picture 3D\">",
"      Acute ISN Light III",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?21/42/22182\" title=\"picture 3E\">",
"      Granulomatous ISN",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?25/13/25809?source=related_link\" title=\"calculator 1\">",
"      Calculator: Fractional excretion of sodium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?24/28/25025?source=related_link\" title=\"calculator 2\">",
"      Calculator: Fractional excretion of sodium (SI units)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/54/19306?source=related_link\">",
"      Causes and diagnosis of membranous nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/13/13528?source=related_link\">",
"      Clinical presentation, evaluation, and treatment of renal atheroemboli",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/3/27706?source=related_link\">",
"      Diagnosis and classification of renal disease in systemic lupus erythematosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/38/25190?source=related_link\">",
"      Diagnosis of urinary tract obstruction and hydronephrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/60/35785?source=related_link\">",
"      Diagnostic approach to the patient with acute kidney injury (acute renal failure) or chronic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/17/8472?source=related_link\">",
"      Fractional excretion of sodium, urea, and other molecules in acute kidney injury (acute renal failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/0/24582?source=related_link\">",
"      NSAIDs: Acute kidney injury (acute renal failure) and nephrotic syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/55/13178?source=related_link\">",
"      Overview of IgG4-related disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/19/4409?source=related_link\">",
"      Pathogenesis and diagnosis of anti-GBM antibody (Goodpasture's) disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?15/22/15713?source=related_link\">",
"      Patient information: Acute interstitial nephritis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/12/20677?source=related_link\">",
"      Renal disease in Sj&ouml;gren's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/31/40438?source=related_link\">",
"      Renal disease in sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/39/34418?source=related_link\">",
"      The significance of urinary eosinophils",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/28/34245?source=related_link\">",
"      Treatment of acute interstitial nephritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/0/20486?source=related_link\">",
"      Tubulointerstitial nephritis and uveitis (TINU syndrome)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_36_27210="Prenatal diagnosis and obstetrical management of umbilical cord abnormalities";
var content_f26_36_27210=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Prenatal diagnosis and obstetrical management of umbilical cord abnormalities",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/36/27210/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/36/27210/contributors\">",
"     Waldo Sepulveda, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/36/27210/contributors\">",
"     Neil J Sebire, FRCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/36/27210/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/36/27210/contributors\">",
"     Deborah Levine, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/36/27210/contributors\">",
"     Susan M Ramin, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/36/27210/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/36/27210/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/36/27210/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H22646013\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The fetus obtains all of its nutrients and oxygen and eliminates carbon dioxide and most waste products via the umbilical cord, thus it is a critical organ during prenatal life. Despite this, it is a relatively simple and unprotected structure containing two arteries and one vein surrounded by a gelatinous stroma (Wharton&rsquo;s jelly) and covered by a single layer of amnion.",
"   </p>",
"   <p>",
"    The umbilical arteries transport deoxygenated blood and wastes from the fetus to the placenta. They are branches of the internal iliac artery that curve around the fetal bladder, eventually becoming adjacent to one another at the umbilicus. At that point, they exit the fetus and course along the length of the cord, usually in a helicoidal fashion surrounding the umbilical vein, finally separating at the placenta, where they divide into chorionic arteries on the surface of the chorionic plate and form perforating branches to the underlying villi (",
"    <a class=\"graphic graphic_figure graphicRef59367 \" href=\"UTD.htm?39/48/40712\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The left umbilical vein is formed at the chorionic plate by the confluence of chorionic veins, and transports oxygenated blood and nutrients back to the fetus. In the fetal abdomen, it runs cephalad from the cord insertion site until it enters the liver, where it anastomoses with the left portal vein (",
"    <a class=\"graphic graphic_figure graphicRef66765 \" href=\"UTD.htm?14/43/15032\">",
"     figure 2",
"    </a>",
"    ). The right umbilical vein usually degenerates very early in embryogenesis, but rarely persists as the only umbilical vein [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/1,2\">",
"     1,2",
"    </a>",
"    ] or as a fourth umbilical vessel (see",
"    <a class=\"local\" href=\"#H22646128\">",
"     'Supernumerary vessels'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    The intraabdominal portions of the umbilical vessels degenerate after birth; the umbilical arteries become the lateral ligaments of the bladder and the umbilical vein develops into the round ligament of the liver.",
"   </p>",
"   <p>",
"    This topic will review the most important aspects of the structural abnormalities of the umbilical cord, as determined by prenatal ultrasound. The gross anatomy and histology of the umbilical cord are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/56/40840?source=see_link&amp;anchor=H4#H4\">",
"     \"Gross examination of the placenta\", section on 'Umbilical cord'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/46/27370?source=see_link&amp;anchor=H2#H2\">",
"     \"Histopathology of placental disorders\", section on 'Umbilical cord'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646020\">",
"    <span class=\"h1\">",
"     NORMAL ULTRASOUND ANATOMY OF THE UMBILICAL CORD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both normal anatomy and malformations can be depicted by conventional two-dimensional, color Doppler, and three-dimensional imaging techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/3-8\">",
"     3-8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17297905\">",
"    <span class=\"h2\">",
"     First trimester",
"    </span>",
"    &nbsp;&mdash;&nbsp;The umbilical cord can be visualized sonographically from the eighth menstrual week. In the first trimester, the cord is usually coiled and its length is approximately the same as the crown-rump length (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef60884 \" href=\"UTD.htm?31/41/32401\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/9\">",
"     9",
"    </a>",
"    ]. Before the 12th week, the fetal insertion often appears bulky due to normal physiological midgut herniation of intestinal loops into the cord [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/10\">",
"     10",
"    </a>",
"    ]. The presence of herniated liver or the persistence of herniation beyond 11 weeks of gestation is not normal and suggests the presence of an anterior abdominal wall defect. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/28/34247?source=see_link\">",
"     \"Prenatal sonographic diagnosis of fetal abdominal wall defects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17297912\">",
"    <span class=\"h2\">",
"     Second and third trimesters",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American Institute of Ultrasound in Medicine recommends imaging the umbilical cord during second and third trimester prenatal ultrasound examination to determine the number of vessels in the cord, when possible [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/11\">",
"     11",
"    </a>",
"    ]. The two arteries and the vein can be seen clearly in both the transverse and longitudinal planes with two-dimensional ultrasound and color Doppler (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef66628 \" href=\"UTD.htm?33/11/33974\">",
"     image 2",
"    </a>",
"    ). The umbilical arteries have smaller diameters than the vein and are usually seen looping around it.",
"   </p>",
"   <p>",
"    The prenatal examination of the umbilical cord is focused on determining the number of vessels in order to detect a single umbilical artery (SUA). We perform a more detailed examination of the cord at the time of the second-trimester scan, including assessment of the fetal and placental insertion sites, determination of the helical pattern, and evaluation of the amount of Wharton&rsquo;s jelly [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/12\">",
"     12",
"    </a>",
"    ]; however, this expanded assessment is not standard of care in most ultrasound departments, despite the fact that poor perinatal outcome has been associated with specific characteristics of the umbilical cord, such as being thin [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/13\">",
"     13",
"    </a>",
"    ], having a velamentous insertion [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/14\">",
"     14",
"    </a>",
"    ], and abnormal coiling [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/15\">",
"     15",
"    </a>",
"    ]. Other cord abnormalities, such as cysts and masses, may be noted incidentally during the examination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646034\">",
"    <span class=\"h1\">",
"     VASCULAR ANOMALIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646042\">",
"    <span class=\"h2\">",
"     Single umbilical artery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prenatal diagnosis of single umbilical artery will be discussed here. Additional detailed information on this abnormality, including prevalence, associated anomalies, pregnancy management, and outcome, can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/14/8423?source=see_link\">",
"     \"Single umbilical artery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646064\">",
"    <span class=\"h3\">",
"     Prenatal diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following characteristics are useful in prenatal identification of SUA:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Identification of a two-vessel cord",
"      </strong>",
"      - The basic technique for identifying the normal three-vessel cord is a detailed examination of both transverse and longitudinal views of a free loop of the cord, using adequate magnification. Only two vessels are identified in SUA; the larger vessel is the vein and the smaller is the artery [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/16\">",
"       16",
"      </a>",
"      ]. The sensitivity of prenatal ultrasound for diagnosis of SUA is 65 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/17\">",
"       17",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      When the amount of Wharton&rsquo;s jelly is adequate, the transverse section of the two-vessel cord resembles a &ldquo;soda can tab&rdquo; (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef73747 \" href=\"UTD.htm?0/28/455\">",
"       image 3",
"      </a>",
"      ). In the longitudinal view, the two-vessel cord frequently appears straight and non-coiled, although occasionally the single artery may loop around the vein. The use of color flow imaging increases diagnostic certainty by providing better visualization of the umbilical vessels.",
"      <br/>",
"      <br/>",
"      Clear identification of the number of vessels can be limited by early gestational age, maternal obesity, oligohydramnios, multiple gestation, or multiple loops of cord that lie in close proximity to each other. It can also be difficult to establish the diagnosis of SUA in hypercoiled cords (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef79742 \" href=\"UTD.htm?19/22/19810\">",
"       image 4",
"      </a>",
"      ).",
"      <br/>",
"      <br/>",
"      A potential pitfall in diagnosis is visualization of the cord close to the placental insertion because the umbilical arteries may fuse along a short (&lt;3 cm) segment of cord at this site [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/18\">",
"       18",
"      </a>",
"      ]. Occasionally, the arteries are fused for a longer distance, resulting in an umbilical cord with a distal (placental) segment containing two vessels and a proximal (fetal) segment with three vessels (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef51055 \" href=\"UTD.htm?33/18/34089\">",
"       image 5",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/19,20\">",
"       19,20",
"      </a>",
"      ]. In these cases, it is particularly important to look at the intraabdominal vessels to confirm the diagnosis (see below).",
"     </li>",
"     <li>",
"      <strong>",
"       Single intraabdominal umbilical artery",
"      </strong>",
"      - Absence of one umbilical artery in the cord necessarily implies the absence of the corresponding intraabdominal portion of the umbilical artery. This finding can be detected prenatally in a transverse view of the fetal pelvis by examining the vessels running alongside the bladder [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/21\">",
"       21",
"      </a>",
"      ]. Use of color flow imaging facilitates examination of these vessels and appears to be the best screening and diagnostic technique for SUA, if color Doppler ultrasound is available (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef72664 \" href=\"UTD.htm?3/41/3734\">",
"       image 6",
"      </a>",
"      ). Absence of an intraabdominal umbilical artery alongside the bladder is pathognomonic of SUA. Due to the importance of the diagnosis of SUA in clinical practice, we routinely use color Doppler ultrasound to identify the intraabdominal umbilical arteries as a screening technique in our practice.",
"     </li>",
"     <li>",
"      <strong>",
"       Increased diameter of the single artery",
"      </strong>",
"      - In the normal three-vessel cord, blood flow to the placenta is approximately equally distributed through both arteries. In the two-vessel cord, the entire fetoplacental circulation is transported through only one artery, resulting in a compensatory increase of the arterial diameter. The diameter of the single artery usually measures more than 50 percent of the diameter of the vein, resulting in an umbilical vein-to-artery ratio &lt;2 (",
"      <a class=\"graphic graphic_figure graphicRef63821 \" href=\"UTD.htm?35/56/36738\">",
"       figure 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/22,23\">",
"       22,23",
"      </a>",
"      ]. In contrast, the arteries in a three-vessel cord usually measure less than 50 percent of the diameter of the vein, resulting in an umbilical vein-to-artery ratio &gt;2. With current ultrasound equipment and good scanning technique, the compensatory increase in the single artery diameter is evident even during the early second trimester [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/23,24\">",
"       23,24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Doppler velocimetry",
"      </strong>",
"      - High-resolution color Doppler ultrasound may demonstrate differences in both the size and the impedance indices in the pelvic circulation of fetuses with SUA [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/25,26\">",
"       25,26",
"      </a>",
"      ]. The discordant intraluminal blood flow between common iliac arteries is more marked as pregnancy progresses, which may be due to both the decrease in resistance in the placental circulation and the increase in resistance in femoral arteries [",
"      <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/25,26\">",
"       25,26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646078\">",
"    <span class=\"h2\">",
"     Hypoplasia or atrophy of one umbilical artery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypoplasia of one umbilical artery is a variant of SUA in which both arteries are present, but there is a gross disparity in their size. The hypoplastic but functional artery can occasionally be detected prenatally by ultrasound [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/27-33\">",
"     27-33",
"    </a>",
"    ]. Constriction of the umbilical arteries after delivery makes the diagnosis difficult to document postnatally in spite of routine examination of the umbilical cord.",
"   </p>",
"   <p>",
"    If one artery is atrophic rather than hypoplastic, the muscular remnants of the atrophic artery can only be detected by histological examination of the umbilical cord [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646107\">",
"    <span class=\"h3\">",
"     Prenatal diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prenatal diagnosis of a hypoplastic umbilical artery is based upon the presence of size and flow discordancy between umbilical arteries.",
"   </p>",
"   <p>",
"    Size discordancy is best appreciated in a magnified cross-sectional view of the umbilical cord following suspected SUA [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/28\">",
"     28",
"    </a>",
"    ]. There is no universal standard for the definition of discordancy; differences in arterial diameter of 1 to 3 mm between arteries have been described and occur in up to 2 percent of pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/27,30,31\">",
"     27,30,31",
"    </a>",
"    ]. However, the prevalence is much lower using a definition of arterial diameter difference of more than 50 percent, only 12 cases of hypoplastic umbilical artery among 31,000 (0.04 percent) consecutive second- and third-trimester scans [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/29\">",
"     29",
"    </a>",
"    ]. The lower prevalence in the latter series is probably the result of using a very strict definition of hypoplastic umbilical artery and the inclusion of many early second-trimester pregnancies (before 20 weeks of gestation, the detection of marked discordancy between umbilical arteries is difficult to document owing to the small size of the arteries).",
"   </p>",
"   <p>",
"    Color Doppler ultrasound is required to confirm the presence of flow within the hypoplastic artery, thus ruling out the possibility of an atrophic nonfunctional artery (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef52677 \" href=\"UTD.htm?31/58/32674\">",
"     image 7",
"    </a>",
"    ). In addition, Doppler is used to document another criterion for prenatal diagnosis of this condition: discordant umbilical artery flow velocity waveforms [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. Therefore, to establish the diagnosis, Doppler studies should identify two patent umbilical arteries, one of which is smaller than the other, and demonstrate discordant umbilical artery flow velocity waveforms between the arteries [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/27\">",
"     27",
"    </a>",
"    ]. The resistance index is almost always higher in the smaller artery, and there may be absent end-diastolic flow.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646114\">",
"    <span class=\"h3\">",
"     Clinical significance",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical significance of hypoplastic umbilical artery has not been clearly established. An increased risk of poor pregnancy outcome has been reported, as well as associations with maternal diabetes mellitus, polyhydramnios, fetal growth restriction, congenital anomalies, abnormal insertion of the umbilical cord, and placental abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/27-32\">",
"     27-32",
"    </a>",
"    ]. Among the 39 prenatally diagnosed cases of hypoplastic umbilical artery, seven (18 percent) fetuses had associated anomalies, including three cases of trisomy 18 and one case each of biliary atresia, hydronephrosis and duplex collecting system, agenesis of the corpus callosum and kyphoscoliosis, and tetralogy of Fallot [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/27-32\">",
"     27-32",
"    </a>",
"    ]. The high prevalence of associated structural anomalies in these reports should be interpreted with caution because most cases of hypoplastic umbilical artery were diagnosed in a high-risk population.",
"   </p>",
"   <p>",
"    Atrophy of one umbilical artery has been associated with umbilical cord angiomyxoma [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/35\">",
"     35",
"    </a>",
"    ] and marginal insertion of the umbilical cord [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646121\">",
"    <span class=\"h3\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;A thorough examination of fetal anatomy and both cord insertion sites should be performed to look for additional abnormalities. We suggest ultrasound examination for fetal growth and assessment of amniotic fluid at 28 and 34 weeks. This recommendation is based on the limited clinical experience obtained from the few case reports and small series reported in the literature. At any follow-up ultrasound examination, both umbilical arteries should undergo Doppler analysis of flow, as umbilical artery waveforms are frequently discordant. Clinical management should be based on the Doppler findings of the normal artery.",
"   </p>",
"   <p>",
"    Prenatal and intrapartum care are routine, unless there are additional maternal, fetal, or pregnancy complications. In such cases, further maternal-fetal assessment and pregnancy management depend on the specific clinical situation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646128\">",
"    <span class=\"h2\">",
"     Supernumerary vessels",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common type of multivessel cord contains two arteries and two veins. The extra vein has been attributed to persistence of the extracorporeal portion of the right umbilical vein [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/36\">",
"     36",
"    </a>",
"    ], but could also represent an abnormal splitting of an umbilical vessel in the third to fifth week of development. A false impression of multivessel cord can occur when the transverse view of the cord is through a false knot and includes multiple loops of the same vessel. This also explains some four-vessel cords identified in histological sections. If a multivessel cord is identified, associated anomalies and conjoined twins must be ruled out. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/46/40682?source=see_link&amp;anchor=H180876174#H180876174\">",
"     \"Twin pregnancy: Prenatal issues\", section on 'Conjoined twins'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The presence of more than three vessels in the umbilical cord is exceedingly rare. It has been reported in singleton fetuses and neonates [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/36-40\">",
"     36-40",
"    </a>",
"    ], but it is a common finding in conjoined twins, and is an ultrasound landmark for diagnosis of thoracopagus and omphalopagus twins who share the same cord (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef65418 \" href=\"UTD.htm?22/63/23537\">",
"     image 8",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. Only two prenatally detected cases have been reported in singletons; in one case, a four-vessel cord was associated with holoprosencephaly and polyhydramnios [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/3\">",
"     3",
"    </a>",
"    ], and in the other, it was an isolated finding in a normal fetus [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/36\">",
"     36",
"    </a>",
"    ]. A four-vessel cord has been noted in normal neonates [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/37,38,40\">",
"     37,38,40",
"    </a>",
"    ], but also in neonates with multiple congenital anomalies [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/39\">",
"     39",
"    </a>",
"    ]. In one case, four arteries were found in the cord of a macerated stillborn with multiple anomalies, including ectopia cordis, bifid liver, and bilateral cleft lip and palate [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prenatal and intrapartum care are routine, unless there are additional maternal, fetal, or pregnancy complications (eg, conjoined twins, congenital anomalies). In such cases, further maternal-fetal assessment and pregnancy management depend on the specific clinical situation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646172\">",
"    <span class=\"h2\">",
"     Aneurysm and varix",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aneurysm and varix represent focal dilatations of the umbilical artery and vein, respectively. Both abnormalities are rare. They were initially diagnosed on postpartum examination of the umbilical cord in stillborn infants [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/43-46\">",
"     43-46",
"    </a>",
"    ], and have been associated with fetal demise when diagnosed prenatally [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/47,48\">",
"     47,48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A few cases of umbilical artery aneurysm have been reported prenatally in association with SUA, other congenital anomalies, trisomy 18 (",
"    <a class=\"graphic graphic_picture graphicRef66178 \" href=\"UTD.htm?42/57/43927\">",
"     picture 1",
"    </a>",
"    ), and fetal demise [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/49-56\">",
"     49-56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Umbilical vein varix typically occurs in the intra-abdominal portion of the vein [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/57-61\">",
"     57-61",
"    </a>",
"    ]. Prenatal diagnosis of varix in the intra-amniotic portion of the vein (",
"    <a class=\"graphic graphic_picture graphicRef55016 \" href=\"UTD.htm?5/6/5223\">",
"     picture 2",
"    </a>",
"    ) has been reported in detail only twice; both cases were associated with thrombosis of the umbilical vessels [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/62,63\">",
"     62,63",
"    </a>",
"    ]. Varix of the intraamniotic segment of the umbilical vein can rupture, resulting in intra-amniotic hemorrhage through the amniotic sheath, with fetal exsanguination and thrombosis leading to fetal death [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/62\">",
"     62",
"    </a>",
"    ]. In 184 autopsies of dead newborns, stillborn infants and aborted fetuses (mostly with congenital malformations), varix of the umbilical vein was observed in 7 of the 57 cases with cord malformations [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/47\">",
"     47",
"    </a>",
"    ]; the incidence in an unselected population is unknown.",
"   </p>",
"   <p>",
"    The diagnosis of aneurysm or varix should be suspected when focal dilatation is observed in any of the umbilical vessels. In these cases, the differential diagnosis must include all types of cystic masses of the cord, including pseudocyst or true cyst. Color Doppler and color flow imaging are useful in prenatal differential diagnosis by demonstrating whether there is arterial, nonpulsatile, or turbulent flow within the mass (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef78214 \" href=\"UTD.htm?24/8/24710\">",
"     image 9",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Given the rarity of these lesions, the natural history and optimum management of affected pregnancies are unknown. Some authors have suggested delivery as soon as fetal lung maturity is confirmed [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/49\">",
"     49",
"    </a>",
"    ] because of reports of fetal demise, as described above [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/43-48\">",
"     43-48",
"    </a>",
"    ]. Before fetal maturity is reached, fetal surveillance with nonstress testing once or twice a week is reasonable.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646209\">",
"    <span class=\"h1\">",
"     CYSTIC LESIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cystic lesions of the umbilical cord are rare (",
"    <a class=\"graphic graphic_picture graphicRef63688 \" href=\"UTD.htm?23/57/24479\">",
"     picture 3",
"    </a>",
"    ). The reported incidence in patients scanned between 8 and 12 weeks varies from 0.4 to 1.3 percent (8 of 2070 and 2 of 150 pregnancies, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. In the second and third trimesters, most reports are based on isolated cases or small series. Cystic lesions include umbilical cord cyst, allantoic cyst, vesico-allantoic cyst, omphalomesenteric cyst, pseudocyst, focal umbilical cord edema, and cystic degeneration of the Wharton&rsquo;s jelly.",
"   </p>",
"   <p>",
"    Umbilical cord cystic lesions may represent true cysts or pseudocysts, which can only be definitively differentiated by histological examination after delivery. True cysts correspond to embryonic remnants and are epithelial lined, whereas pseudocysts are due to local degeneration or focal edema of the Wharton&rsquo;s jelly and, therefore, lack an epithelial lining.",
"   </p>",
"   <p>",
"    Prenatal detection by ultrasound is not difficult because, in most cases, the surrounding amniotic fluid provides a clear acoustic window, which enhances identification of the cyst. Most, if not all, umbilical cord cystic lesions are discovered incidentally during ultrasound assessment of the amniotic fluid in the second or third trimester. Typically, a fluid-filled mass is noted in close proximity to the umbilical cord.",
"   </p>",
"   <p>",
"    Management depends on the type, size, and location of the cyst; gestational age at detection; presence of associated anomalies; and potential for complications, such as compression of surrounding vessels or torsion along the axis of the cord.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646246\">",
"    <span class=\"h2\">",
"     True cysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;True umbilical cord cysts originate from embryonic remnants such as the allantois or omphalo-mesenteric duct [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/18,66\">",
"     18,66",
"    </a>",
"    ]. Omphalo-mesenteric cysts originate from the vitelline duct [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/67\">",
"     67",
"    </a>",
"    ] and allantoic cysts from the persistence of the urachus [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/68\">",
"     68",
"    </a>",
"    ]. In the latter case, persistence of a communication between the bladder and the umbilical cord, known as patent urachus, may allow extravasation of urine from the bladder into the base of the cord, resulting in cystic dilatation of the extraembryonic portion of the allantois [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/68\">",
"     68",
"    </a>",
"    ]. Less frequently, the urine may leak into the Wharton&rsquo;s jelly, resulting in a giant umbilical cord [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/69-73\">",
"     69-73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646268\">",
"    <span class=\"h3\">",
"     Prenatal diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prenatal diagnosis of omphalo-mesenteric cysts has only been reported twice, although conclusive histological proof in these particular cases was not provided [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/74,75\">",
"     74,75",
"    </a>",
"    ]. On the other hand, prenatal diagnosis of allantoic cysts has been reported by several authors, usually in association with urachal anomalies [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/68,76-81\">",
"     68,76-81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the differential diagnosis between allantoic cyst and other umbilical cord cystic masses is difficult, several ultrasound features are helpful. In cases of allantoic cysts, the umbilical cord cystic mass is always in close relationship with the fetal anterior abdominal wall and can be mistaken for an anterior abdominal wall defect. Allantoic cysts can also coexist with an omphalocele [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/82\">",
"     82",
"    </a>",
"    ]. Careful examination of the umbilical cord insertion in the fetal abdomen establishes the correct diagnosis.",
"   </p>",
"   <p>",
"    A key feature of an allantoic cyst due to patent urachus is a communication between the cyst and the fetal bladder (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82732 \" href=\"UTD.htm?36/59/37810\">",
"     image 10",
"    </a>",
"    ). However, this communication is not always present and only rarely detected prenatally. Embryologically, the allantois is the only vestigial remnant located at the center of the umbilical cord and is surrounded by the umbilical vessels. If an allantoic cyst develops because of retrograde micturition into the umbilical cord, progressive separation of the umbilical vessels will occur (",
"    <a class=\"graphic graphic_figure graphicRef58326 \" href=\"UTD.htm?37/63/38902\">",
"     figure 4",
"    </a>",
"    ). By using color Doppler flow imaging, it is possible to identify umbilical vessels surrounding the cyst (",
"    <a class=\"graphic graphic_picture graphicRef56599 \" href=\"UTD.htm?0/3/62\">",
"     picture 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/79,80\">",
"     79,80",
"    </a>",
"    ]. With other types of cystic lesions, the cyst displaces the vessels so that they remain together and seen on only one side of the cyst wall.",
"   </p>",
"   <p>",
"    Prenatal resolution of allantoic cysts has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/77\">",
"     77",
"    </a>",
"    ], but does not necessarily mean that the urachus became obliterated. Resolution has also been attributed to cyst rupture [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/83\">",
"     83",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646275\">",
"    <span class=\"h3\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once an allantoic cyst is diagnosed, we perform weekly follow-up examinations to monitor the size of the cyst until the size stabilizes. We also perform color Doppler velocimetry of the umbilical artery because a rapidly enlarging cyst has been reported to produce progressive obliteration of the blood flow within the cord, necessitating immediate delivery for fetal indications [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/84\">",
"     84",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because all allantoic cysts are associated with urachal anomalies, parents should be counseled that the neonate might leak urine through the umbilicus and require surgery. An association between umbilical cord cysts and obstructive uropathy has been observed in a few cases [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/83,85-87\">",
"     83,85-87",
"    </a>",
"    ]. Pediatric urology consultation is recommended.",
"   </p>",
"   <p>",
"    If the diagnosis of allantoic cyst is uncertain (ie, a pseudocyst cannot be excluded) and a structural anomaly is found, prenatal karyotyping should be offered (see",
"    <a class=\"local\" href=\"#H22646282\">",
"     'Pseudocysts'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    With the exceptions described, prenatal and intrapartum care are routine, unless there are additional maternal, fetal, or pregnancy complications. In such cases, further maternal-fetal assessment and pregnancy management depend on the specific clinical situation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646282\">",
"    <span class=\"h2\">",
"     Pseudocysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Umbilical cord pseudocysts are rare, but more common than true cysts, and have been associated with fetal chromosomal defects and other congenital anomalies, particularly omphalocele [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/88-91\">",
"     88-91",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pathogenesis of umbilical cord pseudocyst is unknown. One theory is that they represent an area of focal edema. In these cases, increased vascular pressure within the umbilico-placental circulation leads to raised umbilical cord hydrostatic pressure, which favors transfer of fluid into the Wharton&rsquo;s jelly [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/91\">",
"     91",
"    </a>",
"    ]. This could occur with abdominal wall defects or intrauterine growth restriction from obliteration of portions of the villous vasculature.",
"   </p>",
"   <p>",
"    Pseudocysts could also result from focal cystic or mucoid degeneration of Wharton&rsquo;s jelly due to a local pathological process of the umbilical cord [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/92\">",
"     92",
"    </a>",
"    ]. Pseudocysts are frequently associated with angiomyxoma of the cord (see",
"    <a class=\"local\" href=\"#H22646375\">",
"     'Angiomyxoma'",
"    </a>",
"    below), suggesting that exudation of plasma from the tumor is an etiologic factor in cyst formation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646304\">",
"    <span class=\"h3\">",
"     Prenatal diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ultrasound appearance of umbilical cord pseudocyst varies widely. The most common feature is a large, round, cystic lesion located either close to the fetal insertion or in a free loop of cord (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef76568 \" href=\"UTD.htm?11/1/11285\">",
"     image 11",
"    </a>",
"    ). Occasionally, more than one cystic mass is detected, most often close to each other; multiple small cysts may be detected in close relation to a localized thickening of Wharton&rsquo;s jelly. When associated with an umbilical cord angiomyxoma, the pseudocyst is always located close to the tumor, and may be large.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646311\">",
"    <span class=\"h3\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prenatal detection of a cystic mass in the umbilical cord should prompt a detailed examination of the fetal anatomy. If a structural anomaly is found, prenatal karyotyping should be offered. In one review of 13 prenatally diagnosed umbilical cord cystic lesions histologically-proven to be pseudocyst, 8 were associated with aneuploidy and 2 were euploid with other anomalies [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/90\">",
"     90",
"    </a>",
"    ]. In the largest series of umbilical cord pseudocysts in a high-risk population, chromosomal abnormalities were noted in 7 of 13 cases, and 3 additional euploid fetuses had structural defects, including one each of cystic hygroma, omphalocele, and acrania [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/91\">",
"     91",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Conversely, if an umbilical cord cystic mass is found in isolation, there appears to be no increased risk for poor pregnancy outcome, although few such cases have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/93\">",
"     93",
"    </a>",
"    ]. Sonographic follow-up is advocated, as there is a potential risk for rare local complications such as torsion or thrombohematoma leading to fetal death [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/94,95\">",
"     94,95",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prenatal and intrapartum care are routine, unless there are additional maternal, fetal, or pregnancy complications. In such cases, further maternal-fetal assessment and pregnancy management depend on the specific clinical situation.",
"   </p>",
"   <p>",
"    Aspiration of the cyst is indicated if the cyst is very large and causes symptoms. We have managed a large pseudocyst associated with an angiomyxoma with two percutaneous sonographically-guided aspirations of 400 mL of fluid at 27 and 32 weeks because of premature contractions (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef57967 \" href=\"UTD.htm?29/35/30259\">",
"     image 12",
"    </a>",
"    ). The cyst fluid reaccumulated so a cesarean delivery was performed at term because of presumed fetal dystocia. Postpartum examination revealed a short cord, a large pseudocyst, and an angiomyxoma of the cord.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646318\">",
"    <span class=\"h2\">",
"     First-trimester umbilical cord cyst",
"    </span>",
"    &nbsp;&mdash;&nbsp;Umbilical cord cysts detected in the first trimester are discussed as an independent clinical entity because current evidence suggests that the majority of cases correspond to transient findings during transvaginal sonographic evaluation of the embryo [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. They have been identified in 2 to 3 percent of pregnancies scanned at 7 to 14 weeks of gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/85,96\">",
"     85,96",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cysts usually present at 8 to 9 weeks of gestation and are almost always benign, gone by the second trimester, and associated with normal pregnancy outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/97\">",
"     97",
"    </a>",
"    ]. In contrast, cysts detected in the late first trimester (ie, at the time of the nuchal scan at 11 to 14 weeks) may be associated with structural anomalies and aneuploidy. In one study, fetal structural anomalies and chromosomal defects were present in about 25 percent of cases identified in a high-risk population [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/85\">",
"     85",
"    </a>",
"    ]. In a report of 24 cases of umbilical cord cyst detected between 7 to 14 weeks, all 18 fetuses presenting with a single cyst had complete resolution and normal pregnancy outcome, whereas five of the six fetuses presenting with multiple cysts had poor outcome, including four miscarriages and one case of obstructive uropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/96\">",
"     96",
"    </a>",
"    ]. The detection of an umbilical cord cyst associated with megacystis at the 11- to 14-week ultrasound scan has been strongly associated with a patent urachus [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/98\">",
"     98",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The origin of first-trimester umbilical cord cysts is unknown. One theory is that they represent embryonic remnants such as allantoic or omphalo-mesenteric cysts, amniotic inclusion cyst, or mucoid degeneration or edema of the Wharton&rsquo;s jelly (pseudocysts). In the only case in which sonographic-histopathologic correlation is available, an amniotic inclusion cyst and adjacent mucoid degeneration of the Wharton&rsquo;s jelly were found, suggesting first-trimester umbilical cord cysts could represent either entity [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/65\">",
"     65",
"    </a>",
"    ]. The rapid resolution of the cysts suggests they are pseudocysts rather than true cysts. They are always located laterally to the umbilical vessels, which also suggests that they are pseudocysts rather than a cystic component of embryologic remnants. Since the formation of these cysts is coincidental with both the onset of umbilical cord coiling and formation of the physiological midgut hernia, these developmental phenomena could increase hydrostatic pressure within the umbilical vessels, favoring exudation of water into the Wharton&rsquo;s jelly and formation of pseudocysts [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/85\">",
"     85",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646339\">",
"    <span class=\"h3\">",
"     Prenatal diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;An umbilical cord cyst is diagnosed in the first trimester when a round, thin-walled anechoic structure is identified within the amniotic cavity in close connection to the umbilical cord and separate from the fetal pole and physiologic hernia. The cyst must be clearly differentiable from the yolk sac, which has a more echoic wall and is extraamniotic in location (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef69407 \" href=\"UTD.htm?31/22/32102\">",
"     image 13",
"    </a>",
"    ). Color-Doppler imaging is useful to exclude the possibility of a prominent umbilical vessel or an aneurysm and to document the cyst&rsquo;s relationship with the umbilical vessels (lateral to, or surrounded by, the umbilical vessels).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3387075\">",
"    <span class=\"h3\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fetal karyotype is reasonable in patients with cysts that persist into the second trimester and are associated with fetal structural anomalies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646353\">",
"    <span class=\"h1\">",
"     SOLID OR COMPLEX MASSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Solid or complex masses of the umbilical cord include true tumors (eg, angiomyxomas and teratomas) and pseudotumors (eg, hematomas). Umbilical cord hematomas are considered pseudotumors because they have a similar appearance to true tumors on prenatal ultrasound [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/99\">",
"     99",
"    </a>",
"    ]. Abdominal wall defects such as omphaloceles, gastroschisis, and umbilical hernias can also present prenatally as echogenic masses in the base of the cord; however, they are not considered abnormalities of the umbilical cord, but rather gastrointestinal or abdominal wall malformations. Nevertheless, these conditions must be considered in the differential diagnosis.",
"   </p>",
"   <p>",
"    True tumors and spontaneous hematomas of the umbilical cord are extremely rare. In contrast, iatrogenic hematomas following cordocentesis are common [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/100\">",
"     100",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646375\">",
"    <span class=\"h2\">",
"     Angiomyxoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angiomyxomas (hemangioma of the cord, angioma of the cord) are extremely rare and arise from proliferation of the primitive angiogenic mesenchyme of the cord [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/18,66\">",
"     18,66",
"    </a>",
"    ]. The term angiomyxoma is based on the prominent myxoid material contained within the tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646391\">",
"    <span class=\"h3\">",
"     Prenatal diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of its rarity, the prenatal diagnosis of angiomyxoma is based on findings described in isolated case reports [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/101-103\">",
"     101-103",
"    </a>",
"    ]. The tumor usually presents as a hyperechogenic mass in close relation to the umbilical vessels and is frequently associated with a pseudocyst of variable size. Sometimes the cyst is the most prominent finding [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/103,104\">",
"     103,104",
"    </a>",
"    ], with one case reporting a 16-cm cyst which required prenatal aspiration to achieve vaginal delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/104\">",
"     104",
"    </a>",
"    ]. Color-Doppler ultrasound can support the suspected diagnosis by demonstrating blood vessels with low flow within the echogenic component of the tumor (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef81730 \" href=\"UTD.htm?22/21/22869\">",
"     image 14",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Angiomyxomas can mimic small omphaloceles, especially those located close to the fetal insertion of the umbilical cord [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/105\">",
"     105",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646405\">",
"    <span class=\"h3\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although angiomyxomas may be considered a counterpart of chorioangioma of the placenta, which is sometimes associated with pregnancy complications if large, most cord angiomyxomas are incidental findings of no clinical significance. However, compression of the adjacent umbilical vessels, fetal hydrops, and torsion around the axis of the cord could lead to fetal death; therefore, when fetal viability is reached, the prenatal detection of an umbilical cord angiomyxoma should prompt serial fetal monitoring, including Doppler studies of the umbilical vessels and assessment of the size of the pseudocyst.",
"   </p>",
"   <p>",
"    Neonates with angiomyxoma of the cord may also demonstrate skin hemangiomas [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/106\">",
"     106",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646412\">",
"    <span class=\"h2\">",
"     Teratoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Teratomas of the cord are rare tumors derived from ectopically located totipotential germ cells and containing tissue from the three germ-cell layers [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/18,66\">",
"     18,66",
"    </a>",
"    ]. Some investigators have proposed that cord teratomas represent small acardiac twins rather than true neoplasms [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/107-109\">",
"     107-109",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prenatal diagnosis of teratoma of the cord has been reported only twice [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/110,111\">",
"     110,111",
"    </a>",
"    ], but the diagnosis should be considered whenever a heterogeneous lesion of the cord is detected prenatally. In the two cases detected prenatally by ultrasound, one was associated with an omphalocele and the other was associated with trisomy 13. Both pregnancies diagnosed with cord teratomas prenatally were terminated because of associated abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/110,111\">",
"     110,111",
"    </a>",
"    ], so no information on the natural history of affected pregnancies is available.",
"   </p>",
"   <p>",
"    Differential diagnosis mainly includes small acardiac twins, especially those of the amorphous type. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/10/165?source=see_link\">",
"     \"Diagnosis and management of twin reversed arterial perfusion (TRAP) sequence\"",
"    </a>",
"    .) Acardiac twins can be differentiated from umbilical cord teratomas by the following criteria: acardiac twins always have an independent, although rudimentary, umbilical cord, whereas teratomas are located within the umbilical cord; they usually have a craniocaudal skeletal organization, whereas teratomas do not; and they are always covered by skin, whereas teratomas are covered by amnion. Placental teratomas should also be excluded. Findings that support the diagnosis of placental teratoma rather than cord teratoma include a location closely related to the placenta or a tumor surrounded by placental tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/112\">",
"     112",
"    </a>",
"    ]. The possibility of an umbilical cord hernia should also be considered [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/113\">",
"     113",
"    </a>",
"    ]. A definitive histopathological examination is usually needed to establish the definitive diagnosis.",
"   </p>",
"   <p>",
"    A review of postnatally diagnosed cases revealed that 4 of the 10",
"    <span class=\"nowrap\">",
"     fetuses/newborns",
"    </span>",
"    died due to associated malformations [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/110\">",
"     110",
"    </a>",
"    ]. In fetuses with no associated anomalies, the prognosis seems to be good. However, growth of the tumor could cause umbilical vessel compression and close monitoring is advised depending on the size and growth rate of the tumor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22646449\">",
"    <span class=\"h2\">",
"     Hematoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Umbilical cord hematomas are considered pseudotumors because they have a similar appearance to true tumors on prenatal ultrasound [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/99\">",
"     99",
"    </a>",
"    ]. They present prenatally as solid-appearing masses attached to, or within, the umbilical cord. They can be caused by intentional puncture of the cord during a previous invasive procedure such as cordocentesis or fetal transfusion, or from unintended cord trauma during amniocentesis. They may also occur spontaneously.",
"   </p>",
"   <p>",
"    On prenatal ultrasound, hematomas may appear as solid masses of variable shape and size in close relation to the umbilical cord or have a variable appearance, depending on the time elapsed between the bleeding and sonographic evaluation. Acute hematomas appear isoechoic or may be heterogeneous, while chronic hematomas appear hypoechoic to anechoic. Cord hematomas may cause discordant umbilical artery flow velocity waveforms due to uneven compression of the arteries [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/114\">",
"     114",
"    </a>",
"    ]. Intraamniotic clots secondary to placental abruption can attach to the umbilical cord and can resemble a spontaneously generated umbilical cord hematoma [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/115\">",
"     115",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fetal bradycardia is often observed as an iatrogenic cord hematoma",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hemorrhage develop during postprocedure monitoring. Management is described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/31/11768?source=see_link&amp;anchor=H21#H21\">",
"     \"Fetal blood sampling\", section on 'Cord hematoma'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Spontaneous hematomas are typically an incidental finding at obstetrical ultrasound. We suggest follow-up sonographic examination to assess the size and appearance of the hematoma and to obtain blood flow velocity waveforms of the umbilical arteries. We also perform nonstress tests twice weekly until the hematoma stabilizes in size.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23682636\">",
"    <span class=\"h1\">",
"     ABNORMAL CORD INSERTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The fetal and placental insertions (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef55337 \" href=\"UTD.htm?1/63/2038\">",
"     image 15",
"    </a>",
"    ) are examined to look for abdominal wall defects at the fetal insertion site (eg, omphalocele, gastroschisis) and abnormalities such as a velamentous or marginal insertion at the placental insertion site [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/116-118\">",
"     116-118",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/28/34247?source=see_link\">",
"     \"Prenatal sonographic diagnosis of fetal abdominal wall defects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/18/20775?source=see_link&amp;anchor=H2#H2\">",
"     \"Velamentous umbilical cord insertion and vasa previa\", section on 'Velamentous umbilical cord'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/56/40840?source=see_link&amp;anchor=H7#H7\">",
"     \"Gross examination of the placenta\", section on 'Placental insertion'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17298002\">",
"    <span class=\"h1\">",
"     ABNORMAL COILING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies of postnatal examination",
"    <sup>",
"    </sup>",
"    of the umbilical cord have clearly shown an association",
"    <sup>",
"    </sup>",
"    between hypo-coiled and hyper-coiled cords and adverse perinatal outcomes, including fetal death. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/56/40840?source=see_link&amp;anchor=H6#H6\">",
"     \"Gross examination of the placenta\", section on 'Coiling'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are few studies on abnormal coiling",
"    <sup>",
"    </sup>",
"    diagnosed antenatally, and data from these studies are inconsistent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/119-123\">",
"     119-123",
"    </a>",
"    ]. This is because sonographic measurement",
"    <sup>",
"    </sup>",
"    of the number of complete coils per centimeter of cord is technically difficult, the degree",
"    <sup>",
"    </sup>",
"    of coiling varies with the location of the segment of cord being",
"    <sup>",
"    </sup>",
"    evaluated, and there is no prenatal, gestational age specific, standard for defining hypo-coiled and hyper-coiled cords [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/12\">",
"     12",
"    </a>",
"    ]. This area deserves further study.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23682751\">",
"    <span class=\"h1\">",
"     INADEQUATE WHARTON'S JELLY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The amount",
"    <sup>",
"    </sup>",
"    of Wharton&rsquo;s jelly is assessed by visualizing a mid segment",
"    <sup>",
"    </sup>",
"    of the umbilical cord in cross section, measuring the area using",
"    <sup>",
"    </sup>",
"    the software of the ultrasound machine, and then comparing the measurement",
"    <sup>",
"    </sup>",
"    with an established",
"    <sup>",
"    </sup>",
"    umbilical cord area nomogram [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/124\">",
"     124",
"    </a>",
"    ]. Thin cords have vessels that are more vulnerable to compression and have been associated with intrauterine growth restriction and",
"    <sup>",
"    </sup>",
"    fetal distress during labor [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13962068\">",
"    <span class=\"h1\">",
"     KNOTS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13963121\">",
"    <span class=\"h2\">",
"     True knot",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prenatal identification of a true knot of the umbilical cord is rare and challenging [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/125-128\">",
"     125-128",
"    </a>",
"    ]. The ultrasonographic appearance has been described as similar to a four leaf clover, but this pattern is nonspecific and can be seen with false knots or closely apposed loops of umbilical cord [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/127\">",
"     127",
"    </a>",
"    ]. Use of color Doppler ultrasound, particularly three-dimensional power Doppler imaging [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/129\">",
"     129",
"    </a>",
"    ], may support the suspected diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/56/40840?source=see_link&amp;anchor=H9#H9\">",
"     \"Gross examination of the placenta\", section on 'Knots'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13963194\">",
"    <span class=\"h2\">",
"     False knot",
"    </span>",
"    &nbsp;&mdash;&nbsp;False knots represent exaggerated loops of umbilical vessels. There is only one report of prenatal diagnosis of a false knot, which is described as a focal bulge of the umbilical cord containing umbilical vessels [",
"    <a class=\"abstract\" href=\"UTD.htm?26/36/27210/abstract/130\">",
"     130",
"    </a>",
"    ]. False knots are not associated with adverse fetal outcome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/56/40840?source=see_link&amp;anchor=H9#H9\">",
"     \"Gross examination of the placenta\", section on 'Knots'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8621905\">",
"    <span class=\"h1\">",
"     OTHER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prenatal diagnosis and management of other umbilical cord abnormalities are discussed separately:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nuchal cords (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/13/25815?source=see_link\">",
"       \"Nuchal cords\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Funic presentation and prolapse (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/51/29494?source=see_link\">",
"       \"Umbilical cord prolapse\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Absent umbilical cord (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/21/6488?source=see_link\">",
"       \"Obstetrical and neonatal management of body stalk anomalies and cloacal abnormalities\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4234534\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the second and third trimesters, the primary goal of ultrasound examination of the umbilical cord is to determine the number of vessels. A two-vessel cord on transverse and longitudinal views of a free loop suggests a single umbilical artery (SUA). Visualization of one artery going around the fetal bladder instead of one artery on each side of the bladder supports the diagnosis. (See",
"      <a class=\"local\" href=\"#H22646042\">",
"       'Single umbilical artery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Size and flow discordancy between umbilical arteries in a three-vessel cord suggests the diagnosis of hypoplastic umbilical artery. (See",
"      <a class=\"local\" href=\"#H22646078\">",
"       'Hypoplasia or atrophy of one umbilical artery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The presence of more than three vessels in the umbilical cord is rare in singleton fetuses and neonates, but it is a common finding in conjoined twins. (See",
"      <a class=\"local\" href=\"#H22646128\">",
"       'Supernumerary vessels'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Aneurysm and varix represent anechoic focal dilatations of the umbilical artery and vein, respectively. Spontaneous hemorrhage and thrombosis can occur and can be lethal. (See",
"      <a class=\"local\" href=\"#H22646172\">",
"       'Aneurysm and varix'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An allantoic cyst is always in close relationship with the fetal anterior abdominal wall and can be mistaken for an anterior abdominal wall defect. We monitor the size of these cysts and perform color Doppler velocimetry of the umbilical artery because rapidly increasing cyst size may compromise fetal blood flow. (See",
"      <a class=\"local\" href=\"#H22646246\">",
"       'True cysts'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Umbilical cord pseudocysts represent focal cystic degeneration of the Wharton&rsquo;s jelly or localized cord edema. They are rare, but more common than true cysts, and they have been associated with fetal chromosomal defects and other congenital anomalies, particularly omphalocele. (See",
"      <a class=\"local\" href=\"#H22646282\">",
"       'Pseudocysts'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      First trimester pregnancies with multiple cord cysts appear to have a poorer prognosis than single cysts. (See",
"      <a class=\"local\" href=\"#H22646282\">",
"       'Pseudocysts'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H22646318\">",
"       'First-trimester umbilical cord cyst'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cord hematomas may be iatrogenic or spontaneous. They appear as solid masses of variable shape and size in close relation to the umbilical cord or have a variable appearance, depending on the time elapsed between the bleeding and sonographic evaluation. (See",
"      <a class=\"local\" href=\"#H22646449\">",
"       'Hematoma'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/1\">",
"      Shen O, Tadmor OP, Yagel S. Prenatal diagnosis of persistent right umbilical vein. Ultrasound Obstet Gynecol 1996; 8:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/2\">",
"      Jeanty P. Persistent right umbilical vein: an ominous prenatal finding? Radiology 1990; 177:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/3\">",
"      Hill LM, Kislak S, Runco C. An ultrasonic view of the umbilical cord. Obstet Gynecol Surv 1987; 42:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/4\">",
"      Dudiak CM, Salomon CG, Posniak HV, et al. Sonography of the umbilical cord. Radiographics 1995; 15:1035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/5\">",
"      Sherer DM, Anyaegbunam A. Prenatal ultrasonographic morphologic assessment of the umbilical cord: a review. Part I. Obstet Gynecol Surv 1997; 52:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/6\">",
"      Sherer DM, Anyaegbunam A. Prenatal ultrasonographic morphologic assessment of the umbilical cord: a review. Part II. Obstet Gynecol Surv 1997; 52:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/7\">",
"      Sepulveda W. Time for a more detailed prenatal examination of the umbilical cord? Ultrasound Obstet Gynecol 1999; 13:157.",
"     </a>",
"    </li>",
"    <li>",
"     Sepulveda W, Sebire NJ, Harris R, et al. The placenta, umbilical cord, and membranes. In: Diagnostic imaging of fetal anomalies. Nyberg DA, McGahan JP, Pretorius DH, Pilu G (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2003. p.85.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/9\">",
"      Hill LM, DiNofrio DM, Guzick D. Sonographic determination of first trimester umbilical cord length. J Clin Ultrasound 1994; 22:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/10\">",
"      Bowerman RA. Sonography of fetal midgut herniation: normal size criteria and correlation with crown-rump length. J Ultrasound Med 1993; 12:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/11\">",
"      American Institute of Ultrasound in Medicine. AIUM practice guideline for the performance of obstetric ultrasound examinations. J Ultrasound Med 2010; 29:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/12\">",
"      Sepulveda W, Wong AE, Gomez L, Alcalde JL. Improving sonographic evaluation of the umbilical cord at the second-trimester anatomy scan. J Ultrasound Med 2009; 28:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/13\">",
"      Ghezzi F, Raio L, G&uuml;nter Duwe D, et al. Sonographic umbilical vessel morphometry and perinatal outcome of fetuses with a lean umbilical cord. J Clin Ultrasound 2005; 33:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/14\">",
"      Eddleman KA, Lockwood CJ, Berkowitz GS, et al. Clinical significance and sonographic diagnosis of velamentous umbilical cord insertion. Am J Perinatol 1992; 9:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/15\">",
"      de Laat MW, Franx A, van Alderen ED, et al. The umbilical coiling index, a review of the literature. J Matern Fetal Neonatal Med 2005; 17:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/16\">",
"      Persutte WH, Hobbins J. Single umbilical artery: a clinical enigma in modern prenatal diagnosis. Ultrasound Obstet Gynecol 1995; 6:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/17\">",
"      Jones TB, Sorokin Y, Bhatia R, et al. Single umbilical artery: accurate diagnosis? Am J Obstet Gynecol 1993; 169:538.",
"     </a>",
"    </li>",
"    <li>",
"     Benirschke K, Kaufmann P. Umbilical cord and major fetal vessels. In: Pathology of the Human Placenta, 2nd, Springer-Verlag, New York 1990. p.180.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/19\">",
"      Rosenak D, Meizner I. Prenatal sonographic detection of single and double umbilical artery in the same fetus. J Ultrasound Med 1994; 13:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/20\">",
"      Sepulveda W, Dezerega V, Carstens E, Gutierrez J. Fused umbilical arteries: prenatal sonographic diagnosis and clinical significance. J Ultrasound Med 2001; 20:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/21\">",
"      Jeanty P. Fetal and funicular vascular anomalies: identification with prenatal US. Radiology 1989; 173:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/22\">",
"      Sep&uacute;lveda WH. Antenatal sonographic detection of single umbilical artery. J Perinat Med 1991; 19:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/23\">",
"      Sepulveda W, Peek MJ, Hassan J, Hollingsworth J. Umbilical vein to artery ratio in fetuses with single umbilical artery. Ultrasound Obstet Gynecol 1996; 8:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/24\">",
"      De Catte L, Burrini D, Mares C, Waterschoot T. Single umbilical artery: analysis of Doppler flow indices and arterial diameters in normal and small-for-gestational age fetuses. Ultrasound Obstet Gynecol 1996; 8:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/25\">",
"      Sepulveda W, Bower S, Flack NJ, Fisk NM. Discordant iliac and femoral artery flow velocity waveforms in fetuses with single umbilical artery. Am J Obstet Gynecol 1994; 171:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/26\">",
"      Sepulveda W, Nicolaidis P, Bower S, et al. Common iliac artery flow velocity waveforms in fetuses with a single umbilical artery: a longitudinal study. Br J Obstet Gynaecol 1996; 103:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/27\">",
"      Dolkart LA, Reimers FT, Kuonen CA. Discordant umbilical arteries: ultrasonographic and Doppler analysis. Obstet Gynecol 1992; 79:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/28\">",
"      Sepulveda W, Flack NJ, Bower S, Fisk NM. The value of color Doppler ultrasound in the prenatal diagnosis of hypoplastic umbilical artery. Ultrasound Obstet Gynecol 1994; 4:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/29\">",
"      Petrikovsky B, Schneider E. Prenatal diagnosis and clinical significance of hypoplastic umbilical artery. Prenat Diagn 1996; 16:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/30\">",
"      Aoki S, Hata T, Ariyuki Y, et al. Antenatal diagnosis of aberrant umbilical vessels. Gynecol Obstet Invest 1997; 43:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/31\">",
"      Raio L, Ghezzi F, Di Naro E, et al. The clinical significance of antenatal detection of discordant umbilical arteries. Obstet Gynecol 1998; 91:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/32\">",
"      Sepulveda W, Reyes M, Gon&ccedil;alves LF. Two uncommon umbilical vessel anomalies in a fetus with trisomy 18. Prenat Diagn 1998; 18:1098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/33\">",
"      Nyberg DA, Mahony BS, Luthy D, Kapur R. Single umbilical artery. Prenatal detection of concurrent anomalies. J Ultrasound Med 1991; 10:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/34\">",
"      Altshuler G, Tsang RC, Ermocilla R. Single umbilical artery. Correlation of clinical status and umbilical cord histology. Am J Dis Child 1975; 129:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/35\">",
"      Benirschke K, Dodds JP. Angiomyxoma of the umbilical cord with atrophy of an umbilical artery. Obstet Gynecol 1967; 30:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/36\">",
"      P&eacute;rez-Cosio C, Sheiner E, Abramowicz JS. Four-vessel umbilical cord: not always a dire prognosis. J Ultrasound Med 2008; 27:1389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/37\">",
"      Murdoch DE. Umbilical-cord doubling. Report of a case. Obstet Gynecol 1966; 27:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/38\">",
"      Rodriguez MA. Four-vessel umbilical cord without congenital abnormalities. South Med J 1984; 77:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/39\">",
"      Painter D, Russell P. Four-vessel umbilical cord associated with multiple congenital anomalies. Obstet Gynecol 1977; 50:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/40\">",
"      Beck R, Naulty CM. A human umbilical cord with four arteries. Clin Pediatr (Phila) 1985; 24:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/41\">",
"      Gore RM, Filly RA, Parer JT. Sonographic antepartum diagnosis of conjoined twins. Its impact on obstetric management. JAMA 1982; 247:3351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/42\">",
"      Cohen HL, Shapiro ML, Haller JO, Schwartz D. The multivessel umbilical cord: an antenatal indicator of possible conjoined twinning. J Clin Ultrasound 1992; 20:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/43\">",
"      Ghosh A, Woo JS, MacHenry C, et al. Fetal loss from umbilical cord abnormalities--a difficult case for prevention. Eur J Obstet Gynecol Reprod Biol 1984; 18:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/44\">",
"      Clausen I. Umbilical cord anomalies and antenatal fetal deaths. Obstet Gynecol Surv 1989; 44:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/45\">",
"      Benirschke K. Obstetrically important lesions of the umbilical cord. J Reprod Med 1994; 39:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/46\">",
"      Heifetz SA. The umbilical cord: obstetrically important lesions. Clin Obstet Gynecol 1996; 39:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/47\">",
"      Konstantinova B. Malformations of the umbilical cord. Acta Genet Med Gemellol (Roma) 1977; 26:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/48\">",
"      Fortune DW, Ost&ouml;r AG. Umbilical artery aneurysm. Am J Obstet Gynecol 1978; 131:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/49\">",
"      Siddiqi TA, Bendon R, Schultz DM, Miodovnik M. Umbilical artery aneurysm: prenatal diagnosis and management. Obstet Gynecol 1992; 80:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/50\">",
"      Berg C, Geipel A, Germer U, et al. Prenatal diagnosis of umbilical cord aneurysm in a fetus with trisomy 18. Ultrasound Obstet Gynecol 2001; 17:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/51\">",
"      Sepulveda W, Corral E, Kottmann C, et al. Umbilical artery aneurysm: prenatal identification in three fetuses with trisomy 18. Ultrasound Obstet Gynecol 2003; 21:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/52\">",
"      Shen O, Reinus C, Baranov A, Rabinowitz RR. Prenatal diagnosis of umbilical artery aneurysm: a potentially lethal anomaly. J Ultrasound Med 2007; 26:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/53\">",
"      Sentilhes L, Vivet-Lef&eacute;bure A, Patrier S, et al. Umbilical artery aneurysm in a severe growth-restricted fetus with normal karyotype. Prenat Diagn 2007; 27:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/54\">",
"      Weber MA, Sau A, Maxwell DJ, et al. Third trimester intrauterine fetal death caused by arterial aneurysm of the umbilical cord. Pediatr Dev Pathol 2007; 10:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/55\">",
"      Hill AJ, Strong TH Jr, Elliott JP, Perlow JH. Umbilical artery aneurysm. Obstet Gynecol 2010; 116 Suppl 2:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/56\">",
"      Olog A, Thomas JT, Petersen S, et al. Large umbilical artery aneurysm with a live healthy baby delivered at 31 weeks. Fetal Diagn Ther 2011; 29:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/57\">",
"      Mahony BS, McGahan JP, Nyberg DA, Reisner DP. Varix of the fetal intra-abdominal umbilical vein: comparison with normal. J Ultrasound Med 1992; 11:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/58\">",
"      Fung TY, Leung TN, Leung TY, Lau TK. Fetal intra-abdominal umbilical vein varix: what is the clinical significance? Ultrasound Obstet Gynecol 2005; 25:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/59\">",
"      Byers BD, Goharkhay N, Mateus J, et al. Pregnancy outcome after ultrasound diagnosis of fetal intra-abdominal umbilical vein varix. Ultrasound Obstet Gynecol 2009; 33:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/60\">",
"      Zalel Y, Lehavi O, Heifetz S, et al. Varix of the fetal intra-abdominal umbilical vein: prenatal sonographic diagnosis and suggested in utero management. Ultrasound Obstet Gynecol 2000; 16:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/61\">",
"      Mankuta D, Nadjari M, Pomp G. Isolated fetal intra-abdominal umbilical vein varix: clinical importance and recommendations. J Ultrasound Med 2011; 30:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/62\">",
"      White SP, Kofinas A. Prenatal diagnosis and management of umbilical vein varix of the intra-amniotic portion of the umbilical vein. J Ultrasound Med 1994; 13:992.",
"     </a>",
"    </li>",
"    <li>",
"     Carpio RA, De Loredo R, Ochua G. Prenatal diagnosis of intramniotic umbilical vein varix (abstract). Ultrasound Obstet Gynecol 1999; 14:S55.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/64\">",
"      Rempen A. Sonographic first-trimester diagnosis of umbilical cord cyst. J Clin Ultrasound 1989; 17:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/65\">",
"      Skibo LK, Lyons EA, Levi CS. First-trimester umbilical cord cysts. Radiology 1992; 182:719.",
"     </a>",
"    </li>",
"    <li>",
"     Fox H, Sebire NJ. Pathology of the umbilical cord. In: Pathology of the placenta. Major problems in pathology, 3rd, WB Saunders, London 2007. p.473.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/67\">",
"      Heifetz SA, Rueda-Pedraza ME. Omphalomesenteric duct cysts of the umbilical cord. Pediatr Pathol 1983; 1:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/68\">",
"      Persutte WH, Lenke RR, Kropp K, Ghareeb C. Antenatal diagnosis of fetal patent urachus. J Ultrasound Med 1988; 7:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/69\">",
"      Chantler C, Baum JD, Wigglesworth JS, Scopes JW. Giant umbilical cord associated with a patent urachus and fused umbilical arteries. J Obstet Gynaecol Br Commonw 1969; 76:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/70\">",
"      Ente G, Penzer PH, Kenigsberg K. Giant umbilical cord associated with patent urachus. An external clue to internal anomaly. Am J Dis Child 1970; 120:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/71\">",
"      Nobuhara KK, Lukish JR, Hartman GE, Gilbert JC. The giant umbilical cord: an unusual presentation of a patent urachus. J Pediatr Surg 2004; 39:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/72\">",
"      Wildhaber BE, Antonelli E, Pfister RE. The giant umbilical cord. Arch Dis Child Fetal Neonatal Ed 2005; 90:F535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/73\">",
"      Schaefer IM, M&auml;nner J, Faber R, et al. Giant umbilical cord edema caused by retrograde micturition through an open patent urachus. Pediatr Dev Pathol 2010; 13:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/74\">",
"      Rosenberg JC, Chervenak FA, Walker BA, et al. Antenatal sonographic appearance of omphalomesenteric duct cyst. J Ultrasound Med 1986; 5:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/75\">",
"      McCalla CO, Lajinian S, DeSouza D, Rottem S. Natural history of antenatal omphalomesenteric duct cyst. J Ultrasound Med 1995; 14:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/76\">",
"      Donnenfeld AE, Mennuti MT, Templeton JM, Gabbe SG. Prenatal sonographic diagnosis of a vesico-allantoic abdominal wall defect. J Ultrasound Med 1989; 8:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/77\">",
"      Persutte WH, Lenke RR. Disappearing fetal umbilical cord masses. Are these findings suggestive of urachal anomalies? J Ultrasound Med 1990; 9:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/78\">",
"      Frazier HA, Guerrieri JP, Thomas RL, Christenson PJ. The detection of a patent urachus and allantoic cyst of the umbilical cord on prenatal ultrasonography. J Ultrasound Med 1992; 11:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/79\">",
"      Sepulveda W, Bower S, Dhillon HK, Fisk NM. Prenatal diagnosis of congenital patent urachus and allantoic cyst: the value of color flow imaging. J Ultrasound Med 1995; 14:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/80\">",
"      Tolaymat LL, Maher JE, Kleinman GE, et al. Persistent patent urachus with allantoic cyst: a case report. Ultrasound Obstet Gynecol 1997; 10:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/81\">",
"      Yoo SJ, Lee YH, Ryu HM, et al. Unusual fate of vesicoallantoic cyst with non-visualization of fetal urinary bladder in a case of patent urachus. Ultrasound Obstet Gynecol 1997; 9:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/82\">",
"      Fink IJ, Filly RA. Omphalocele associated with umbilical cord allantoic cyst: sonographic evaluation in utero. Radiology 1983; 149:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/83\">",
"      Bureau M, Bolduc S. Allantoic cysts and posterior urethral valves: a case report. Ultrasound Obstet Gynecol 2011; 38:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/84\">",
"      Battaglia C, Artini PG, D'Ambrogio G, Genazzani AR. Cord vessel compression by an expanding allantoic cyst: case report. Ultrasound Obstet Gynecol 1992; 2:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/85\">",
"      Ross JA, Jurkovic D, Zosmer N, et al. Umbilical cord cysts in early pregnancy. Obstet Gynecol 1997; 89:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/86\">",
"      Pal K, Ashri H, Al-Ghazal FA. Allantoic cyst and patent urachus. Indian J Pediatr 2009; 76:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/87\">",
"      Zimmer EZ, Bronshtein M. Fetal intra-abdominal cysts detected in the first and early second trimester by transvaginal sonography. J Clin Ultrasound 1991; 19:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/88\">",
"      Jauniaux E, Donner C, Thomas C, et al. Umbilical cord pseudocyst in trisomy 18. Prenat Diagn 1988; 8:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/89\">",
"      Sepulveda W, Pryde PG, Greb AE, et al. Prenatal diagnosis of umbilical cord pseudocyst. Ultrasound Obstet Gynecol 1994; 4:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/90\">",
"      Smith GN, Walker M, Johnston S, Ash K. The sonographic finding of persistent umbilical cord cystic masses is associated with lethal aneuploidy and/or congenital anomalies. Prenat Diagn 1996; 16:1141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/91\">",
"      Sepulveda W, Gutierrez J, Sanchez J, et al. Pseudocyst of the umbilical cord: prenatal sonographic appearance and clinical significance. Obstet Gynecol 1999; 93:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/92\">",
"      Iaccarino M, Baldi F, Persico O, Palagiano A. Ultrasonographic and pathologic study of mucoid degeneration of umbilical cord. J Clin Ultrasound 1986; 14:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/93\">",
"      Zangen R, Boldes R, Yaffe H, et al. Umbilical cord cysts in the second and third trimesters: significance and prenatal approach. Ultrasound Obstet Gynecol 2010; 36:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/94\">",
"      Brown R, Nicolaides K. Umbilical cord hematoma associated with an umbilical cord cyst and fetal death at 28 weeks of gestation. J Ultrasound Med 2000; 19:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/95\">",
"      Sepulveda W, Wong AE, Gonzalez R, et al. Fetal death due to umbilical cord hematoma: a rare complication of umbilical cord cyst. J Matern Fetal Neonatal Med 2005; 18:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/96\">",
"      Ghezzi F, Raio L, Di Naro E, et al. Single and multiple umbilical cord cysts in early gestation: two different entities. Ultrasound Obstet Gynecol 2003; 21:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/97\">",
"      Sepulveda W, Leible S, Ulloa A, et al. Clinical significance of first trimester umbilical cord cysts. J Ultrasound Med 1999; 18:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/98\">",
"      Sepulveda W, Rompel SM, Cafici D, et al. Megacystis associated with an umbilical cord cyst: a sonographic feature of a patent urachus in the first trimester. J Ultrasound Med 2010; 29:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/99\">",
"      Clausen I, Thomsen SG. Pseudotumors of the umbilical cord and fetal membranes. Acta Obstet Gynecol Scand 1992; 71:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/100\">",
"      Jauniaux E, Donner C, Simon P, et al. Pathologic aspects of the umbilical cord after percutaneous umbilical blood sampling. Obstet Gynecol 1989; 73:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/101\">",
"      Ghidini A, Romero R, Eisen RN, et al. Umbilical cord hemangioma. Prenatal identification and review of the literature. J Ultrasound Med 1990; 9:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/102\">",
"      Jauniaux E, Moscoso G, Chitty L, et al. An angiomyxoma involving the whole length of the umbilical cord. Prenatal diagnosis by ultrasonography. J Ultrasound Med 1990; 9:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/103\">",
"      Yavner DL, Redline RW. Angiomyxoma of the umbilical cord with massive cystic degeneration of Wharton's jelly. Arch Pathol Lab Med 1989; 113:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/104\">",
"      Wilson RD, Magee JF, Sorensen PH, Johnson A. In utero decompression of umbilical cord angiomyxoma followed by vaginal delivery. Am J Obstet Gynecol 1994; 171:1383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/105\">",
"      Miller KA, Gauderer MW. Hemangioma of the umbilical cord mimicking an omphalocele. J Pediatr Surg 1997; 32:810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/106\">",
"      Daniel-Spiegel E, Weiner E, Gimburg G, Shalev E. The association of umbilical cord hemangioma with fetal vascular birthmarks. Prenat Diagn 2005; 25:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/107\">",
"      KREYBERG L. A teratoma-like swelling in the umbilical cord possibly of acardius nature. J Pathol Bacteriol 1958; 75:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/108\">",
"      Smith D, Majmudar B. Teratoma of the umbilical cord. Hum Pathol 1985; 16:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/109\">",
"      Kreczy A, Alge A, Menardi G, et al. Teratoma of the umbilical cord. Case report with review of the literature. Arch Pathol Lab Med 1994; 118:934.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/110\">",
"      Satg&eacute; DC, Laumond MA, Desfarges F, Chenard MP. An umbilical cord teratoma in a 17-week-old fetus. Prenat Diagn 2001; 21:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/111\">",
"      Hargitai B, Csabai L, B&aacute;n Z, et al. Rare case of exomphalos complicated with umbilical cord teratoma in a fetus with trisomy 13. Fetal Diagn Ther 2005; 20:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/112\">",
"      El-Messidi A, Fung Kee Fung K. Umbilical cord hernia mimicking a cord teratoma. J Obstet Gynaecol Can 2009; 31:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/113\">",
"      Ahmed N, Kale V, Thakkar H, et al. Sonographic diagnosis of placental teratoma. J Clin Ultrasound 2004; 32:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/114\">",
"      Sepulveda W, Shennan AH, Bower S, Fisk NM. Discordant umbilical artery flow velocity waveforms in spontaneous umbilical cord hematoma. J Clin Ultrasound 1995; 23:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/115\">",
"      Kurata H, Sekizuka N, Kato R, et al. Intra-amniotic maternal hemorrhage in preterm labor: a case report. J Perinat Med 1995; 23:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/116\">",
"      Pretorius DH, Chau C, Poeltler DM, et al. Placental cord insertion visualization with prenatal ultrasonography. J Ultrasound Med 1996; 15:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/117\">",
"      Di Salvo DN, Benson CB, Laing FC, et al. Sonographic evaluation of the placental cord insertion site. AJR Am J Roentgenol 1998; 170:1295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/118\">",
"      Sepulveda W, Rojas I, Robert JA, et al. Prenatal detection of velamentous insertion of the umbilical cord: a prospective color Doppler ultrasound study. Ultrasound Obstet Gynecol 2003; 21:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/119\">",
"      Sebire NJ. Pathophysiological significance of abnormal umbilical cord coiling index. Ultrasound Obstet Gynecol 2007; 30:804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/120\">",
"      Qin Y, Lau TK, Rogers MS. Second-trimester ultrasonographic assessment of the umbilical coiling index. Ultrasound Obstet Gynecol 2002; 20:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/121\">",
"      De Laat MW, Franx A, Nikkels PG, Visser GH. Prenatal ultrasonographic prediction of the umbilical coiling index at birth and adverse pregnancy outcome. Ultrasound Obstet Gynecol 2006; 28:704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/122\">",
"      Predanic M, Perni SC, Chasen ST, et al. Ultrasound evaluation of abnormal umbilical cord coiling in second trimester of gestation in association with adverse pregnancy outcome. Am J Obstet Gynecol 2005; 193:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/123\">",
"      Degani S, Leibovich Z, Shapiro I, et al. Early second-trimester low umbilical coiling index predicts small-for-gestational-age fetuses. J Ultrasound Med 2001; 20:1183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/124\">",
"      Raio L, Ghezzi F, Di Naro E, et al. Sonographic measurement of the umbilical cord and fetal anthropometric parameters. Eur J Obstet Gynecol Reprod Biol 1999; 83:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/125\">",
"      Ram&oacute;n Y Cajal CL, Mart&iacute;nez RO. Prenatal diagnosis of true knot of the umbilical cord. Ultrasound Obstet Gynecol 2004; 23:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/126\">",
"      Gembruch U, Baschat AA. True knot of the umbilical cord: transient constrictive effect to umbilical venous blood flow demonstrated by Doppler sonography. Ultrasound Obstet Gynecol 1996; 8:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/127\">",
"      Sepulveda W, Shennan AH, Bower S, et al. True knot of the umbilical cord: a difficult prenatal ultrasonographic diagnosis. Ultrasound Obstet Gynecol 1995; 5:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/128\">",
"      Collins JH. First report: prenatal diagnosis of a true knot. Am J Obstet Gynecol 1991; 165:1898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/129\">",
"      Hasbun J, Alcalde JL, Sepulveda W. Three-dimensional power Doppler sonography in the prenatal diagnosis of a true knot of the umbilical cord: value and limitations. J Ultrasound Med 2007; 26:1215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/36/27210/abstract/130\">",
"      Hertzberg BS, Bowie JD, Bradford WD, Bolick D. False knot of the umbilical cord: sonographic appearance and differential diagnosis. J Clin Ultrasound 1988; 16:599.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16277 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-3E1552308A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_36_27210=[""].join("\n");
var outline_f26_36_27210=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H4234534\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22646013\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22646020\">",
"      NORMAL ULTRASOUND ANATOMY OF THE UMBILICAL CORD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17297905\">",
"      First trimester",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17297912\">",
"      Second and third trimesters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22646034\">",
"      VASCULAR ANOMALIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22646042\">",
"      Single umbilical artery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22646064\">",
"      - Prenatal diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22646078\">",
"      Hypoplasia or atrophy of one umbilical artery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22646107\">",
"      - Prenatal diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22646114\">",
"      - Clinical significance",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22646121\">",
"      - Management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22646128\">",
"      Supernumerary vessels",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22646172\">",
"      Aneurysm and varix",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22646209\">",
"      CYSTIC LESIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22646246\">",
"      True cysts",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22646268\">",
"      - Prenatal diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22646275\">",
"      - Management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22646282\">",
"      Pseudocysts",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22646304\">",
"      - Prenatal diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22646311\">",
"      - Management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22646318\">",
"      First-trimester umbilical cord cyst",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22646339\">",
"      - Prenatal diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3387075\">",
"      - Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22646353\">",
"      SOLID OR COMPLEX MASSES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22646375\">",
"      Angiomyxoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22646391\">",
"      - Prenatal diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22646405\">",
"      - Management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22646412\">",
"      Teratoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22646449\">",
"      Hematoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23682636\">",
"      ABNORMAL CORD INSERTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17298002\">",
"      ABNORMAL COILING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23682751\">",
"      INADEQUATE WHARTON'S JELLY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13962068\">",
"      KNOTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13963121\">",
"      True knot",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13963194\">",
"      False knot",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8621905\">",
"      OTHER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4234534\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/16277\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/16277|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?31/41/32401\" title=\"diagnostic image 1\">",
"      First trimester ultrasound image of umbilical cord",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?33/11/33974\" title=\"diagnostic image 2\">",
"      Prenatal ultrasound images of normal three vessel umbilical cord",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?0/28/455\" title=\"diagnostic image 3\">",
"      Prenatal ultrasound images of single umbilical artery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?19/22/19810\" title=\"diagnostic image 4\">",
"      Prenatal ultrasound of SUA in hypercoiled cord",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?33/18/34089\" title=\"diagnostic image 5\">",
"      Fused umbilical arteries",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?3/41/3734\" title=\"diagnostic image 6\">",
"      Color Doppler of intraabdominal single umbilical artery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?31/58/32674\" title=\"diagnostic image 7\">",
"      Prenatal ultrasound image of hypoplastic umbilical artery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?22/63/23537\" title=\"diagnostic image 8\">",
"      Prenatal ultrasound image of multivessel umbilical cord",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?24/8/24710\" title=\"diagnostic image 9\">",
"      Prenatal ultrasound image of umbilical artery aneurysm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?36/59/37810\" title=\"diagnostic image 10\">",
"      Prenatal ultrasound image of allantoic cyst and patent urachus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?11/1/11285\" title=\"diagnostic image 11\">",
"      Prenatal ultrasound image of umbilical cord pseudocyst",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?29/35/30259\" title=\"diagnostic image 12\">",
"      Prenltrasound image of umbilical cord pseudocyst and angiomyxoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?31/22/32102\" title=\"diagnostic image 13\">",
"      Prenatal ultrasound image of first trimester umbilical cord cyst",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?22/21/22869\" title=\"diagnostic image 14\">",
"      Prenatal ultrasound image of umbilical cord angiomyxoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?1/63/2038\" title=\"diagnostic image 15\">",
"      Prenatal ultrasound images of umbilical cord insertion sites",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/16277|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/48/40712\" title=\"figure 1\">",
"      Placental vasculature",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/43/15032\" title=\"figure 2\">",
"      Fetal circulation 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?35/56/36738\" title=\"figure 3\">",
"      Umbilical vein to umbilical artery ratio with SUA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/63/38902\" title=\"figure 4\">",
"      Schematic of allantoic cyst",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/16277|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/57/43927\" title=\"picture 1\">",
"      Umbilical artery aneurysm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/6/5223\" title=\"picture 2\">",
"      Umbilical vein varix",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/57/24479\" title=\"picture 3\">",
"      Umbilical cord cyst",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/3/62\" title=\"picture 4\">",
"      Allantoic cyst",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/10/165?source=related_link\">",
"      Diagnosis and management of twin reversed arterial perfusion (TRAP) sequence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/31/11768?source=related_link\">",
"      Fetal blood sampling",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/56/40840?source=related_link\">",
"      Gross examination of the placenta",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/46/27370?source=related_link\">",
"      Histopathology of placental disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/13/25815?source=related_link\">",
"      Nuchal cords",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/21/6488?source=related_link\">",
"      Obstetrical and neonatal management of body stalk anomalies and cloacal abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/28/34247?source=related_link\">",
"      Prenatal sonographic diagnosis of fetal abdominal wall defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/14/8423?source=related_link\">",
"      Single umbilical artery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/46/40682?source=related_link\">",
"      Twin pregnancy: Prenatal issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/51/29494?source=related_link\">",
"      Umbilical cord prolapse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/18/20775?source=related_link\">",
"      Velamentous umbilical cord insertion and vasa previa",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_36_27211="Analgesic routes admin";
var content_f26_36_27211=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F80298&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F80298&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Routes of administration",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Route",
"      </td>",
"      <td class=\"subtitle1\">",
"       Comments",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Oral (PO)",
"      </td>",
"      <td>",
"       Requires functioning GI tract",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Rectal (PR)",
"      </td>",
"      <td>",
"       Absorption may be unpredictable",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Intramuscular (IM)",
"      </td>",
"      <td>",
"       Not recommended due to painful injections and fluctuations in drug levels",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Intravenous (IV)",
"      </td>",
"      <td>",
"       Single, repetitive bolus, continuous infusion, or patient-controlled analgesia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Subcutaneous (SC)",
"      </td>",
"      <td>",
"       Single, repetitive bolus, continuous infusion, or patient-controlled analgesia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Transdermal (TD)",
"      </td>",
"      <td>",
"       Noninvasive; delayed onset of action with first dose",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Oral transmucosal (OT)",
"      </td>",
"      <td>",
"       Includes sublingual and several rapid onset formulations",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Epidural analgesia (EA)",
"      </td>",
"      <td>",
"       Indwelling catheter is tunneled under the skin and left percutaneous or connected to a port",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Intrathecal analgesia (IA)",
"      </td>",
"      <td>",
"       An indwelling intrathecal catheter is placed for long-term analgesia",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_36_27211=[""].join("\n");
var outline_f26_36_27211=null;
var title_f26_36_27212="Pediatric systemic inflammatory response syndrome criteria";
var content_f26_36_27212=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F86087&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F86087&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Pediatric systemic inflammatory response syndrome criteria",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"6\" width=\"16%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Age group",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Heart rate (beats/min)",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Respiratory rate (breaths/min)",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Leukocyte count (leukocytes x 10",
"        <sup>",
"         3",
"        </sup>",
"        /mm",
"        <sup>",
"         3",
"        </sup>",
"        )",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Systolic blood pressure (mmHg)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Tachycardia",
"       </td>",
"       <td class=\"subtitle2\">",
"        Bradycardia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Newborn (0 days to 1 wk)",
"       </td>",
"       <td>",
"        &gt;180",
"       </td>",
"       <td>",
"        &lt;100",
"       </td>",
"       <td>",
"        &gt;50",
"       </td>",
"       <td>",
"        &gt;34",
"       </td>",
"       <td>",
"        &lt;59",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neonate (1 wk to 1 mo)",
"       </td>",
"       <td>",
"        &gt;180",
"       </td>",
"       <td>",
"        &lt;100",
"       </td>",
"       <td>",
"        &gt;40",
"       </td>",
"       <td>",
"        &gt;19.5 or &lt;5",
"       </td>",
"       <td>",
"        &lt;79",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infant&nbsp; (1 mo to 1 yr)",
"       </td>",
"       <td>",
"        &gt;180",
"       </td>",
"       <td>",
"        &lt;90",
"       </td>",
"       <td>",
"        &gt;34",
"       </td>",
"       <td>",
"        &gt;17.5 or &lt;5",
"       </td>",
"       <td>",
"        &lt;75",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Toddler and preschool (&gt;1 to 5 yrs)",
"       </td>",
"       <td>",
"        &gt;140",
"       </td>",
"       <td>",
"        NA",
"       </td>",
"       <td>",
"        &gt;22",
"       </td>",
"       <td>",
"        &gt;15.5 or &lt;6",
"       </td>",
"       <td>",
"        &lt;74",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        School age (&gt;5 to 12 yrs)",
"       </td>",
"       <td>",
"        &gt;130",
"       </td>",
"       <td>",
"        NA",
"       </td>",
"       <td>",
"        &gt;18",
"       </td>",
"       <td>",
"        &gt;13.5 or &lt;4.5",
"       </td>",
"       <td>",
"        &lt;83",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Adolescent (&gt;12 to &lt;18 yrs)",
"       </td>",
"       <td>",
"        &gt;110",
"       </td>",
"       <td>",
"        NA",
"       </td>",
"       <td>",
"        &gt;14",
"       </td>",
"       <td>",
"        &gt;11 or &lt;4.5",
"       </td>",
"       <td>",
"        &lt;90",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     NA: not applicable.",
"    </div>",
"    <div class=\"reference\">",
"     Originally published in: Goldstein B, Giroir B, Randolph A, et al. International pediatric spesis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6:2. Correction published in: Gebara BM. Values for systolic blood pressure. Pediatr Crit Care Med 2005; 6:500. Copyright &copy; 2005 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_36_27212=[""].join("\n");
var outline_f26_36_27212=null;
var title_f26_36_27213="Gamma knife LINAC radiosu";
var content_f26_36_27213=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F72944&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F72944&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 498px\">",
"   <div class=\"ttl\">",
"    The use of multiple, overlapping isocenters in Gamma Knife and LINAC radiosurgery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 478px; height: 271px; background-image: url(data:image/gif;base64,R0lGODlh3gEPAcQAAP///39/f4CAgJ+fnw8PDz8/P+/v77+/vxAQEAAAAC8vL8DAwPDw8B8fH9/f309PT6CgoG9vb19fX4+Pj9DQ0M/Pz2BgYDAwMCAgIODg4JCQkEBAQLCwsK+vr1BQUHBwcCH5BAAAAAAALAAAAADeAQ8BAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaanqKmqq6w/FAsLGgKztAIasBSturs/sR8bCAkEBQUPAcfIAQ/EBAkIGx+3vNPUKwwcHxcJDcYHFTEVB8oNCRcfHAzV6rsZGhsJChEdBjsGHREKCRsaGev+pQw0aHswwMEQBwMelNOQ7p/DTQssJCgwgB4SAwMKJLCw4KFHShAwEIhg0ImDCAQw/0D4yJJRyAYDqgxooLKlTUIvY2KZWfNmkAywatGC1c8nkwUYYHbh2dEoDgoaLLwbViBCsgARmOmzoCGX0yEZNhCYEGYCgQ1Fv8LgYAFBAwkTDlhkcWCChAYILHBQ60MAAglzwRiQgEAAXxYRESiY8M1GhQkK8jY9XIPChQYHzhxocMErZRIvA5Tc4SAAzZWfY2hIECGwmQgJNKQGEJLikIw9Z6tgsAFzm80bGqpFqiCzkQMKMEzWXYICggeu1Rh4gMCzTwYeCOhMMoCAB+HMaScgK2dCAtQ3OSBo3cRABAR7w1sg0HhOBQIWbDKYb/zJAfzgHcabAqPR4YACwX2Uwf8FBUTXXgEXpMUXAxdAl8d0FwSojnMRXPGedU5RgIEEfRAGIjXqbWfFAPCp5RyJfpi4DgTabdEdejc5F0AgAVRXDQf0dXFffDY5p+IfLJ64ipFfJFkkAjsSMoGPumSAwJFcsCihQwyMeIgEGGh4CoUdihFBhh5RCOOXaK5iQQFlFJDfQxs8sMgDG6wCpINeGEAAketYoACfgxigwJxjItAfGQcgIOYuGhBAKCF+ynaKB2WeEYEH6yyQQH2M3LecKAtImoafo+rCwJWRsPhoJxhgWcYAGFRzwZqQSHABKRAo0IYCOLYigK+UKGCYKBgsmsYBte5SKqiRiBoKBHC6UUD/sKl0KSsktL56Saxv0KqLB3Zi8gCnnizQQBwNpGrKnpn4CagmFkT5RgCIorJqB5t04GgnCBTYhgMIrPJBuZs88AEnHBAbhwLzklKqwJg4QIC7lFhAXhwT5FvKBRtzMsGumiAArRsVFHxKr6EAG8kCENACQUcUrEtHA7nALDPGlqyqLCeNejsIBB7AY8wxD+TD4KRqQGg0Mkkn4AEEQj8iAMKgPHBsIhogQJGDGBUwFsfDVHRC2AhYakkGCVDciQMJbDnIgsW1gByBAytQN10KRGiJBbiGIoHHgnAYQwBBqnFfpi70qGQjGRDgticWy/0HkzJ0d/IY9227gpOS1HsK/76EWOk5C91N/oXFp3+OgOWKRM40J37CvscF9tIQgMNkKJD7DAGQ/IjoqJAeiAa817BYGZDloIDajLCtOihw236Hzzn8R4afP8/Q6CMfBG6KBAv/Qe0OtomREfrYHrLq9KEQXPUcHrQOQ0JjELTDAOguokG1qygA9PaQgNm9wAAJGEMB65FARiSrFR1oFh8WkDwc7O0LyOmBAngmCHXtol19gADWcvCAkC1lhDh4wAANobFddKwPAvgdDo4RBhryIABbc98CdYHA+b0hhj2w4ReEqAMcKkIDKFyFCvkAxBtK4ADwW4IDDiCOqxRAhjcwYiIuwC9edEB4eRBhD5Imtv+JwGVzRXiMBDRCFaskQwJJtMED2lc4AlSDAI+bAwU12J+63IUAEugiETogAQK8JS6EyiAPNpiIDzBuFxEonx52mAMEouAxCgBk97JXyMWg8QSUxIElE4GBT6qiAhLMQ/32F8cRlKYBStkfLEUjA/3pgH+JqNk6cLaH8+kgfagrQCxtMBNgZg6AOLhWIx/Ji0jyQVHZsyMMkOMb7zXggjUgwCZj8L0tbpMVBwAjHpDnPBO6oDsWOuADapSD5llwhXOT5joIYL04cCABWITB7mrgHgIIcgUdGIkBX+C7LIqzEBoQ3zQkAE857Ec77JxB6m7wH8CoYDDa9AHraqAlRaz/0h+4vMOCGgSAzkk0cTcwQAHwdoIDkfQHJs0clRIRymqMsg6GG8F98pkCxJlSBig52eKGsNPDnWcRe3QII+mQIhMcCJspuFsUM+dPEgTUfjl46jdHcLcpRYwQAmBmNSKQQzjQyHNm+drZMjI2IHRHJ29FQlrNZoKwtfVGidjAP9fRgTzJAUg/BUBCnoa0fNhSCPfpQEAD+4PBKuBoyjDskYaEiJqq46ZvwJwLDjAAZAxgqz3oTkSZwFnPbhN0hEjqQ5bqBtOBYaNg6CghNCBWdUSgoWcgk2DiMYYz+dAOH31ISNvwpjCsMU6E80MpP4JKN8DrCwEd6BXkJQgGNPAj/wn4bRew9wXuaeZfgFgAMh9SAA6KAVNheEBtw7CpQIS1JWRdQ6mkG4X/0DcLqAJEC1nyQjWACwzDRIO4/rAB0E7jAH5FA8tiW8EzuMwPlv0HZs3wQAAbGAzM8oN1b0IA7WLBl00ab9PoWAfx3qS8aPjvFwK8hgH3spX+mOMZPIhhm70BhHtoYku0WAbifUECPEWD8fSw35b0twwBC4Pk4kAwPhT4Jgg2Q8PC0IEGswFie3iyTaLcY3NuAS5zODIermsTMovBZEpmrBlSRkCjmBkMugRDBWwsB17m4c3YLUNCy6JQNzA0Dyb2CYrHUGQvgJkOYi6xiD8yaDFo+QsFuP+wZhL8BQR4oCszCPSJzZsFPG/B028AdacTQGoMWAAC9SSBpm3SaDBELgwWuwM9XyCUWtv61rjOtVBIzWtem+OrJaCtUW47hlV34QCLhkOrV6DrZjv72b3u9QYEkMcR6NgmPAaDsbmA7Dssmwu9/jUMrr3jsnrhvWDAyh3iCwZTo3oG5GZJtr8Q7y0QcQ7znkO9PZLvLuw7C/eWQ7/j8G+HDHwLBb9CwONw8B8G+R8Nz0LCrbBwOES8DRNfx8WvkHEqVPxe5pZDx6uxcSuge4jrdQO77TByapS8CtveQrft8G2RP9wfL6dCzLUw8zrUPA7C9gmxxfDq18qTDrO+w87/yctpLERYC093g6jfsHSH/JwLj/ZCpOsQTkAnm+lkKHQXDh3m5Mqh6v+4+hb2DAa71OHPeNiwT6auhTh/Yc51sPOY3WwGNIMBpXBg8yT53mXjepkNibZD1j/CZTJMGQxVngOW9bB4jzSeDEn++1TJ0OQ9iN0jiQ+Djw198zIMOQ8t30XOr0BjDNK5DTjWgxhtIuMzqNgLLFaDi/WAdnWo3Qsg9sL6rEViOsi9JdlNQ4VXbJwpVvEqVNw8FDIM4fuyYsJlWLAXKvCABrCRGG5ERlbKWIAzZuHBfaj8Py5ve6w+gZCGhItcNmuXBgByr1DYPR8+/4/Qk2G+WHAAncQY/zeASZoUBfn1ByfnESuXBuglE7MkfS7wSrmXBO0VXl/ne033BdwVBcXkfhwlTCDYA0ETCMfnEcnHBs/lBJsBVUJATZKmA9QlCMvlEc3lBsXVHus0gvtDAOkkg1R0FQEQF3JCCMHlEMPFBrq1BAHFHkzQT/gHA/aQFaRGDED2RsTgDNCADn8QdA8xdK3FKhdRSDEYBBV1Xw4AGRMRAB0wVQ7QAQGgERfADxNkZWPlARsoBppFBC5lfUGgUiy1AhiRSYHkhyJgD4V0AVQzSYZoCp11Gm8AWGk0Eh4CeHWFOApAV5U0AJEhAB52BnrVEjxRfGRwVjJQWsfwWSpwVVnQHf9RaACIs3VAgGyF8YlksIAfMRMXkIde0FQt4FiQFTUE4RpxpQXFOALdIYtDQIukqAaqhW0E8AG2mAU5lQJzBTZstTGLJSRVBQAOIExRKAQd0ABoQQdR5xDfqBxsMFIOolV2ozcOEFNLQR/d4YRJ4B4I0IxncIQ3YRYhVwYPpSxDpU8EMFpdYB4ZxYIAAnR9xhJz9h0quB4WIY/3Y4lb0IcICCGpRgZF9xUq1SZqgB3aAVsnJYFOcB8NyQQy8gYXUIbroCvVVmwYgE9ZZIdUcB+H9wSoxQaORBkruQbkZEE5KQUUKRMztQZ2xxeEMY1X0IE2oD1ZUJQrcpT+pWYeoSv/TFkFwXcDxnSTBrkTVIkGPfkZuqIG/EhMMNYevOUFvsUGFHB0h3EoaXCOMYB9UVAM6UVpacBFqeEn+qgFz+g8LjkEu9OIT2gsbIBEs9EoMbkFs7cDJUQF/2GVXsmLW2BdhqkOwWMGqccCH6cEBtAAQ7kFExAma8B/aoGYt1h6+sSaRZAVZ1AAkoQGrfcZKbORHOeajaObiLVkZmAxjfkFGBCOX3GBYvCYOnBYT3BFaRAAemkG/6MbCRgGgWlBg+kD45iZUhCawCYG76MbE/CcXkCXUkh3RlCBZKB/ZhA+zBF7YHCWHJWWRjATsPeXXCA9ujEA4skFW2kDXckEmdgG/wNwUD3Gmx7hJ8FpBdCEA1DpH6+nBu5pBrKjG6f3BUF5A8sDBUB2L2ZHaAb6EPIzBrhTkwjYNm8AN1lJBZFjkh5Re2HgWjQwUVAwAfJZBkukBoCTn/0TBnv4ApojBQEKBwO6BvjZlymoh1ByOBbJBHCjnfgVN2twNbrhokR3AS54AlI1BfgjB1SaWwv6Gf5noV6jiSRgV6OpBMoZLjuKBhdKGZ13BkRDWJGVAGkqBb7JZCqzBiAzG3gkXzGzARRxnWn0oDeWoF4wManRpWnQmdxRo2igqGdwMKkRALOpBoyKBFZRB5TaBvvyGey3qB+KBMooB5+KBiuoFm8apSkXBf93Kgepugbk8hnmSZ0ZGAWzOpdvoC2UwVrOWKv+YZO/YpmHuqSb1gYdeQU9Rwe/VwbDchgF0J1lQJ5N0AG+ugbPGge3wher1wXqJwWf2QbbyoFi6BThugWoGQXfygblOqyUSXL/CJ0p+QTpugbr6gWR4qSpUK9YkJRVMK9qoK9dICj4Ojrv2nftegT+2pwFuwZ1YhQAewXnKq+hOgYPywVq4hMVWwWPR3ETKwYZe5lewmrQ2ncsWgTU6m0j65YIcKbUsKxh17FmWK1NI6xm0KNKRbNdUJtToEh1wKs4laR5Fge3NwW3igZFi5R/4RGv2gb9yaolKwZLawcv8hClygb/yzcFoxoHVVsHFPKDmlmpbqB9U5CpdLCpfTAgTysKkNoGQ5t/jnoGa4sH83Gwo9CnemQqU4B3N2OocrAaLGsKgkcHDzgFrXqieQoIzuG1rRCmnPqlUVCnArqmf8Ab1aQLcetceOuBb0sGl8sHq7Gqo9BDciuzRdCkcYBAuJkHllG5qZCEXHsBoHsEQRouBDoIfmFRqaBMeQCjM7q56YVbghAWbWUKIaoHNrsECJS2WoCijYAU6OkJFYoHkqihMIsF0asIORG6dssHpuigN4azfpC9oKCfgOCLTjC7ule7jRASI6G8iBChfFCNTECfbNAA9okIETERZFoEGLEM9ogG/+E5N0vjBM+rPqnUMwJBpwVxEIM1h6dqBtNpgvwxrQ0wsE7AnZ3QDu8QD/NQD/eQD/uQFoOrKZIbCOrxv6Javei6n5lwDdmwDd3QruEwDuVwDhpiJXRbBbeJCCLJgzqAEu4LBcBpCr4ADMJADJCVDMtQRs8QDZzWrA62sOGFAVc6i8nhAaSLBbLZCq8QC7Z2CwvAtyMwoqanvoVQGz4cA7ixEl3yt1dQminqEM4hqP4RltibFLTEA6+UGwDwLJxzMeEBGpnbXQRwv4OQGJ5UgJAhGScwLBbMv6oZyCMgKGIgl5bAFm4hfy/gR3ihFyvQsGCAJ5JsAtn6Y2YcCVBhAf/a0EZXMX7NsAFckaBL2AVtOcokcLFjB5IZHBS1RhQ0cLxTKcYCkrRf9jpfAcxaase2DABTmwU/GSLjGszLnAKWEa9NACbCvA7I7AQ7Oc0mQCEvtZ0QEsfT0MxT8MzefALY0QA57AMPSc7UwI4Z6TfpzAICMLxN4I+BHJD+sZD13AJIUQBBTAPpCL4sAQESibzvYcj1zAAfQAAqrKTSOM1h0QDECQTjWI7/LAMLcBlpLFGcYdBGgdBZO4sFkI8bbQPi61aQmNIM4BclvQO06IkpjQOhMdCuZBp8XNMvrRj7awODWIs1vQP5uxjKm4b5wBFDrc4QcAH314iISACKCM+hSz0CDEA0mayKdjMAd2Fpi1jVKdAO2nBFbdgCbxiHC5G6YJ1pAuABM+l9V2RFwpQAGOABAiDS/+zC7zAR5XcVa6QR+mDDa50ErxAzQjEz2TzYJcAAvCwUsEDVih3Zkj3ZlF3Zln3ZmJ3Zmr3ZnN3Znv3ZoB3aoj3apF3apn3aqJ3aqr3arN3arv3asB3bsj3btF3btn3buJ3bur3bvE0ZIQAAOw==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Overlapping multiple isocenters of different sizes (left) allows for conformal radiation of irregularly shaped lesions (right). However, this is achieved at the expense of dose homogeneity.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_36_27213=[""].join("\n");
var outline_f26_36_27213=null;
var title_f26_36_27214="Contents: Pediatric hepatology";
var content_f26_36_27214=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?1/34/1568\">",
"       Family Medicine and General Practice",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Pediatric hepatology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Pediatric hepatology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Biliary tract disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/63/39929\">",
"           Biliary atresia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/47/9977\">",
"           Biliary cysts",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/53/2902\">",
"           Caroli disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/3/20536\">",
"           ERCP for biliary disease in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Disorders of bilirubin metabolism",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/18/27943\">",
"           Bilirubin metabolism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/57/7065\">",
"           Classification and causes of jaundice or asymptomatic hyperbilirubinemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/45/13018\">",
"           Clinical manifestations, diagnosis, and natural history of Wilson disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/3/6201\">",
"           Crigler-Najjar syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/50/42790\">",
"           Diagnostic approach to the patient with jaundice or asymptomatic hyperbilirubinemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/37/13910\">",
"           Epidemiology and pathogenesis of Wilson disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/35/17975\">",
"           Evaluation of jaundice caused by unconjugated hyperbilirubinemia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/23/42359\">",
"           Gilbert's syndrome and unconjugated hyperbilirubinemia due to bilirubin overproduction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/3/39992\">",
"           Pathogenesis and etiology of unconjugated hyperbilirubinemia in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/48/14088\">",
"           Tests used in the diagnosis of Wilson disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/11/23737\">",
"           Treatment of Wilson disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Evaluation",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/60/24519\">",
"           Approach to neonatal cholestasis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/18/34090\">",
"           Approach to the patient with abnormal liver biochemical and function tests",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/50/16169\">",
"           Causes of neonatal cholestasis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/50/42790\">",
"           Diagnostic approach to the patient with jaundice or asymptomatic hyperbilirubinemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/57/19353\">",
"           Enzymatic measures of cholestasis (eg, alkaline phosphatase, 5-nucleotidase, gamma-glutamyl transpeptidase)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/35/17975\">",
"           Evaluation of jaundice caused by unconjugated hyperbilirubinemia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/63/21494\">",
"           Liver biochemical tests that detect injury to hepatocytes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/61/43989\">",
"           Transient hyperphosphatasemia of infancy and early childhood",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hepatitis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/63/37881\">",
"           Hepatitis viruses and the newborn: Clinical manifestations and treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/51/13114\">",
"           Management of acetaminophen (paracetamol) poisoning in children and adolescents",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hepatitis A virus",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/38/1641\">",
"           Hepatitis A virus vaccination and postexposure prophylaxis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/58/16295\">",
"           Overview of hepatitis A virus infection in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hepatitis B virus",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/35/21045\">",
"           Characteristics of the hepatitis B virus and pathogenesis of infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/31/4602\">",
"           Epidemiology, transmission, and prevention of hepatitis B virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/60/31690\">",
"           Hepatitis B virus vaccination",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/41/31386\">",
"           Overview of hepatitis B virus infection in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hepatitis C virus",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/5/29780\">",
"           Characteristics of the hepatitis C virus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/2/6186\">",
"           Hepatitis C virus infection in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/19/26936\">",
"           Vertical transmission of hepatitis C virus",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Liver failure",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/55/22394\">",
"           Acute liver failure in children: Etiology and evaluation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/39/6777\">",
"           Acute liver failure in children: Management",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Metabolic disease of the liver",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/4/23624\">",
"           Disorders of tyrosine metabolism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/18/18730\">",
"           Parenteral nutrition-associated liver disease in infants",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-3CDC2339E0-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f26_36_27214=[""].join("\n");
var outline_f26_36_27214=null;
var title_f26_36_27215="Endotracheal tube hockey stick";
var content_f26_36_27215=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F53547&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F53547&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Hockey stick configuration for endotracheal tube versus gentle curve",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 246px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bending the styletted endotracheal tube into a hockey stick configuration as opposed to a gentle curve allows for the tube to be directed anteriorly through the glottis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Joshua Nagler, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_36_27215=[""].join("\n");
var outline_f26_36_27215=null;
      